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I 
 
ABSTRACT 
 
Malnutrition describes any nutritional imbalance, including undernutrition, 
overnutrition and the ‘dual burden’ of excess calorific intake combined with an 
insufficient intake of micronutrients. Malnutrition can be caused by a poor diet and/or 
by medical conditions that affect nutrient assimilation. In developing but also in 
industrialised countries, malnutrition often goes hand in hand with hunger, but 
increasingly results from the consumption of inexpensive, calorie-rich but nutrient-
poor diets. Such diets reflect developments in agriculture and food processing 
technology that reduce the micronutrient content of foods, contributing to both 
malnutrition and obesity, and exacerbating many chronic diseases including 
cardiovascular disease, diabetes and cancer. Plants provide a good source of vitamins 
and minerals but these micronutrients are present at insufficient levels in staple cereal 
crops such as corn and rice. For example, cereal grains do not produce high levels of 
carotenoids, which confer health-promoting antioxidant activity and in some cases 
(provitamin-A carotenoids) act as essential nutrients. Biofortification by genetic 
engineering is a cost-effective strategy to improve the nutrient content of crops, but 
their development requires a mandatory risk assessment as an integral component of 
approval process prior to commercialization. The safety of a carotenoid-enriched 
engineered corn variety (High-carotenoid corn) produced by the Applied Plant 
Biotechnology group at Lleida University was therefore evaluated in a 90-day 
subchronic toxicity study in mice. This showed no evidence of toxicity compared to 
mice fed on control diet (based on near-isogenic unmodified M37W corn). Having 
established safety, diets based on the engineered corn were fed to a mouse cancer 
model associated with induced colitis, a mouse obesity and insulin resistance model 
developed by initial feeding on a high-fat diet, and finally a heterozygous phosphatase 
and tensin homolog knockout mouse line (PTEN+/-) as a model of multiple-organ 
neoplasia and liver disease. These experiments showed that the carotenoid-enriched 
corn variety was chemopreventive and also induced promising health-promoting 
effects on risk parameters related to metabolic syndrome and insulin sensitivity. 
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RESUM 
 
El terme malnutrició s’aplica a qualsevol condició de nutrició desequilibrada, ja sigui 
per una alimentació deficitària, per sobrealimentació o per una doble vessant 
d’ambdues: una ingesta calòrica excessiva combinada amb una ingesta insuficient de 
micronutrients. La malnutrició pot ser causada per una dieta pobra i/o per estats 
patològics que afectin la correcta assimilació dels nutrients. En països en vies de 
desenvolupament però també en països industrialitzats, la malnutrició sovint va de la 
mà amb la fam, i cada cop més, acompanyada d’un augment del consum de dietes 
riques en calories de baix cost i pobres en nutrients. Aquestes dietes són reflex del 
progrés en l’agricultura i en les tecnologies de processament d’aliments que 
contribueixen a reduir els continguts de micronutrients dels aliments, cosa que 
afavoreix tan a la malnutrició com a l’obesitat, i agreuja diverses malalties cròniques 
com les malalties cardiovasculars, diabetis i càncer. Les plantes són una font important 
de vitamines i minerals, però aquests micronutrients es troben en nivells insuficients 
en cultius bàsics de cereal com el panís o l’arròs. Per exemple, les llavors d’aquests 
cereals no produeixen nivells alts de carotens, els quals en alguns casos intervenen en 
la promoció de la salut pel seu efecte antioxidant, i en altres casos (com és el cas dels 
carotens provitamina A) actuen com a micronutrients essencials. La biofortificació a 
través de l’enginyeria genètica és una estratègia cost-efectiva per millorar el contingut 
nutricional del panís; no obstant això, la seva elaboració requereix d'una avaluació de 
riscs obligatòria com a component integral del procés d'aprovació prèvia a la 
comercialització. Així doncs, es va avaluar la seguretat d’un panís genèticament 
millorat per augmentar el seu contingut en carotens (High-carotenoid corn), produït 
pel Grup de Biotecnologia Vegetal Aplicada de la Universitat de Lleida, mitjançant un 
estudi de toxicitat subcrònica de 90 dies en ratolins. No es van trobar evidències de 
toxicitat quan es va comparar amb ratolins alimentats amb una dieta control (basada 
en un panís no modificat anomenat M37W). Un cop establerta la seguretat del panís, 
es va administrar una dieta basada en el panís genèticament millorat a ratolins model 
de càncer de còlon associat a colitis, a ratolins model d’obesitat i resistència a la 
insulina induïdes a través d’una dieta amb alt contingut en greixos, i finalment, a una 
línia de ratolí heterozigot per l’homòleg de fosfatasa i tensina (PTEN+/-) com a model 
de neoplàsia en múltiples òrgans i de malaltia hepàtica. Aquests experiments mostren 
que la varietat de panís enriquit en carotens presenta un efecte quimioprotector i 
també efectes prometedors en la promoció de la salut en paràmetres de risc 
relacionats amb la síndrome metabòlica i la sensibilitat a la insulina. 
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RESUMEN 
 
El término malnutrición se aplica a cualquier condición de nutrición desequilibrada, ya 
sea por una alimentación deficitaria, por sobrealimentación o por la combinación de 
las dos: una ingesta calórica excesiva combinada con una ingesta insuficiente de 
micronutrientes. La malnutrición puede ser causada por una dieta pobre y/o por 
estados patológicos que afecten a la correcta asimilación de los nutrientes. En países 
en vías de desarrollo pero también en países industrializados, la malnutrición a 
menudo va de la mano del hambre, y cada vez más, acompañada de un aumento del 
consumo de dietas altas en calorías de bajo coste y pobres en nutrientes. Estas dietas 
son reflejo del progreso en la agricultura y en las tecnologías de procesado de 
alimentos que contribuyen a la reducción de los contenidos de micronutrientes de los 
alimentos, hecho que favorece tanto a la malnutrición como a la obesidad, y agrava 
diferentes enfermedades crónicas como las enfermedades cardiovasculares, diabetes y 
cáncer. Las plantas son una fuente importante de vitaminas y minerales, pero estos 
micronutrientes se encuentran en niveles insuficientes en cultivos básicos de cereal 
como el maíz o el arroz. Por ejemplo, las semillas de estos cereales no producen 
niveles altos de carotenos, los cuales en algunos casos intervienen en la promoción de 
la salud por su efecto antioxidante, y en otros casos (como es el caso de los carotenos 
provitamina A) actúan como micronutrientes esenciales. La biofortificación a través de 
la ingeniería genética es una estrategia costo-efectiva para mejorar el contenido 
nutricional del maíz; sin embargo, su elaboración requiere una evaluación de riesgos 
obligatoria como componente integral para un proceso de aprobación previa a la 
comercialización. Así pues, se evaluó la seguridad de un maíz genéticamente mejorado 
para aumentar su contenido de carotenos (High-carotenoid corn), producido por el 
grupo de Biotecnología Vegetal Aplicada de la Universidad de Lleida, mediante un 
estudio de toxicidad subcrónica de 90 días en ratones. No se encontraron evidencias 
de toxicidad cuando se comparó con ratones alimentados con una dieta control 
(basada en maíz no modificado llamado M37W). Una vez establecida la seguridad del 
maíz, se administró una dieta basada en maíz genéticamente mejorado a ratones 
modelos de cáncer de colon asociado a colitis, a ratones modelo de obesidad y 
resistencia a la insulina inducidas a través de una dieta con un alto contenido en grasa, 
y finalmente, a una línea de ratones heterocigotos por el homólogo de fosfatasa y 
tensina (PTEN+/-) como modelo de neoplasia en múltiples órganos y de enfermedad 
hepática. Los experimentos muestran que la variedad de maíz enriquecido con 
carotenos presenta un efecto quimioprotector y también efectos prometedores en la 
promoción de la salud en parámetros de riesgo relacionados con el síndrome 
metabólico y la sensibilidad a la insulina. 
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1. GENERAL INTRODUCTION 
 
1.1.  Forms of malnutrition: undernutrition and overnutrition  
 
Undernutrition is any condition resulting from the inadequate intake or assimilation of 
nutrients and it is responsible for more than 30% of all deaths worldwide in children 
under 5 years old (Relman, 2013). In developing countries, undernutrition reflects the 
common phenomenon of insufficient access to nutritious food, which is often caused 
by poverty. These factors act in concert to increase the prevalence of poor health and 
disability, impaired cognitive development and premature death (Berman et al., 2013; 
Pérez-Massot et al., 2013). There is an urgent need to find sustainable solutions that 
address these problems in developing countries, but strategies aiming to deal with 
undernutrition often fail because of poor infrastructure and organization. For example, 
attempting to address undernutrition by providing diverse sources of fresh food, 
supplements or fortified food products has not been successful because there is a lack 
of funding and because distribution networks are unstable (Gómez-Galera et al., 2010; 
Yuan et al., 2011). As a sustainable alternative, biofortification aims to modify staple 
crops, particularly local elite breeding varieties, so that they accumulate essential 
nutrients at source. This solution has no impact on the agricultural performance of the 
crop but provides added value in the form of single or multiple essential nutrients 
(Pérez-Massot et al., 2013; Zhu et al., 2013).  
Undernutrition is a form of malnutrition, but the latter encompasses all deviations 
from an adequate or optimal nutritional status and therefore also includes excessive 
energy intake (overnutrition) and the intake of an unbalanced diet with an excess of 
some nutrients but a lack of others (Shetty, 2006). For example, it is quite possible for 
an individual with excess calorific intake to be malnourished due to a lack of vitamins 
(Kaidar-Person et al., 2008). Approximately 34% of adults in the developing world were 
classified as overweight or obese in 2008 (compared to 23% in 1980). In high-income 
countries the prevalence of obesity grew 1.7-fold over t he same period (Stevens et al., 
2012). It seems paradoxical, but the rapid increase in obesity has not been 
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accompanied by a proportional reduction in undernutrition and these two nutritional 
states (known as the ‘dual burden’) persist alongside each other in many countries 
(FAO, 2011; Doak et al., 2005).  
Obesity can be promoted by environmental, behavioral and genetic factors. Over the 
last few decades, the populations of many countries have become accustomed to 
inexpensive, calorie-rich but nutrient-poor diets resulting from developments in 
agriculture and food processing technology which reduce the micronutrient content of 
foods. This has a negative impact on nutritional health and increases susceptibility to 
obesity, with a startling impact on the many chronic diseases including cardiovascular 
disease, diabetes and cancer (Riaz et al., 2009; Swinburn et al., 2011). 
 
1.2. The impact of malnutrition on chronic diseases 
 
Because the prevalence of obesity is rising, metabolic syndrome and its concomitant 
diseases are becoming a severe health problem worldwide (Braun, 2011). Metabolic 
syndrome includes hypertension, abdominal obesity, hyperglycemia, dyslipidemia and 
it has been linked to insulin resistance and the resulting development of diabetes 
mellitus and nonalcoholic fatty liver disease (Jaggers et al., 2009; Braun, 2011). 
 
1.2.1. Cancer and malnutrition 
 
Malnutrition is a risk factor in cancer, but early studies failed to determine 
unequivocally whether increasing the intake of fruits and vegetables beyond the level 
needed to prevent malnutrition is necessarily beneficial (Bjelke, 1975; Armstrong and 
Doll, 1975). The World Cancer Research Fund and the American Institute for Cancer 
Research have reported ‘convincing’ evidence that consuming fruits and vegetables 
reduces the risk of various types of cancer (World Cancer Research Fund/American 
Institute for Cancer Research, 1997). However, more recent prospective investigations 
with more subjects did not show a clear association between higher consumption and 
lower cancer risk (Key, 2011). It is likely that dietary carcinogens have a greater impact 
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on malnourished individuals reflecting the lack of protective factors found in balanced 
diets, including the fiber found in fruits and vegetables (Lutz, 1999). Examples of 
dietary carcinogens include alcohol (excessive intake), heterocyclic aromatic amines, 
cadmium, polycyclic aromatic hydrocarbons and mycotoxins such as aflatoxin B1, which 
have an adverse impact on mitochondrial metabolism, oxidative stress, protein 
synthesis, cell proliferation, hormonal and immune functions and gene regulation 
(Lutz, 1999). Moderate amounts of fruits and vegetables help to prevent nutrient 
deficiency and may reduce the risk of cancer, but further investigations are required to 
evaluate the risks of dietary carcinogens and overnutrition as risk factors in cancer 
(Key, 2011; Lutz, 1999). 
On the one hand, dietary intake plays an important role in the progression of cancer 
because more than 85% of cancer patients develop clinical malnutrition. Poor 
nutritional status can inhibit the therapeutic response and increase the severity of 
side-effects, and these factors must be considered to improve prognosis and increase 
the chances of recovery (Davies, 2005). Cancer-associated malnutrition usually equates 
to undernutrition (Argilés, 2005), and its multifactorial etiology may reflect a generally 
lower food intake, metabolic changes in the patient, or the direct local effects of a 
tumor (Van Cutsem and Arends, 2005). Nutritional screening should therefore be used 
to identify malnourished patients or those at the highest nutritional risk (Kim et al., 
2011). 
On the other hand, obesity and diabetes have been associated with renal, pancreatic, 
breast, colorectal, endometrial and hepatic cancer (Calle et al., 2003). The American 
Cancer Society reported that nearly one in three cancer-related deaths in the United 
States was due to obesity, poor diet or inactivity (www.acscan.org). Metabolic 
syndrome (or its components) could play a decisive role, not only in the prognosis but 
also in the etiology and progression of certain cancer types (Braun, 2011).  
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1.2.2. Type 2 diabetes and malnutrition 
 
Insulin resistance often manifests in obese individuals and it is a sign of pre-diabetes, 
which can develop into type 2 diabetes (T2D) subsequently if insulin sensitivity is not 
ameliorated (Kalupahana et al., 2012).  Insulin resistance refers to the incapacity of 
insulin-sensitive tissues (e.g. fat, skeletal muscle and liver) to respond to insulin. 
However, pancreatic β cells compensate by secreting higher levels of insulin, which 
initially helps to maintain normal sugar levels. Over time, the progressive failure of β 
cells to secrete sufficient insulin induces hyperglycemia and eventually T2D (Guilherme 
et al., 2008). Oxidative stress is also increased in diabetic patients because persistent 
hyperglycemia and the oxidation of excess glucose can generate reactive oxidative 
species (ROS) that contribute to the development of diabetic complications (e.g. 
neuropathy, atherosclerosis, retinopathy and the destruction of β cells). Certain 
dietary micronutrients can counter these complications because of their antioxidant 
activity and their requirement as a cofactors in the metabolism of glucose, the insulin 
signaling cascade and the function of β cells (DeFronzo, 2009). 
 
1.2.3. Non-alcoholic fatty liver disease and malnutrition 
 
The associations among obesity, insulin resistance, T2D and steatosis have been 
recognized for a long time (Farrell and Larter, 2006). Non-alcoholic fatty liver disease 
(NAFLD) occurs when fat accumulates within liver cells (steatosis) in the absence of 
excess alcohol intake; the disease affects 20–30% of the general population 
(McCullough, 2004; Petta et al., 2009). NAFLD spans a range of symptoms, from 
steatosis alone to non-alcoholic steatohepatitis (NASH), which is the most severe form 
of NAFLD and includes hepatocellular carcinoma, cirrhosis and advanced liver disease 
(Ziouzenkova et al., 2007). 
Malnutrition based on excess fat and carbohydrate intake often causes chronic 
increases in the levels of insulin, glucose and fatty acids in the blood. This induces 
resistance to insulin-stimulated glucose uptake by skeletal muscles as well as a 
suppression of triglyceride hydrolysis in adipose tissues, and thus causes glucose levels 
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in the blood and liver to rise. Non-insulin-dependent glucose uptake also increases, 
resulting in its conversion into free fatty acids and glycogen through insulin-mediated 
stimulation of de novo lipogenesis. The production of free cholesterol is also 
stimulated. The body therefore accumulates cholesterol esters and triacylglycerols in 
the liver (Ziouzenkova et al., 2007). 
 
1.3. The biofortification of staple foods 
 
Biofortification is a cost-effective strategy to address micronutrient deficiency and it is 
particularly advantageous in developing countries because it can increase the nutrient 
content of local elite staple crops at source. This is important because many staple 
crops (such as rice or corn) lack adequate amounts of essential micronutrients such as 
vitamins and minerals (Zorrilla-López et al., 2013). Biofortification can be achieved by 
conventional breeding and/or genetic engineering as discussed below (Zhu et al., 
2007). 
 
1.3.1. Conventional breeding  
 
Conventional breeding methods involve the cross-breeding of sexually compatible 
plants of the same or different species and/or using in vitro culture techniques to 
generate plants with combinations of improved characteristics from parents with 
desirable attributes. When the desired trait is not present in sexually compatible plants 
that can be crossed with an elite breeding variety and selected by repetitive 
backcrossing, the elite lines can be mutated e.g. using chemicals or radiation, 
generating libraries of random mutations that can be selected for the trait of interest 
(Fitzmaurice et al., 1999; Ahloowalia and Maluszynski, 2001; Jander et al., 2003). 
Alternative approaches rely on natural variation within plant species, allowing the 
identification of quantitative trait loci (QTLs), i.e. genomic regions related to relevant 
phenotypic traits (Maloof, 2003). The major limitations of conventional breeding for 
nutritional improvement include the dependence on a compatible gene pool, the long 
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time required to breed a specific trait into an elite crop, and the layers of complexity 
introduced when attempting to select for different nutritional traits simultaneously 
(Bai et al., 2011). 
 
1.3.2.  Genetic engineering in plants 
 
Genetic engineering allows the modulation of metabolic pathways directly in order to 
improve nutritional characteristics. The process begins with the identification of 
appropriate genes, followed by transformation, in which genetic constructs are 
introduced into the plant genome to confer novel or improved traits. Agrobacterium 
tumefaciens is a ubiquitous soil bacterium that is often used for genetic engineering in 
plants because it has a natural capacity to introduce a segment of DNA carried on a 
resident plasmid, and this segment of DNA integrates into the plant genome at the 
onset of pathogenesis (Comai et al., 1983). For plants that are recalcitrant to 
Agrobacterium-mediated transformation, electroporation or chemical transfection 
mediated by polyethylene glycol transformation are examples of direct DNA transfer, 
although these strategies work best with protoplasts and often require complex 
regeneration protocols (Zhang et al., 1988). Particle bombardment is a more versatile 
direct DNA transfer strategy based on the acceleration of DNA-coated metal particles 
that deliver genetic material into plant cells (Altpeter et al., 2005). The advantages of 
particle bombardment include the simple and straightforward technique, the ability to 
transfer DNA to any species of plant, and the ability to introduce multiple genes for 
simultaneous biofortification with different nutrients at the same genetic locus (Zhu et 
al., 2007). 
 
1.4. Genetically engineered plants 
 
The first commercial genetically engineered crops were deployed in 1996 (1.7 million 
hectares in six countries) and this has grown to 175.2 million hectares in 25 countries 
in 2013 (http://www.isaaa.org/). The four principal biotech crops are corn, soybean, 
1. GENERAL INTRODUCTION 
 9  
 
cotton and canola, and the biggest producers are the United States, Argentina, Brazil, 
Canada, India and China (Magaña-Gómez and de la Barca, 2009; Manjunath, 2010).    
Three generations of biotech crops can be recognized according to the purpose of the 
introduced trait (Figure 1.1). The first-generation transgenic crops were generated to 
enhance productivity by avoiding biotic stress constraints caused by insects and 
weeds, without affecting other characteristics (e.g. appearance, flavor and nutritional 
composition). Second-generation transgenic crops were modified to enhance their 
nutritional traits, e.g. by increasing the quantity and/or quality of proteins, lipids, 
carbohydrates and essential micronutrients such as vitamins and minerals (Magaña-
Gómez and de la Barca, 2009; Zhu et al., 2007). Third-generation transgenic crops are 
being developed as factories to produce pharmaceutical and industrial  molecules 
(Sakakibara and Saito, 2006).  
 
The early development and 
commercialization of transgenic crops 
occurred largely without incident, the 
products were labelled voluntarily to 
confirm the presence of ingredients from 
genetically engineered plants and there 
was no apparent hostility from 
consumers (Stewart et al., 2000).  
However, this changed in 1999 with the 
publication of two controversial papers. 
The first claimed that potatoes 
genetically engineered to express the 
lectin Galanthus nivalis agglutinin  were 
toxic towards rats, causing abnormalities 
in the immune system (Ewen and Pusztai, 
1999), and the second claimed that 
pollen from corn plants engineered to express pest-specific Bacillus thuringiensis (Bt) 
toxins were harmful to monarch butterflies (Losey et al., 1999). These and other 
First 
generation 
•Herbicide tolerance 
•Insect resistance 
•Virus resistance 
•Disease tolerance 
•Delayed ripening 
Second 
generation 
•High nutritional value 
•Amino acid rich 
•Premium qualitity 
•Low allergenicity 
Third 
generation 
•Vaccine 
•Antibody 
•Pharmaceutical proteins 
Figure 1. 1. Three generations of GE plants. Adapted 
from Sakakibara and Saito, 2006. 
1. GENERAL INTRODUCTION 
 
 10  
 
similar papers were later discredited but the damage was already done (Enserink, 
1999; Sears et al., 2001; Stanley-Horn et al., 2001; Gatehouse et al., 2002).  
These initial publications resulted in a plethora of additional studies which were 
published in the general media and on the internet without peer review, and were 
seized upon by extreme environmental groups and Green political parties in Europe. 
These organizations mounted a campaign of misinformation to create alarm and 
distrust among the public, resulting in increasing hostility towards transgenic plants 
and the underlying technology (Stewart et al., 2000). It is often assumed by the public 
that this politically-motivated pressure precipitated the development of guidelines for 
the safety assessment of transgenic plants and products derived from them, but these 
guidelines have always been an integral part of the approval process. As in other 
technological areas, safety assessment guidelines evolve constantly in an attempt to 
keep pace with the most recent scientific developments (Magaña-Gómez and de la 
Barca, 2009).   
More recently, a 2-year animal feeding trial was published in Food and Chemical 
Toxicology describing the potential toxicity towards Sprague-Dawley rats of a 
glyphosate herbicide-resistant corn variety and also independently the herbicide itself 
(Séralini et al., 2012). Once again, the study was riddled with errors and was 
comprehensively debunked, but it was nevertheless used as a justification to ban the 
import of genetically engineered crops into several countries and pressurized 
European Food Safety Authority (EFSA) to introduce an additional requirement for 2-
year chronic toxicity assessments into the approval process (EFSA, 2013). Although the 
Séralini study was peer-reviewed, there were errors in experimental design, statistical 
analysis and interpretation (Arjó et al., 2013) which resulted in retraction of the paper 
by the journal one year later following intense pressure from the scientific community 
and regulatory agencies (Elsevier, 2013). These events remind us that the safety 
evaluation of genetically engineered crops is currently inseparable from politics and 
the media so there is a need to follow strict ethical guidelines and scientifically 
rigorous evaluation methods when dealing with such crops, to act with absolute 
transparency and to ensure the peer review system is closely monitored (Arjó et al., 
2013). 
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It is remarkable that since the work described in this thesis began, EFSA has updated 
the safety assessment guidelines for transgenic crops four times (EFSA, 2010; EFSA, 
2011a; EFSA, 2011b; EFSA, 2013). Even so, the EU has the most restrictive legislation in 
the world governing the “deliberate release” of transgenic plants. Only one additional 
crop (other than MON810 expressing Bt) has been approved in the last 14 years, and 
even this was intended for industrial use rather than human consumption (Amflora 
potato, event EH92-527-1), perhaps because the political consequences of positive 
approvals are too great (Masip et al., 2013). The current safety assessment procedure 
for new genetically engineered crops can cost up to €11 million and is described below 
(Masip et al., 2013; Kalaitzandonakes et al., 2007) . It is interesting to note that the EU 
applies different standards for the cultivation and import of transgenic crops (see 
Masip et al., 2013). 
 
1.5. Safety assessment of genetically engineered crops 
 
1.5.1. Safety assessment of new plant varieties  
 
The creation of risk assessment guidelines has been discussed by scientific 
organizations such as the FAO (Food and Agriculture Organization, of the United 
Nations), WHO (World Health Organization), OECD (Organization for Economic Co-
Operation and Development), EU (European Union) and ILSI (International Life 
Sciences Institute), and in other contexts, since foods derived from genetically 
engineered crops were first produced (Kuiper et al., 2001; König et al., 2004).  
The first guidelines discussed the regulation of genetically engineered microorganisms 
and plants in the environment without any mention of food safety. The concept of 
substantial equivalence was introduced by the OECD in 1993, referring to appropriate 
comparators between genetically engineered plants and their conventional 
counterparts. When substantial equivalence exists in a novel product, it is considered 
as safe as its unmodified counterpart according to WHO and FAO (Kuiper et al., 2002).  
This inherently involves the comparison of genotypic, compositional and phenotypic 
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variations between the novel and parental varieties grown under the same conditions 
(Kok et al., 2008). 
ILSI FAO/WHO guidelines therefore recommend that safety evaluation should be based 
on the concept of equivalence, according to parameters such as nutritional, 
phenotypic, molecular, toxicological and allergenic characteristics (FAO/WHO, 1996; 
Jonas et al., 1996). In 2003, the Codex Alimentarius published guidelines to develop 
risk assessment tests for genetically engineered organisms (FAO/WHO, 2003), and in 
2004, an EU consortium comprising 60 members from 14 different European countries 
(Entransfood, http://www.entransfood.com/) published a paper listing strategies and 
methodologies to evaluate unintended effects and potential gene transfer 
consequences (Cellini et al., 2004; Kuiper, 2004;  van den Eede et al., 2004). Hazard 
identification tests in this approach were based on substantial equivalence, analyzing 
the introduced gene and protein sequences (in silico analysis), testing to ascertain 
characteristics of novel sequences (mode and insertion site) and the phenotypic and 
compositional characteristics including key macronutrients, micronutrients, 
antinutrients and natural toxins (Kok et al., 2008). Currently such parameters are 
tested by DNA/mRNA microarray hybridization, event-specific polymerase chain 
reaction (PCR) detection methods and other specific techniques (Magaña-Gómez and 
de la Barca, 2009).  
In 2006, OECD described procedures for the analysis of key plant components 
(nutrients and anti-nutrients) to screen for potential unintended effects in genetically 
engineered plants, including assays for toxicity, allergenicity, potential for gene 
transfer to non-target organisms and other unintended effects which are not usually 
defined a priori (OECD, 2006). 
 
1.5.2. Regulatory issues concerning genetically engineered plants 
 
In the EU, there are specific regulations (Regulation 1829/2003) describing the legal 
basis of the market approval process for genetically engineered foods/feeds, 
ingredients, additives or enzymes. The European Commission is advised by EFSA and 
member states, and for this purpose EFSA developed a “Guidance document for the 
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risk assessment of genetically modified plants and derived food and feed” based on 
comparative safety evaluations of genetically engineered plants and the corresponding 
unmodified parental lines (EFSA, 2006). This has recently been replaced with 
“Guidance for risk assessment of food and feed from genetically modified plants” 
which brings the rules concerning field trials, toxicological assessments and whole 
food/feed animal feeding studies up to date (EFSA, 2011a). 
In the US, the requirement is that genetically engineered crops have equivalent 
compositional and nutritional characteristics to their non-engineered counterparts, 
except for any specifically introduced traits. The US Environmental Protection Agency 
(EPA) is responsible for the safety assessment of plants improved by pesticide proteins, 
and among other parameters the regulations require an assessment for allergenicity as 
mandated in the Federal Insecticide, Fungicide, and Rodenticide Act. The United States 
of America (USA) Food and Drug Administration (FDA) is responsible for the 
assessment of any remaining traits in genetically engineered plants (Kok et al., 2008).  
The following section describes the tools currently used to evaluate the safety of food 
derived from genetically engineered crops. This information suggests strategies for the 
application of experimental procedures to evaluate the safety of such products. 
 
1.5.3. Current comparative safety assessment methods for plant -derived 
foods 
 
Molecular analysis. Unlike other authorities, the EU requires the analysis of genetically 
engineered plants according to the defined site of transgene insertion and the 
surrounding sequence to rule out mutational effects (Kok et al., 2008). Event-specific 
PCR detection methods are therefore used to identify and quantify genetically 
engineered plants (Kong-Sik Shin et al., 2013; Yang et al., 2013) . 
Compositional characterization. Here the aim is to analyze key plant components 
(nutrients, anti-nutrients and toxins) phenotypic traits and compounds that are altered 
intentionally by genetic engineering. Additional data can be obtained by growing the 
genetically engineered plant (and its unmodified counterpart) under diverse field 
conditions and in different growing seasons (FAO/WHO, 1996; OECD, 1996; EFSA, 
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2011a). The ILSI Crop Composition Database shows compositional data from different 
crops grown in different countries (www.cropcomposition.org).  
Toxicology. Internationally agreed protocols for the assessment of toxicology data are 
described in the OECD guidelines for the testing of chemicals  (OECD, 1998; OECD, 
2008; OECD, 2009) and in European Commission Directives on dangerous substances 
(EC, 2002). Strategies to assess toxicity should be chosen depending on the properties 
and function of the introduced protein, and the history of human or animal 
consumption. If both the newly synthesized protein and the plant have a history of 
safe consumption by humans and animals, then toxicity tests are not required at all 
(EFSA, 2011a). 
Laboratory animals are recognized as good models for the prediction of toxicity in 
humans. EFSA recommends a 28-day oral toxicity study in which the introduce proteins 
are fed to rodents (OECD, 2008) plus additional tests as required by the initial results, 
e.g. immunotoxicity assessment (EFSA, 2011a).  
EFSA also recommends a whole-food 90-day toxicity study in rodents if the 
composition of the transgenic crop is changed substantially or if there is any indication 
of potential unintended effects. A minimum of two test doses is recommended. It is 
important to be diligent in dose selection and to avoid nutritional imbalances and at 
least two dose levels are required for the genetically engineered food and comparator 
(at least the highest dose possible without producing a nutritional imbalance). Other 
animal species may be assessed to provide complementary data, e.g. broiler chicks or 
lambs (EFSA, 2008; EFSA, 2011a; EFSA, 2011b).  
OECD test guidelines 407 (28-day oral toxicity study in rodents) and 408 (90-day oral 
toxicity study in rodents) are examples of repeated-dose sub-chronic tests. The aim in 
such studies is to determine adverse effects by repeated exposure to drugs, chemicals, 
food additives or food compounds for a period of one month or longer. The protocols 
are applied in young animals and are designed to reveal signs of toxicity in organs, 
tissues and cells. They provide information for a period sufficient to observe major 
toxic effects without age-associated changes in tissue morphology or function (EFSA, 
2008).  
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EFSA recently published guidelines for whole-food/feed chronic toxicity and/or 
carcinogenicity studies in rodents, adapted from OECD TG 453 which was developed 
for chemicals (EFSA, 2013). These studies assess chronic effects over a long period (up 
to and including the entire life of the test animal) to identify any potential chronic 
toxicity or carcinogenicity effects of defined substances. Additional studies may assess 
reproductive and developmental toxicity (EFSA, 2008). 
Direct immunotoxicity tests focus on the suppression or dysfunction of immune system 
components resulting in allergic or autoimmune reactions. OECD guidelines 407 and 
408 as discussed above provide preliminary immunotoxicity data because they require 
hematological analysis (including differential cell counting, bone marrow analysis and 
serum immunoglobulin levels), weight measurements and histology of lymphoid 
organs and tissues. The immunotoxicity of food in the gut can be investigated by 
analyzing Peyer’s patches and mesenteric lymph nodes, whereas systemic effects can 
be investigated by weighing and analyzing the thymus, spleen and distant lymph node. 
The accuracy of histopathology can be complemented by using techniques such as 
immunocytochemistry and flow cytometry (EFSA, 2008).  
Nutritional evaluation. Two European initiatives (the EuroFIR program and the 
FAOSTAT database) describe macronutrients, micronutrients and bioactive 
components in food, and list consumption data for different countries. They are useful 
as reference databases for the assessment of food derived from genetically engineered 
crops (Kok et al., 2008). Nutritional assessment should demonstrate that such 
engineered food or feed products are no less nutritious than the equivalent 
unmodified crops. Studies in rodents, poultry and livestock have been published to 
assess the nutritional characteristics of several genetically engineered plants. The 
bioavailability and biological efficacy of nutrients in genetically engineered plants 
should also be considered, because they affect the feed conversion rate in animals 
(EFSA, 2011b). 
Allergenicity. There are several guidelines describing food allergenicity assays 
(Metcalfe et al., 1996; FAO/WHO, 2001). The introduced protein should be considered 
in terms of the source organism, sequence/structural homology with known allergens 
(in silico analysis), digestibility, thermostability, IgE immunoaffinity tests and studies in 
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animal models (Goodman et al., 2008; Kok et al., 2008). These aspects are summarized 
in Figure 1.2. 
 
Figure 1. 2. Schematic representation of major allergenicity assessment areas, showing high risks (on the 
right) and lower risks (on the left) (Goodman et al., 2008).   
 
The amount of recombinant protein present in foods derived from genetically 
engineered plants, and the ability of such proteins to withstand cooking, may influence 
their resistance to digestion and hence their likelihood of interacting with the 
intestinal mucosa. Most allergenic proteins in food are absorbed in the intestine, and 
patients sensitive to specific allergens may experience symptoms if they are exposed 
to proteins with similar structures, because they will cross-react with allergen-specific 
IgE (Herman et al., 2009).  
The aim of allergenicity studies is therefore to minimize the likelihood that a novel 
food product is more allergenic than its conventional counterpart. One example of 
such an abandoned product was a genetically engineered soybean variety developed 
by Pioneer Hi-Bred International, which contained the Brazil nut 2S albumin. A serum 
IgE test was positive for individuals with Brazil nut allergies, and further development 
was discontinued (Herman et al., 2009).  
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If the source of the introduced transgenes is a known allergenic plant, or if the product 
is related to a respiratory allergen or a contact allergen such as latex, then an 
immunoafinity IgE test with serum from allergic patients should be performed, taking 
into account demographic and age factors, to rule out allergies to specific recombinant 
proteins in transgenic plants. Such studies require large amounts of human serum to 
generate statistically significant results, and sometimes it is difficult to find enough 
people allergic to specific foods to enable such tests (Goodman et al., 2008).  
Bioinformatics analysis can be carried out by searching for amino acid sequence 
similarity between the recombinant protein and known allergens using algorithms such 
as FASTA or BLAST (Table 1.1). Following preliminary assessment, it is necessary to 
determine whether or not the protein has any potential to induce cross-reactivity with 
known allergens and thus induce allergic responses (Goodman et al., 2008).  
 
Table 1. 1. Sequence identity over an 80-amino-acid window between a recombinant protein and an 
allergen identified by BLAST/FASTA alignment, thus requiring serum affinity analysis (Goodman et al., 
2008).  
 
Sequence identity 
percentage 
Potential for 
cross-reaction 
Need for IgE 
affinity test 
> 70% high yes 
50%-70% moderate yes 
50%-35% low yes 
<35% inexistent no 
 
 
Two methods are used to evaluate structural similarity between allergens and 
recombinant proteins in genetically engineered plants. The method shown in Table1. 1 
uses an 80-amino-acid window, based on the typical sequence length of a protein 
epitope recognized by antibodies. Other criteria include short peptides (6–8 residues) 
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based on theoretical B-cell and T-cell epitope sequences, but these are more 
susceptible to false positive matches (Cressman and Ladics, 2009; Herman et al., 2009). 
The last and most definitive test to determine allergenicity is the serum affinity test. 
Serum IgE from allergic donors is tested by enzyme-linked immunosorbent assay 
(ELISA) and immunoblot using recombinant proteins from genetically modified plants 
to assess potential cross-reactivity. Ideally, the assay is carried out using a positive 
control comprising serum from patients known to be allergic to proteins from the 
transgene source or proteins that are similar to the transgene product, and a negative 
control comprising serum from donors allergic to non-related proteins (Goodman et 
al., 2008). However, these tests are complex and the results are often ambiguous. It is 
often unclear whether the tested protein is structurally identical to its naturally 
occurring counterpart, if the amount of protein used in the tests is the same as that 
found in the food, and whether the number of serum donors is statistically significant 
(Goodman et al., 2005; Goodman et al., 2008; Selgrade et al., 2009).  
As mentioned above, if a protein is not digested in the alimentary canal it may be 
allergenic. Most proteins in food are digestible but certain protein allergens are stable 
when exposed to pepsin in vitro. Some non-allergenic proteins are also stable (Thomas 
et al., 2004; Goodman et al., 2008). Digestibility tests include assays with different 
digestion times in a liquid medium which simulates gastric (pepsin) and intestinal 
(pancreatin) fluids at the correct pH and temperature. It is important to consider the 
amount of the tested protein found in food because more abundant proteins are likely 
to survive digestion and are more likely to be allergenic. Currently, there are no 
scientifically objective criteria to assess such abundance data (Goodman et al., 2008) 
but EFSA proposes this as an additional criterion to be considered during the safety 
assessment (EFSA, 2010; EFSA, 2011a). 
The majority of food allergens do not lose allergenicity when heated. Indeed, they can 
even become more allergenic due to covalent modifications caused by the Maillard 
reaction or proteases. In heat-stable allergens, the epitope recognized by IgE maintains 
its native structure when the protein is heated due to the presence of disulfide bonds 
and hydrophobic interactions. Heat stability is therefore an important part of safety 
assessment because processed foods are nearly always subjected to some form of 
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thermal treatment, e.g. oven roasting and frying or wet heating methods such as 
boiling and microwave cooking (Goodman et al., 2005).   
FAO/WHO (FAO/WHO, 2001) recommend that novel foods are evaluated in two 
different species using two protein administration routes in each species. There are no 
standardized animal models to assess food allergies, even though many models have 
been used for this purpose (Singh et al., 2006; Wang et al., 2003; Singh et al., 2009). 
Many factors appear to influence the outcome of such tests, including genetic diversity 
that predisposes some individuals to allergy, genetic differences between humans and 
animal models, and the administration of sensitization doses (FAO/WHO, 2001). EFSA 
considers it useful to provide additional information although recognizes that in vitro 
cell models and animal models have not been validated (EFSA, 2011a). 
Gene transfer. Horizontal gene transfer is the potential for genetic material to be 
transferred from one living cell or organism to another. Interspecies horizontal gene 
transfer has not been demonstrated between transgenic plants and microbes despite 
many efforts (Ramessar et al., 2007). Several studies have been carried out to evaluate 
this phenomenon, all of which emphasized the challenges of protecting the test tissue  
from contamination (Mazza et al., 2005; Nielsen et al., 2005).  
EFSA initially recommended that the risk of homologous recombination with intestinal 
microflora should be investigated (EFSA, 2006). This has been dropped from the 
updated guidelines, although there is a recommendation to evaluate introduced DNA 
for the presence of replication origins and related sequences (EFSA, 2011a).   
Post-market monitoring. Finally, although post-market monitoring should not replace 
pre-marketing safety assessments, such monitoring might complement and confirm 
the results of pre-market risk assessments (Kok et al., 2008).  
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1.6. High-carotenoid corn 
 
1.6.1. Carotenoids  
 
Carotenoids are C40 lipid-soluble pigments produced by plants, fungi, algae, bacteria 
and archaea. They play an important role in light perception during photosynthesis and 
also protect the photosynthetic apparatus from photo-oxidation (Naqvi et al., 2009). 
More than 750 carotenoids have been identified, although only 50 are typically found 
in the human diet, and only 10 can be detected in human blood, including α-carotene, 
β-carotene, lycopene, lutein, zeaxanthin and cryptoxanthin (Gerster, 1997).  Humans 
need carotenoids as metabolic precursors, antioxidants and to prevent diseases such 
as cancer, blindness and immune system abnormalities. The only source of carotenoids 
for humans and many other animals is the diet because these molecules cannot be 
synthesized de novo. Fruits and vegetables are rich in carotenoids, but cereals which 
constitute the staple diet in most developing countries lack these metabolites because 
the metabolic pathway does not exist, or is truncated or inhibited in plant tissues (Zhu 
et al., 2008; Naqvi et al., 2009). 
Lycopene, which gives red fruits and vegetables their color, protects cells against 
oxidative stress, and reduces the risk of cardiovascular diseases, cancer and 
degenerative disorders (Di Mascio et al., 1989). Xanthophylls such as lutein and 
zeaxanthin protect the retina against age-related macular degeneration and help to 
prevent the formation of cataracts (Snodderly, 1995; Agte and Tarwadi, 2010). The 
most abundant carotenoid in nature is β-carotene, and this is also the major source of 
vitamin A in the human diet. The absorption and metabolism of provitamin A 
carotemoids takes place in the intestine, and these molecules are predominantly 
stored in adipose tissue and in the liver as retinyl esters. If β-carotene is not 
metabolized, it is deposited in the epidermis. Vitamin A is necessary for night vision, 
the differentiation and proliferation of cells, embryonic development and to maintain 
correct immunological and reproductive functions (Niles, 2007; Fierce et al., 2008).  
Ketocarotenoids are produced in algae, fungi and bacteria, but only rarely in plants. 
They contain at least one keto group in the linear chain or on one of the β-ionone 
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rings. Astaxanthin is a ketocarotenoid with potent antioxidant activity, and is often 
present in marine animals (such as salmon and prawn) and in birds (flamingos and 
quails). These animals cannot synthesize astaxanthin but they obtain it from their diet 
(Naqvi et al., 2009). 
 
1.6.2. Retinoids 
 
Carotenoids are absorbed in the gut and are incorporated into the liver and adipose 
tissue. The pro-vitamin A carotenoids (α-carotene, β-carotene, γ-carotene and 
β-cryptoxanthin) are converted to retinal (the reduced form of vitamin A) by the 
enzyme 15,15’-oxygenase (BCO1) (Figure 1.3). Retinal is then converted into retinol 
which can be converted into retinoic acid by oxidation (Bachmann et al., 2002; 
Tourniaire et al., 2009; Takaichi, 2011;  Pérez-Massot et al., 2013).  
Retinoids are metabolic regulators that activate specific nuclear receptors such as the 
retinoic acid receptor (RAR) and the retinoid X receptor (RXR). RXRs act as partners to 
other nuclear receptors such as the vitamin D receptor, the thyroid hormone receptor, 
the liver X receptor, and the peroxisome proliferator-activated receptor (PPAR), and 
induce multiple biological effects. RXRs and RARs can also act as a heterodimerization 
partners for transcription factors and thus influence cell growth, differentiation, and 
apoptosis (Germain et al., 2006; Tourniaire et al., 2009).  
The symmetric cleavage of β-carotene produces two retinaldehyde molecules which 
can subsequently be reduced to retinol or though the action of retinaldehyde 
dehydrogenases can produce two retinoic acid molecules (Ziouzenkova and Plutzky, 
2008). However, the asymmetric cleavage of β-carotene by β-carotene 9′,10′-
oxygenase 2 (BCO2) leads the formation of β-apo-10′-carotenal and β-ionone, which 
can act as RAR and PPAR antagonists thus exerting anti-vitamin A activity and 
transcriptional repression (Ziouzenkova et al., 2007; Ziouzenkova and Plutzky, 2008; 
Eroglu et al., 2012; Shete and Quadro, 2013).  
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Figure 1. 3. Pathways from β-carotene to retinoic acid in animals and humans. Symmetric (central) 
oxidative cleavage of β-carotene (BCO1) generates two molecules of retinaldehyde (retinal) which can 
be either reduced to retinol or oxidized into retinoic acid. Moreover, apocarotenals can be generated 
from β-carotene by asymmetric cleavage catalyzed by β-carotene 9′,10′-oxygenase 2 (BCO2) which leads 
to the formation of β-apo-10′-carotenal and β-ionone. β-apo-carotenal that can be oxidized to β-apo-
carotenoic acids and then could be cleaved by BCO1 to yield retinal (however, the mechanisms of this 
conversion has not been completely known) which can be oxidized to retinoic acid (Shete and Quadro, 
2013). Adapted from Bachmann et al., 2002. 
 
1.6.3. Genetically engineered high-carotenoid corn 
 
This study considers the evaluation of a genetically engineered corn variety (High-
carotenoid) produced by the Applied Plant Biotechnology research group in the 
Departament de Producció Vegetal i Ciència Forestal, Universitat de Lleida (Naqvi et 
al., 2009). High-carotenoid corn is a carotenoid rich corn variety (Figure 1.4), 
engineered to express the Zea mays phytoene synthase gene (psy1), the Pantoea 
ananatis carotene desaturase gene (crtI), the rice dehydroascorbate reductase gene 
(dhar) and the Escherichia coli folE gene encoding guanosine triphosphate (GTP) 
cyclohydrolase (GCH1). Particle bombardment was used to transform 10–14-day-old 
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immature zygotic embryos1 with five genetic constructs containing the four metabolic 
genes listed above and the selectable marker gene bar2. All four metabolic genes were 
expressed specifically in the endosperm using the wheat low-molecular-weight (LMW) 
glutenin promoter for psy1 and the barley D-hordein promoter for the others. The 
selectable marker was expressed using a ubi1 promoter. 
 
Expressing the four metabolic 
genes listed above resulted in the 
modification of three distinct 
metabolic pathways, leading to β-
carotene, ascorbate and folate. 
The pathway leading to β-
carotene is shown in Figure 1.5. 
The genes were expressed in the 
South African white corn variety 
M37W, which lacks the 
corresponding pathways in the 
endosperm. This genetically engineered corn line produced 169-fold the normal 
amount of β-carotene, 6-fold the normal amount of ascorbate, and double the normal 
amount of folate (Naqvi et al., 2009).  
                                                          
1
 Immature zygotic embryos can give rise to undifferentiated cells in vitro with the capacity to 
differentiate into tissues and organs. They are isolated from corn seeds 10-14 days after pollination, and 
2
 This is a herbicide-resistance gene from Streptomyces hygroscopicus which confers resistance to the 
herbicide bialaphos (active ingredient, phosphinothricin). 
Figure 1. 4. High-carotenoid corn and its conventional 
counterpart M37W. Carotenoids are pigments so they are 
responsible for the orange color of the corn seeds.  
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Putative transformants were screened by genomic PCR using sets of three primers for 
each gene, resulting in overlapping PCR products that confirmed the transgenes were 
intact. This ruled out the presence of truncated or rearranged copies. Transgene 
expression was confirmed by mRNA blot analysis in immature kernels (Naqvi et al., 
2009).  
The seeds of the transgenic corn were orange in color, contrasting with the white color 
of the parental M37W variety reflecting the lack of carotenoids in corn varieties that 
are typically grown in sub-Saharan Africa for human consumption. Quantitative 
analysis of the carotenoid content was carried out by high-performance liquid 
chromatography (HPLC) showing that the total carotenoid content had increased 112-
fold compared to the wild-type M37W. The high-carotenoid endosperm accumulated 
60 µg of β-carotene, 23 µg of lycopene, 36 µg of zeaxanthin, 15 µg of lutein, 13 µg of α-
cryptoxanthin, 7 µg of α-carotene, 5 µg of β-cryptoxanthin and 5 µg of γ-carotene per 
gram of dry seed weight (dsw). Furthermore, ascorbate levels increased to 110 µg/g 
dsw and folate levels to 1.94 µg/g dsw (Naqvi et al., 2009). 
 
 
Pantoea ananatis 
 
Zea mays 
Figure 1. 5. Metabolic pathway leading to β-carotene, which is absent in the M37W corn variety because 
PSY is not expressed in the endosperm. ZmPsy1 and PaCrtI were introduced into M37W to create the 
high-carotenoid corn (Adapted from Naqvi et al., 2009).  
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An intake of 100–200 g of high-carotenoid corn per day would provide the full 
recommended dietary intake (RDI) of β-carotene as a precursor of vitamin A (Naqvi et 
al., 2009).  
 
1.7. Animal models  
 
Animal models can contribute to the knowledge of cellular and molecular 
pathogenesis of human diseases and disorders. There is a broad range of available 
animals models: fly, zebrafish, mouse, rat, etc., (Lieschke and Currie, 2007). Focusing 
on  mouse models, which is the animal of choice employed in the different 
experiments of this thesis, it has been used in research of several organs and for 
disorders and diseases: cardiovascular, urinary tract, kidney, viral, neural, cancer, 
obesity, metabolic, liver, etc. (Turner, 2013).  
Mouse models useful for cancer research are: chemically-induced models, xenograft 
models and genetically engineered models. Chemically-induced mice are injected with 
carcinogenic compounds which initiate the tumor formation commonly by inducing 
structural DNA changes. They are useful for understanding the molecular mechanisms 
in sporadic cancers. In xenograft models, the tumors are formed by injecting human 
cancer cells into immune deficient mice, either subcutaneously in the flank of mice 
(ectopic) or directly into the target tissue (orthotopic) and are t used for drug 
development and the study of metastasis (Heindryckx et al., 2009; Taketo and 
Edelmann, 2009). Finally, genetically engineered mice give the opportunity to 
investigate carcinogenesis pathways in detail (Heindryckx et al., 2009). 
Rodent models commonly used to better understand the mechanisms of human 
obesity and metabolic syndrome are induced with: high-fat diets, high-carbohydrate 
diets or a combination of the two, diets with high content of fructose or sucrose. Many 
more dietary components have been used to simulate the signs and the symptoms of 
metabolic syndrome (Panchal and Brown, 2010). Moreover, genetically engineered 
diabetic mice, chemically induced and genetic models (i.e. animals with autosomal 
recessive mutations in the leptin gene) are also employed (Panchal and Brown, 2010). 
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Whatever animal model is chosen to carry out experimental investigations, animal 
welfare, humane endpoints, and the application of the 3R principle (replacement: of 
animal with alternative methods if possible, reduction: in the number of animals used, 
and refinement: of methods to minimize animal suffering) should be considered and 
implemented in the design and the development of experiments (Russell and Burch, 
1959; Workman et al., 2010) 
 
.
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2. AIMS AND OBJECTIVES 
 
Aims 
 
The overall aim of the work described in this thesis was to assess the safety of a 
carotenoid-enriched engineered corn line (high-carotenoid corn) using its near-
isogenic unmodified counterpart M37W as a comparator in a subchronic toxicity study, 
and to explore the efficacy of the same engineered corn line in terms of its potential 
benefits in several mouse models of chronic disease. 
 
 
Objectives 
 
1. To investigate potential unintended effects of high-carotenoid corn in animal 
feeding experiments designed to evaluate subchronic toxicity. 
2. To investigate the potential chemopreventive effects of high-carotenoid corn on 
an induced colitis-associated mouse cancer model. 
3. To investigate the potential modulatory effects of high-carotenoid corn on insulin 
sensitivity and energy metabolism in a mouse model of obesity and insulin 
resistance generated by initial feeding on a high-fat diet. 
4. To investigate the potential effects of high-carotenoid corn on heterozygous PTEN 
knockout mice (PTEN +/-) as a model of multiple-organ neoplasia and liver disease.
  30  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3: Mice fe don a diet  
31 
 
 
 
 
 
 
 
 
 
3. EXPERIMENTAL CHAPTERS 
 
 
 
  32  
 
  
CHAPTER 3: Mice fe don a diet  
33 
 
 
 
 
 
 
 
 
CHAPTER 1  
Mice fed on a diet enriched with 
genetically-engineered high-carotenoid 
corn exhibit no subchronic toxicity 
 
 
  34  
 
 
 
 
 
 
 
 
 
 
 
 
3. CHAPTER 1  
 
35 
 
CHAPTER 1 
Mice fed on a diet enriched with genetically-engineered high-
carotenoid corn exhibit no subchronic toxicity 
 
3.1.1. INTRODUCTION 
  
Up to 50% of the world’s population suffers from multiple micronutrient deficiencies 
reflecting an over-dependence on foods that lack essential vitamins and minerals 
(Farre et al., 2010a, Farre et al., 2011a). As it was commented before, strategies that 
tackle micronutrient deficiency at source by creating nutrient-rich crops are known as 
biofortification approaches (Farre et al., 2011b). These should be targeted at staple 
crops such as rice and corn, which are the primary source of calories for more than 
75% of the human population (Food and Agriculture Organization, 2009). 
Genetic engineering is the most versatile approach for biofortification (Farre et al., 
2011b). There have been many reports of genetically engineered staple crops 
accumulating high levels of vitamins (reviewed in Zhu et al., 2008; Farre et al., 2010b; 
Bai et al., 2011). Most of these enhanced varieties are still at the laboratory testing 
phase or in early field trials, but at least one is very near to broad release. This is 
Golden Rice which is engineered with two genes conferring the ability to synthesize 
β-carotene (pro-vitamin A) in the endosperm (Ye et al., 2000; Paine et al., 2005). The 
advantage of high-carotenoid corn is that it addresses multiple nutrient deficiencies 
simultaneously and as such it represents a “next generation” nutritional intervention. 
There are two potential solutions to this challenge, the first to develop nutritionally 
enhanced staples that provide such high levels of a key target nutrient that a very 
small portion offers the full dietary reference intake. Mixed feed of different enhanced 
staples could then provide a full nutritional complement. This is unlikely to be practical 
because it would rely on the simultaneous availability of many varieties as well as user 
compliance to ensure the correct consumption ratio to achieve nutritional 
completeness while avoiding nutrient toxicity. The second solution is to develop staple 
crops simultaneously enhanced with different nutrients, providing a balanced and 
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nutritionally complete meal in a manageable portion. Such crops would be all but 
impossible to generate by conventional breeding even if sufficient genetic diversity 
were available, because many different traits would need to be targeted 
simultaneously (Naqvi et al., 2010). We have begun this process by developing a 
prototype high-carotenoid corn simultaneously engineered to accumulate high levels 
of β-carotene and other carotenoids (Zhu et al., 2008; Naqvi et al., 2009). These are 
biologically relevant levels, taking into account that 100-200g of high-carotenoid grain 
provides the full recommended daily intake (RDI) of β-carotene (provitamin A). 
Genetic engineering provides the only practical approach to develop nutritionally 
complete staples but one limitation of genetically engineered crops is the onerous 
regulatory environment (Ramessar et al., 2010; Sabalza et al., 2011). Such crops must 
undergo extensive tests that are not required of conventional varieties even if they are 
genetically identical, because the trigger for testing is the process used to generate the 
crops not the actual product (in Europe and many developing countries). As it was 
stated before, the assessment of nutritionally-enhanced varieties created by genetic 
engineering must include (among other tests) compositional analysis, laboratory 
feeding trials in animals to test subchronic toxicity as well as tests for allergenicity and 
nutritional assessments (Kuiper et al., 2001; Konig et al., 2004).  
The aim of 90-day subchronic toxicity evaluation is to determine any adverse effects 
caused by repeated exposure over a longer period. These assessments involve young 
animals and are designed to reveal signs of toxicity in organs, tissues and cells over a 
period long enough for major toxic effects to become apparent without any age-
associated change in tissue morphology or function (van Haver et al., 2008). In the case 
of genetically engineered plants, the evaluations are based on substantial equivalence 
or comparative assessment with conventional varieties of the same crop.  
As part of the development of our high-carotenoid corn, we therefore compared the 
proximates composition of high-carotenoid corn and non-transgenic corn diets and we 
carried out a 90-day subchronic feeding study, again with no indications of toxicity 
compared to mice fed on control diets. 
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3.1.2. MATERIALS AND METHODS 
 
3.1.2.1. Plant material 
 
High-carotenoid corn was created by the stable transformation of the South African 
inbred M37W with corn psy1 (phytoene synthase), Pantoea ananatis crtI (carotene 
desaturase), rice dhar (dehydroascorbate reductase) and Escherichia coli folE (GTP 
cyclohydrolase) under the control of various endosperm-specific promoters, together 
with the selectable marker gene bar (Naqvi et al., 2009). The corn used for the feeding 
experiments was from the T7 homozygous generation.  
 
3.1.2.2. Compositional analysis of experimental and control diets  
 
High-carotenoid and control corn plants were grown in the same greenhouse under 
exactly the same conditions over the same growing period. Carotenoid content was 
measured in a minimum of 10 individual plants by HPLC analysis and data were 
analyzed by Analysis of Variance (ANOVA). 
Experimental diets containing high-carotenoid corn and control diets containing wild-
type (WT) M37W corn were prepared from freeze-dried powdered kernels under 
hygienic conditions. Meals were prepared by mixing 2014 Teklad Global 14% Protein 
Rodent Maintenance Diet (Harlan Laboratories, Madison, USA) with the appropriate 
freeze-dried corn powder as a 60:40 ratio (w/w). 
The composition of the corn was compared by quantifying basic chemical parameters 
such as moisture, fat, ash, crude fiber and protein, as well as the target micronutrient 
levels of carotenoids (AOAC International, 2000). Moisture was obtained as the loss of 
weight after drying in an oven at 100ºC to a constant weight. Fat content was 
estimated using Soxhlet extraction. Ash levels were estimated by gravimetric analysis 
after ignition in an electric furnace. Crude fiber was determined from the difference 
between the weight of the residue remaining after the sample was digested under 
specific conditions and the weight of the ash. Protein was estimated through total 
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nitrogen content by the Dumas combustion method. Protein content was calculated by 
applying a nitrogen-to-protein conversion factor of 6.25. 
The β-carotene, ascorbate and folate levels were determined as described in Naqvi et 
al., 2009. 
 
3.1.2.3. Animal feeding studies 
 
The experimental design was adapted from OECD guidelines 408 and 409 for the 28 
and 90-day studies respectively, following EFSA recommendations (European Food 
Safety Authority, 2006). The study complied with Law 5/1995 and Act 214/1997 of the 
Autonomous Community (Generalitat) of Catalonia and EU Directives (EEC 63/2010), 
and was approved by the Ethics Committee on Animal Experiments of the University of 
Lleida.  
Male and female albino BALB/c mice obtained from Harlan Laboratories Models S.L. 
(Sant Feliu de Codines, Spain) were acclimated in individual cages one week before the 
experiment. The mice had ad libitum access to a standard 2014 Teklad Global 14% 
Protein Rodent Maintenance Diet and water. The animal rooms were environmentally 
controlled and maintained at 20 ± 2ºC, relative humidity 50 ± 5%, with a 12-h 
photoperiod. 
Following acclimation, 6-week-old animals were randomly assigned to three groups of 
12 (six male, six female) excluding animals deviating significantly from the group mean 
body weight (p < 0.05). Fresh food was supplied 2–3 times per week as required, for 90 
days. The reference group continued to be fed with the standard 2014 Teklad Global 
14% Protein Rodent Maintenance Diet after acclimation. The control group was fed 
with a 40:60 mixture of powdered wild-type corn kernels and the reference diet. The 
experimental group was fed with a 40:60 mixture of powdered high-carotenoid corn 
kernels and the reference diet.  
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3.1.2.4. Clinical observations 
 
Clinical observations were recorded before the experiment and daily while the 
experiment was in progress. No moribund or dead animals, abnormal behavior, 
abnormal appearance or abnormal droppings were observed. We also measured the 
feed intake and body weight of all mice on a weekly basis. 
We carried out biochemical and hematological tests on blood samples taken from the 
submandibular vein while the animals were under isoflurane anesthesia preceding the 
terminal sacrifice. Whole blood was collected in a tube containing 
Ethylenediaminetetraacetic acid (EDTA) as an anticoagulant and plasma was prepared 
by centrifugation at 1500 x g for 10 minutes prior to the analysis of alanine 
aminotransferase (ALT), total cholesterol, total protein, albumin and blood urea 
nitrogen (BUN) using a Hitachi Modular analyzer (Roche, Badalona, Spain). We also 
measured the white blood cell count (WBC), differential white blood cell count of 
neutrophils, lymphocytes, monocytes, eosinophils, basophiles, red blood cell count 
(RCB), hemoglobin (HGB), hematocrit (HTC), mean corpuscular volume (MCV), mean 
corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration 
(MCHC) using a Sysmex XE-5000 analyzer (Roche, Badalona, Spain).  
We also carried out autopsies on all animals, and determined the weight of adrenals, 
brain, epididymides, heart, kidneys, liver, ovaries, spleen, testes, thymus and uterus 
(paired organs were weighed together). The adrenals, aorta, cecum, cervix uteri, colon, 
duodenum, epididymides, eyes, heart, ileum, jejunum, kidneys, liver, lungs, esophagus, 
ovaries, pancreas, Peyer’s patches, prostate, rectum, sciatic nerve, seminal vesicle, 
spinal cord, spleen, sternum (bone marrow), stomach, bone and muscle (from femur 
and quadriceps), testes, thymus, thyroid/parathyroid, trachea, urinary bladder, uterus, 
vagina, biliar vesicle and skin were then fixed, dehydrated, embedded in paraffin, 
sectioned (4–5 μm) and stained with hematoxylin-eosin. The adrenals, brain, 
epididymides, heart, kidneys, liver, lungs, ovaries, pancreas, spleen, testes, thymus, 
thyroid/parathyroid and uterus of all animals were subject to histopathological 
analysis as these represent the major target organs for toxicity effects, and the 
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remaining samples were reserved for analysis in the event of abnormal histopathology 
of these initial specimens. 
 
3.1.2.5. Statistical analysis  
 
We compared animal weights, feed consumption, biochemical data, hematological 
data and organ weights between the high-carotenoid corn diet group and the 
reference diet group, and (separately) between the high-carotenoid corn diet group 
and the control corn diet group using PASW Statistics 18 (Version 18.0.0, 2009). The 
data were also analyzed separately in male and female groups. Differences were 
considered statistically significant at p < 0.05. 
We carried out preliminary homogeneity of variances (Levene’s Test) and normality of 
data distributions (Q-Q plots, histograms and Shapiro-Wilk tests) on all data 
(continuous values). If these tests were not statistically significant, we assumed 
Normal distribution, and we carried out ANOVA to compare the high-carotenoid corn 
diet group with both controls (t-Student test applying the Bonferroni method of 
correction for multiple comparisons). If one of the preliminary tests was significant, we 
carried out non-parametric tests using Kruskal-Wallis for k independent samples and if 
this yielded a significant result, we evaluated the contrasting data case-by-case using 
the Mann-Whitney test. For multiple comparisons we applied the Bonferroni method 
of adjustment to maintain a 5% type error rate per response variable in both bivariate 
tests. 
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3.1.3. RESULTS 
 
3.1.3.1. Compositional analysis  
 
There were minimal differences in proximate levels between the high-carotenoid corn 
and non-transgenic corn which did not have any impact on nutrition (supporting 
information Table 3.1.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1. 1. Wild-type M37W and high-carotenoid corn lines composition. 
a
Values are in μg per gram dry weight (DW).
 
 
 
Composition (%) Wild-type M37W 
corn grain 
High-carotenoid 
corn grain 
Moisture 5.21 5.89 
Fat 3.75 4.36 
Ash (% DW) 2.09 2.07 
Crude fiber 4.05 4.58 
Protein 14.62 16.75 
Starch 77.5 67.8 
β-carotenea 0.35 59.32 
Zeaxanthina 0.32 35.76 
Lycopenea 0 22.78 
Luteina 0.57 14.68 
α-cryptoxanthina - 13.42 
α-carotenea 0.12 7.26 
β-cryptoxanthina - 5.28 
γ-carotenea 0.09 4.79 
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3.1.3.2. Ninety-day subchronic toxicity assessment  
 
The animals in all three groups exhibited normal clinical signs before and during the 
assessment. There were no signs of abnormal appearance or behavior, no unusual 
droppings and no aversion to any of the diets. No mice died during the experiment. 
 
Figure 3.1. 1. Mean weekly feed consumption (mean ± CI 95%) of male and female mice. Animals were 
fed rodent diet (reference group), and rodent diets containing wild-type and high-carotenoid corn 
(multivitamin) for 13 weeks. 
After 13 weeks, there was no statistically significant difference (p < 0.05) in either food 
consumption (Figure 3.1.1) or body weight (Figure 3.1.2) among the three diet groups 
when comparing the whole groups or individual sexes, although males fed on the high-
carotenoid corn diet were on average marginally heavier (27.76 ± 0.75 g) than their 
counterparts in the other two groups (27.23 ± 1.01 g for the reference diet, 27.04 ± 
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1.13 g for the wild-type corn diet). The females in the reference, wild-type and high-
carotenoid diet groups weighed 21.94 ± 1.44 g, 22.39 ± 1.42 g and 22.24 ± 0.99 g, 
respectively. 
 
Figure 3.1. 2. Mean weekly body weights (mean ± Confidence Interval 95%) of male and female mice. 
Animals were fed rodent diet (reference group), and rodent diets containing wild-type and high-
carotenoid corn (multivitamin) for 13 weeks.  
 
There were no statistically significant differences (p < 0.05) between the high-
carotenoid corn group and either of the controls in terms of biochemical markers 
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(Table 3.1.2 and Table 3.1.3) or hematological parameters (Table 3.1.4 and Table 
3.1.5). 
  
 
Table 3.1. 2. Biochemistry mean values ± SD for males (a. N=5; b. N=4). ALT: alanine aminotransferase; 
BUN: Blood Urea Nitrogen. 
 
 
Group 
reference WT CAR 
Mean ± SD Mean ± SD Mean ± SD 
ALT (U/l) 84 ± 27 79 ± 24a 132 ± 46a 
BUN (ng/L) 0.224 ± 0.012 0.223 ± 0.035 0.215 ± 0.017b 
Total cholesterol 
(mg/dl) 
152 ± 24 148 ± 11 141 ± 10b 
Total protein 
(g/dl) 
4.9 ± 0.6 4.9 ± 0.2 4.8 ± 0.3a 
Albumin (g/dl) 2.99 ± 0.32 3.07 ± 0.18 3.11 ± 0.23a 
 
Blood samples were analyzed to determine the effect of each diet on known disease 
markers and to identify correlations between organ weights and histopathological 
findings. Because only a small amount of blood was available, we focused on a subset 
of the tests: ALT, alanine transaminase normally present in the liver and heart which is 
used to evaluate the health of those organs; BUN (blood urea nitrogen) which is a 
marker of kidney disease; total cholesterol, which is a cardiovascular disease risk 
biomarker; total proteins, which is a marker of immune system dysfunction as well as 
liver and kidney complications; and  albumin, as an indicator of liver damage and 
nutritional status. One high-carotenoid group male blood sample was hemolized and 
other was not possible to determinable it because it was not enough amount. 
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Table 3.1. 3. Biochemistry mean values ± SD for females (a. N=5). ALT: alanine aminotransferase; BUN: 
Blood Urea Nitrogen. 
 Group 
reference WT CAR 
Mean ± SD Mean ± SD Mean ± SD 
ALT (U/l) 136 ± 70 108 ± 40 135 ± 65 
BUN (ng/L) 0.246 ± 0.053 0.246 ± 0.038 0.224 ± 0.045 
Total cholesterol 
(mg/dl) 
118 ± 18 115 ± 14 128 ± 19 
Total protein 
(g/dl) 
4.5 ± 0.3 4.4 ± 0.3 4.6 ± 0.3 
Albumin (g/dl) 3.12 ± 0.13 2.99 ± 0.15a 3.11 ± 0.28 
 
We assessed standard hematological values such as the white blood cell count (WBC) 
and the differential white blood cell count (neutrophils, lymphocytes, monocytes, 
eosinophils and basophils). We also assessed the red blood cell count (RCB), 
hemoglobin content (HGB), hematocrit (HTC), mean corpuscular volume (MCV),  mean 
corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration 
(MCHC) to identify potential preliminary immunotoxicity or anemia caused by liver 
disease, etc.  
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Table 3.1. 4. Hematology mean values ± SD for males (a. N=5; b. N=4). WBC: White Blood Cell Count; 
RCB: Red Blood Cell count; HGB: hemoglobin; HCT: hematocrit; MCV: Mean Corpuscular Volume; MCH: 
Mean Corpuscular Hemoglobin; MCHC: Mean Corpuscular Hemoglobin Concentration. 
 Group 
reference WT CAR 
Mean ± SD Mean ± SD Mean ± SD 
WBC (10^3/uL) 5.80 ± 1.07a 5.94 ± 1.36 4.97 ± 1.45 
Neutrophils 
(10^3/uL) 
0.92 ± 0.22a 0.96 ± 0.26 0.75 ± 0.22a 
Lymhpocytes 
(10^3/uL) 
4.69 ± 0.90a 4.73 ± 1.11 4.09 ± 0.60b 
Monocytes 
(10^3/uL) 
0.13± 0.06 0.21± 0.10 0.13 ± 0.12 
Eosinophils 
(10^3/uL) 
0.04 ± 0.02 0.03 ± 0.02 0.03 ± 0.03 
Basophils (10^3/uL) 0.04 ± 0.08 0.01 ± 0.00 0.02 ± 0.03 
RBC (10^6/uL) 9.88 ± 0.52a 10.14 ± 0.24 9.91 ± 0.35 
HGB (g/dL) 15.12 ± 0.79a 15.57 ± 0.24 15.34 ± 0.56a 
HCT % 43.54 ± 1.79a 44.93 ± 1.02 44.02 ± 1.29 
MCV (fL) 44.45 ± 0.99 44.32 ± 0.22 44.42 ± 0.44 
MCH (pg) 15.33 ± 0.28 15.35 ± 0.22 15.38 ± 0.19a 
MCHC (g/dL) 34.48 ± 0.90 34.65 ± 0.50 34.70 ± 0.42a 
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Table 3.1. 5. Hematology mean values ± SD for females (a. N= 5). WBC: White Blood Cell Count; RCB: 
Red Blood Cell count; HGB: hemoglobin; HCT: hematocrit; MCV: Mean Corpuscular Volume; MCH: Mean 
Corpuscular Hemoglobin; MCHC: Mean Corpuscular Hemoglobin Concentration. 
 
 Group 
reference WT CAR 
Mean ± SD Mean ± SD Mean  ± SD 
WBC (10^3/uL) 5.34 ± 1.21 6.32 ± 2.65 5.52 ± 1.45 
Neutrophils 
(10^3/uL) 
0.67 ± 0.21 0.83 ± 0.20 0.85 ± 0.24 
Lymhpocytes 
(10^3/uL) 
4.09 ± 0.99 3.81 ± 1.00a 4.15 ± 1.19 
Monocytes 
(10^3/uL) 
0.53 ± 0.14 0.62 ± 0.28 0.48 ± 0.14 
Eosinophils 
(10^3/uL) 
0.02 ± 0.02 0.04 ± 0.03 0.03 ± 0.03 
Basophils (10^3/uL) 0.03 ± 0.03 0.07 ± 0.14 0.01 ± 0.00 
RBC (10^6/uL) 9.48 ± 0.26 9.41 ± 0.31 9.56 ± 0.32 
HGB (g/dL) 15.07 ± 0.40 15.08 ± 0.42 15.33 ± 0.55 
HCT % 42.25 ± 1.16 42.00 ± 1.24 42.50 ± 1.52 
MCV (fL) 44.58 ±0.17 44.65 ± 0.23 44.45 ± 0.40 
MCH (pg) 15.90 ±0.37 16.03 ± 0.27 16.03 ± 0.18 
MCHC (g/dL) 35.67 ±0.70 35.93 ± 0.60 36.07 ± 0.42 
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We observed no significant differences (p < 0.05) between the high-carotenoid corn-
fed group and control groups in terms of absolute organ weights, or organ weights 
relative to brain or body weights, changes in which often signify potential 
hepatocellular, myocardial, adrenal gland and renal tubular hypertrophy, neurotoxicity 
in the brain and toxicity-related alterations in reproductive or lymphoid organs. For 
these assays we measured the weights of the adrenals, brain, epididymis, heart, 
kidneys, liver, ovaries, spleen, testes thymus and uterus (Table 3.1.6 and Table 3.1.7)  
 
Table 3.1. 6. Final body weight and absolute organ mean values ± SD for males. 
 
 
Group 
reference WT CAR 
Mean  ± SD Mean ± SD Mean ± SD 
Final body 
weight (g) 
27.23± 1.01 27,04 ± 1,13 27,76 ± 0,75 
Adrenals (g) 0.0033 ± 0.0013 0,0033 ± 0,0016 0,0027 ± 0,0006 
Brain (g) 0.3110 ± 0.0341 0,3352 ± 0,0476 0,3404 ± 0,0480 
Epididymis (g) 0.1055 ± 0.0076 0,1093 ± 0,0122 0,1112 ± 0,0087 
Heart (g) 0.1502 ± 0.0082 0,1479 ± 0,0077 0,1493 ± 0,0062 
Kidneys (g) 0.4070 ± 0.0431 0,3975 ± 0,0322 0,3907 ± 0,0308 
Liver (g) 1.3006 ± 0.1120 1,2889 ± 0,0514 1,2516 ± 0,1447 
Spleen (g) 0.0707 ± 0.0132 0,0876 ± 0,0119 0,0822 ± 0,0039 
Testes (g) 0.2169 ± 0.0225 0,2223 ± 0,0054 0,2153 ± 0,0123 
Thymus (g) 0.0303 ± 0.0021 0,0299 ± 0,0050 0,0318 ± 0,0092 
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Table 3.1. 7.  Final body weight and absolute organ mean values ± SD for females. 
 
 
Group 
reference WT CAR 
Mean ± SD Mean ± SD Mean ± SD 
Final body 
weight 
21.94 ± 1.44 22,39 ± 1,42 22,24 ± 0,99 
Adrenals (g) 0.0054 ± 0.0015 0,0061 ± 0,0014 0,0062 ± 0,0005 
Brain (g) 0.3313 ± 0.0315 0,3299 ± 0,0137 0,3305 ± 0,0302 
Heart (g) 0.1135 ± 0.0093 0,1167 ± 0,0096 0,1148 ± 0,0093 
Kidneys (g) 0.2654 ± 0.0325 0,2629 ± 0,0296 0,2557 ± 0,0024 
Liver (g) 1.0116 ± 0.0914 1,0126 ± 1,0639 1,0203 ± 0,0901 
Ovaries (g) 0.0130 ± 0.0027 0,0106 ± 0,0027 0,0111 ± 0,0022 
Spleen (g) 0.0833 ± 0.0064 0,0947 ± 0,0084 0,0832 ± 0,0110 
Thymus (g) 0.0274 ± 0.0036 0,0272 ± 0,0041 0,0293 ± 0,0058 
Uterus(g) 0.0708 ± 0.0384 0,0609 ± 0,0130 0,0778 ± 0,0054 
 
 
We identified no histopathological anomalies specific to the high-carotenoid corn diet 
(Table 3.1.8). The few anomalies observed were distributed among all three animal 
groups and are commonly observed in rodents of this age and are considered 
spontaneous. Some of these histopathological events are shown with normal tissue 
structures for comparison in Figure 3.1.3. 
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Table 3.1. 8. Histopathologic analyses for male and female mice of reference (REF), WT and CAR groups. 
 
  
Males Females 
  
REF WT CAR REF WT CAR 
epididymides oligospermia 1 0 0 - - - 
heart 
hypertrophy 4 4 3 1 3 3 
contraction band 1 3 1 2 0 0 
kidneys 
lymphoid aggregates 1 1 3 1 0 1 
extravased red blood cells 
in the interstitium 
6 6 6 5 6 6 
liver 
sinusoid congestion and 
central vein dilatation 
6 6 6 6 6 6 
steatosis 5 4 4 0 0 1 
inflammatory cells and 
necrotic debris 
1 3 4 6 5 6 
iron deposits 1 1 0 3 2 2 
apoptotic cells 1 0 0 0 0 0 
spleen pigment, increased 5 6 6 6 6 6 
thyroid/ 
parathyroid 
cyst change 0 0 0 1 0 0 
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Figure 3.1. 3. Histology (hematoxylin and eosin staining) from liver (a-f) and kidneys (g-l) x 20 (x 40 in the 
box) and heart (m-r) x 40 (x 63 in the box); (a) (b) and (c) showing normal liver structure from reference, 
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wild-type and multivitamin (high-carotenoid) groups respectively; (d-f) showing lymphoid aggregates 
(black arrowhead), sinusoid congestion and/or central vein dilatation (white arrow) and steatosis (black 
arrow); (g) (h) and (i) showing normal kidney structure from reference, wild-type and multivitamin 
groups respectively; (j-l) showing lymphoid aggregates (white *) and red blood cells in the interestitium 
(black *);  (m), (n) and (o) showing normal heart structure from reference, wild-type and multivitamin 
groups respectively; (p-r) showing contraction bands (yellow arrow) and hypertrophic cells (yellow 
arrowhead) with increased nuclear size in comparison with normal cell (yellow *). 
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3.1.4. DISCUSSION 
 
We had previously reported the development of a prototype high-carotenoid corn 
variety based on the South African elite white corn inbred M37W. This corn is 
simultaneously engineered to accumulate high levels of carotenoids (Zhu et al., 2008; 
Naqvi et al., 2009).  
All genetically engineered crops intended for consumption by humans must be 
rigorously tested to ensure safety, with the benchmark set by comparison to an 
equivalent unmodified variety which is ‘Generally Regarded As Safe’. Genetically 
engineered crops are evaluated to determine acute and subchronic toxicity as well as 
allergenicity. Similar assessments are not required of non-transgenic varieties even if 
these are genetically identical to a transgenic crop but are produced by mutation or 
conventional breeding. They are not required even if the conventional crop is 
generated by crossing to wild species that are known to contain toxins or allergens. 
The double standards applied to genetically engineered and conventional crops have 
the unfortunate consequence that engineered crops such as Golden Rice, which could 
provide a real and immediate benefit to poor populations in developing countries riven 
by micronutrient deficiency diseases, are held up in a regulatory quagmire and lives 
continue to be lost unnecessarily (Potrykus, 2010). 
The aim of subchronic toxicity evaluation is to determine any adverse effects caused 
by repeated exposure for a longer period. EFSA guidelines recommend that risk 
assessments should include at least a 90-day toxicity assessment on whole food/feed 
in rodents if the composition of the engineered crop is modified substantially or if 
there are indications for possible unintended effects (European Food Safety Authority, 
2011a). However, these requirements have now become de facto standards for 
engineered crops even if there is no evidence of potential adverse effects, and are 
recommended in Europe to increase consumer confidence that food/feed from 
engineered crops is as safe as a conventional counterpart (European Food Safety 
Authority, 2011b). 
Our compositional analysis clearly showed no nutritionally-relevant differences 
between the high-carotenoid corn and the control corn in terms of major constituents, 
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and indeed the only difference was the expected higher levels of carotenoids in the 
high-carotenoid corn. These nutritional differences represent the intended effects of 
the genetic modification and therefore do not constitute ‘unintended effects’ that the 
safety tests are ostensibly designed to identify. Having established the substantial 
equivalence of high-carotenoid and control corn, we carried out a 90-day subchronic 
toxicity evaluation to determine the effects of repeated exposure to the diet over a 
period long enough for toxicity to become apparent but too short for age-related 
effects to interfere with the results. The three groups were indistinguishable, showing 
similar food consumption rates, body weights and body weight gains. Food 
consumption and body weight are usually measured weekly in feeding trials as these 
parameters are health and wellbeing indicators, as well as highlighting unintended 
nutritional effects. The weight gain we observed was within the normal range for 
animals of this age. The mean consumption of high-carotenoid corn in this trial was 
~57 g/kg body weight/day, which is approximately 210-fold more than the safety 
margin in humans (~0.27g/kg body weight/day; DEEMTM, 2002). 
There were no significant differences between the groups in terms of clinical 
observations, hematological parameters, biochemical markers and absolute or relative 
organ weights. Histopathology revealed a similar prevalence of anomalies among the 
three groups which are regarded as spontaneous, in agreement with data from 
previous feeding trials involving crops engineered for herbicide tolerance and pest 
resistance (Appenzeller et al., 2009; Hammond et al., 2004; Hammond et al., 2006; 
Healy et al., 2008). 
In conclusion, the genetically engineered high-carotenoid corn did not show any 
unintended effects in animal feeding trials designed to evaluate subchronic toxicity, 
test which although are not mandated by law in most jurisdictions will facilitate public 
acceptance of high-carotenoid corn for human consumption. Diets prepared with high-
carotenoid corn were palatable, nutritious and safe in animals, which should pave the 
way for human trials and the eventual deployment of high-carotenoid corn in 
developing country settings to help combat simultaneous multiple micronutrient 
deficiencies among populations that subsist on a predominantly cereal-based diet. 
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CHAPTER 2 
Chemoprevention of tumor development in the mouse 
AOM/DSS model of colitis-associated carcinogenesis by diets 
enriched with high-carotenoid corn  
3.2.1. INTRODUCTION 
 
Colorectal cancer (CRC) is the third most common cancer worldwide and the second 
most common in Europe (Bray et al., 2013). The disease has three etiologies: sporadic, 
hereditary and inflammatory (colitis-associated). Furthermore, inflammatory bowel 
disease (IBD), including ulcerative colitis and Crohn’s disease, is associated with a high 
risk of CRC (Wang and Dubois, 2010) .  
Diets rich in fruit, vegetables and whole grains reduce the risk of CRC (Park et al., 2005; 
Haas et al., 2009; Pan et al., 2011; Aune et al., 2011). The ability of healthy diets to 
reduce the risk of cancer has been widely reported, particularly the role of dietary 
phytochemicals (Surh, 2003; Aggarwal and Shishodia, 2006; Pan et al., 2011). Although 
phytochemicals are non-essential nutrients, they can inhibit the signaling pathways 
that promote carcinogenesis (Surh, 2003; Aggarwal and Shishodia, 2006).  
Carotenoids are a family of more than 750 natural, lipid-soluble pigments, 50 of which 
are found in the human diet (Ciccone et al., 2013). Vegetables and fruits typically 
contain α-carotene, β-carotene, β-cryptoxanthin, lutein, lycopene and zeaxanthin 
among others (Farré et al., 2011). Marine animals also accumulate carotenoids when 
they consume algae and plankton (Tanaka et al., 2012). 
Carotenoids act as modulators of several inflammatory cytokines produced during 
colitis-associated carcinogenesis (Tanaka et al., 2012). Cyclo-oxygenase 2 (COX-2) a 
prostaglandin-endoperoxide synthase required for the formation of biological 
mediators of inflammatory responses, including the production of prostaglandins, 
prostacyclin and thromboxane, can be regulated by nuclear factor kappa B (NF-κB) and 
mitogen-activated protein kinase (MAPK), as shown in Figure 3.2.1 (Sheng et al., 2001; 
Dong et al., 2003; Mari et al., 2007; Nagendraprablhu et al., 2011). The signaling 
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protein p44/42MAPK, also known as ERK1/2 and MAPK3/1, regulates cell proliferation, 
differentiation, motility and survival. The inhibition of MAPK pathways results in the 
downregulation and suppression of COX-2 expression (Roux and Blenis, 2004; Binion et 
al., 2008). COX-2 mediates inflammation, apoptosis, differentiation, cell migration and 
progression through the cell cycle, and can also be downregulated by carotenoids in 
CRC mice (Nagendraprablhu et al., 2011; Yasui et al., 2011).  
 
 
 
 
 
 
 
 
Although the ability of carotenoids to prevent CRC in human trials is not clearly 
established (Park et al. 2009; Park et al. 2010; Williams et al. 2010), carotenoid dietary 
supplements have been shown to inhibit disease progression in rodent CRC models  
(Temple and Basu, 1987; Narisawa et al., 1996; Kim et al., 1998; Rijken et al., 1999;
Figure 3.2. 1. Model for the regulation of COX-2 expression by IL-1. IL-1, a key cytokine associated with 
the inflammation of the intestinal mucosa, binds to its receptor and can activate the MAPK, NF-B and 
protein kinase C (PKCζ) pathways. The transcription of COX-2 depends on extracellular signal-regulated 
kinase/mitogen-activated protein kinase (ERK/MAPK) and p38 MAPK activation as well as the generation 
of reactive oxygen species (ROS), driving  NF-κB-mediated activation of the COX-2 promoter. Adapted 
from Mari et al. (2007). 
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Narisawa et al., 1999; Tanaka et al., 2000a; Suzuki et al., 2007; Tanaka et al., 2008; 
Nagendraprablhu et al., 2011; Yasui et al., 2011; Kawabata et al., 2012). The 
development of genetically-engineered high-carotenoid corn provides an opportunity 
to study the impact of the food matrix on carotenoid bioaccessibility and bioavailability 
compared to the provision of carotenoids as supplements. It also allows the analysis of 
the synergic effects caused by several carotenoids in the same feed. The beneficial 
effects can be determined by comparing animals fed on the high-carotenoid corn with 
those fed on a near-isogenic wild-type variety.  
The azoxymethane/dextran sulfate sodium (AOM/DSS) mouse model of colitis-
associated colorectal carcinogenesis closely resembles human inflammation-
associated CRC pathogenesis and therefore provides a good model for 
chemoprotective efficacy experiments (Tanaka et al., 2008; Oyama et al., 2009; Butler 
et al., 2013). Unlike dimethylhydrazine (DMH) used in previous studies (Viñas-Salas et 
al., 1992; Viñas-Salas et al., 1998) the AOM/DSS model uses a single dose of AOM to 
induce colorectal tumors together with DSS as a promoter of colitis (Tanaka et al., 
2003; De Robertis et al., 2011).  
The aim of this study was to evaluate the potential chemoprotective effect of the 
mixture of carotenoids delivered by high-carotenoid corn in an inflammation-related 
AOM/DSS mouse model. The incidence and morphology of tumors was evaluated in 
each individual animal by high-resolution endoscopy during the feeding trial. The 
molecular basis of colitis-associated carcinogenesis was investigated by monitoring 
several inflammation-related markers, such as COX-2 and MAPK. 
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3.2.2. MATERIALS AND METHODS 
 
3.2.2.1. Animal feeding study, diets and chemicals 
 
The study complied with Law 5/1995 and Act 214/1997 of the Autonomous 
Community (Generalitat) of Catalonia, as well as EU Directive EEC 63/2010. It was 
approved by the Ethics Committee on Animal Experiments of the University of Lleida 
and by the Ethics Commission on Animal Experimentation of the Generalitat de 
Catalunya (approved protocol number 7746). 
 
Figure 3.2. 2. Experimental design and timeline of the colitis-associated colon carcinogenesis 
experiment. The animals were fed on diets based on wild-type (WT) or high-carotenoid (CAR) corn 
commencing at 6 weeks old. After 8 weeks, the mice were injected with azoxymethane (AOM), and 1.5% 
dextran sodium sulfate (DSS) was introduced into the drinking water 1 week later. Endoscopic follow-up 
was carried out 6 weeks after the AOM injection at 2-week intervals for 2 months. The animals were 
assigned to each group (day 0) as follows: WT control n = 2, WT 1.5% DSS n = 2, WT AOM n = 2, WT 
AOM/DSS n = 14; CAR control n = 2, CAR 1.5% DSS n = 2, CAR AOM n = 2, CAR AOM/DSS n = 14. 
 
Female ICR (CD-1®) mice obtained from Harlan Laboratories S.L. (Sant Feliu de Codines, 
Spain) were acclimated in individual cages 1 week before the experiment. The mice 
had ad libitum access to a standard 2014 Teklad Global 14% protein rodent 
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maintenance diet and water. The animal rooms were environmentally controlled and 
maintained at 20 ± 2°C and 50 ± 5% relative humidity, with a 12-h photoperiod. 
Following acclimation, 40 6-week-old females were randomly assigned to eight groups 
(Figure 3.2.2) and housed in separate cages (five mice per cage) with access to food 
and water as above. Body weight and food consumption were measured weekly for 20 
weeks. Experimental diets containing the wild-type or high-carotenoid corn (grown 
under the same conditions and harvested at the same time) were prepared from 
freeze-dried powdered kernels under hygienic conditions. Feed was prepared by 
mixing the purified AIN-76A diet (Research Diets, Inc.) with the appropriate freeze-
dried corn powder in a 60:40 ratio (w/w).  
The feeding trial was run for 8 weeks, and then the 14-week-old mice were injected 
intraperitoneally with one dose (10 mg/kg body weight) of AOM (Sigma-Aldrich, 
Taufkirchen, Germany) in phosphate-buffered saline (PBS). They were then provided 
with 1.5% DSS (50,000 molecular weight; MP Biomedicals, Illkirch, France) in drinking 
water for 7 days, one week after the AOM injection.  
 
3.2.2.2. Colonoscopy 
 
Six weeks after the AOM injection and at 2-week intervals thereafter, colonoscopy was 
carried out under anesthesia (2% isoflurane) using a Coloview rigid colonoscope (Karl 
Storz, Tuttlingen, Germany). Approximately 4 cm of the colon was visualized with air 
insulation to score the number, size and changing morphology of the lesions. The 
tumor size score was adapted from Becker et al. (2005) and graded 1 (ranging from a 
small detectable tumor to a tumor covering up to 12.5% of the colonic circumference) 
or 2 (tumor covering ≥ 25% of the colonic circumference). 
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3.2.2.3. Blood analysis and histopathology  
 
Twelve weeks after the AOM injection (26-week-old mice) blood samples were 
obtained via cardiac puncture under 2% isoflurane anesthesia and the mice were 
sacrificed by exsanguination. Whole blood was collected in a tube containing EDTA, 
and plasma was prepared by centrifugation at 1500 x g (10 min) before analyzing 
hematological parameters. Complete necropsy was carried out and colons were 
excised and flushed with PBS so that the colon length (ceccum, distal, proximal) and 
liver weight could be measured. Colonic mucosa, colonic lesions and liver tissue were 
immediately frozen in liquid nitrogen for storage or were placed in 10% neutral-
buffered formalin and embedded in paraffin for histopathology. Sections (4-5 µm) 
were stained with hematoxylin and eosin. Colonic tumors were analyzed for tumor 
incidence (number of animals presenting tumors), tumor multiplicity (number of 
tumors per tumor-bearing animal) and tumor size (mm2). 
 
3.2.2.4. Total RNA extraction and quantitative real-time PCR 
 
Total RNA was extracted from the colonic mucosa using the RNeasy Total RNA kit 
(Qiagen, Valencia, CA, USA) and cDNA was generated using the High Capacity cDNA 
Archive Kit (Applied Biosystems, Foster City, CA). The cDNA was heated to 95°C for 
10 min, and amplified by 40 PCR cycles of 95°C for 15 s and 60°C for 1 min. 
Quantitative real-time PCR was carried out on the ABI Prism 7900 Sequence Detection 
System (Applied Biosystems) using Promega GoTaq® qPCR Master Mix (California, 
USA). Relative mRNA expression levels were calculated using the ∆∆Ct method and 
presented as ratios based on the housekeeping genes GAPDH encoding 
glyceraldehyde-3-phosphate dehydrogenase, used for the tumor necrosis factor alpha 
(TNF-α) control, or TBP encoding the TATA-binding protein, used as a control for all 
other genes. The primers were based on the following deposited sequences: TNF-α, 
Mm00443260_g1; NF-κB1, Mm00476361_m1; NF-E2-related factor 2 (NRF-2), 
Mm00477784_m1; TBP, Mm00446971_m1; GAPDH, Mm99999915_g1. 
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3.2.2.5. Immunohistochemistry 
 
Paraffin-embedded sections of colon tissue (4-5 µm) were dried for 16 h at 56°C, 
cleared in xylene, rehydrated through a graded ethanol series (60%, 95% and 100%) 
and washed in PBS. The slides were microwave-heated for 2 min in 10 mmol/l citrate 
buffer (pH 6.5) or EDTA buffer (pH 8.0) for antigen retrieval. Endogenous peroxidase 
activity was blocked by immersing the sections in hydrogen peroxide. The primary 
antibody was anti-COX-2 (sc-1746, 1:200 dilution; Santa Cruz Biotechnology, Inc., Santa 
Cruz, CA, USA). After incubation, horseradish peroxidase activity was visualized using 
the EnVision Detection Kit (DAKO) with 3,3’-diaminobenzidine chromogen as the 
substrate. The sections were counterstained with hematoxylin. Immunoreactivity was 
scored by determining the percentage of COX-2 positive cells under an Olympus BX50 
optical microscope as follows: 1+ = 1–24%, 2+ = 25–49%, 3+ = 50–74%, 4+ =75–100%. 
 
3.2.2.6. Western blot 
 
Colons were homogenized in a Polytron® device at 4°C using a buffer containing 180 
mM KCl, 5 mM MOPS, 2 mM EDTA, 1 mM diethylene triamine penta-acetic acid, 1 μM 
butylated hydroxyltoluene, 10 μg/ml aprotinin, 1 mM NaF, 1 mM Na3VO4 and 1% v/v 
protease inhibitor mix 80–6501-23 (GE Healthcare, Piscataway, USA). Proteins were 
quantified using the Bradford method and mixed pools of each group (40 g total 
protein per lane) were separated by sodium dodecylsulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) using 10% polyacrylamide gels. The proteins were 
transferred to polyvinylidene difluoride membranes (Immobilon-P Millipore, Bedford, 
MA, USA) and stained with Ponceau S as a loading control. Primary and secondary 
antibodies are listed in Table 3.2.1. Protein bands were visualized using 
chemiluminescent horseradish peroxidase (Millipore Corporation, Billerica, MA, USA) 
and band intensity was measured using the Bio-Rad Gel Doc/Chemi Doc Imaging 
System and Image Lab 4.0.1 software (Bio-Rad Laboratories, Munich, Germany). 
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Table 3.2. 1. Primary and secondary antibodies for western blot immunodetection. 
Antigen Supplier Reference Dilution 
COX-2 Santa Cruz 
Biotechnology 
sc-1746 1:200 
p44/42 MAP Kinase Cell Signaling 4695 1:1000 
Anti-rabbit IgG Thermo Scientific 
Pierce 
31460 1:100000 
Anti-goat IgG Santa Cruz 
Biotechnology 
SC2020 1:12000 
 
3.2.2.7. Statistics 
Values are presented as means ± standard errors of the mean (SEM). Data were 
compared by one-way ANOVA with Bonferroni correction or Student’s t-test. Fisher’s 
exact probability test was used to compare the incidence of lesions among groups.  
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3.2.3. RESULTS 
 
3.2.3.1. General observations 
 
Three animals from the WT AOM/DSS group and one from the CAR AOM/DSS group 
died or were sacrificed after exposure to AOM/DSS because they exhibited 
gastrointestinal bleeding and lethargy. One mouse in the WT AOM/DSS group was 
unable to recover from anesthesia after the first colonoscopy. The high-carotenoid 
corn diet showed no evidence of toxicity and there was no abnormal change in liver 
histology compared to animals fed on the wild-type corn diet. These results were 
consistent with our previously-reported 90-day subchronic toxicity feeding trial (Arjó et 
al. 2012). The mean initial and final body weights, liver weight and relative weight and 
colon length are shown in Table 3.2.2. 
We first considered the impact of different treatments in each of the diet groups. The 
AOM/DSS WT group consumed significantly more food than the control WT group (p = 
0.0004) and their mean liver weight was significantly lower (p = 0.0246). The mean 
liver weight of the AOM/DSS WT group was also significantly lower than the DSS WT 
group (p = 0.0267). In contrast, there were no significant differences between the 
treatment groups when mice were fed the high-carotenoid corn, except that the mean 
liver weight of the AOM/DSS CAR mice was significantly lower than the control CAR 
group (p = 0.0097). The lowest mean liver weights and relative liver weights were 
found in mice exposed to AOM/DSS or DSS alone. The latter group also had 
significantly shorter colons than the untreated control when both were fed on the 
wild-type corn diet (p = 0.0095).   
The relevant comparison to determine the effects of high-carotenoid corn was 
between AOM/DSS-treated mice in the different diet groups (WT and CAR). There 
were no statistically significant differences between these groups in terms of initial and 
final body weight, colon length or liver weight, although the relative liver weight in the 
AOM/DSS CAR group was significantly lower than that of the AOM/DSS WT group (p = 
0.0306) (Table 3.2.2). There were no significant differences in hematology parameters 
between diet groups under the same treatment regime (Table 3.2.3), only between the 
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DSS WT and DSS CAR groups in the percentage of lymphocytes, monocytes, 
hemoglobin and hematocrit. 
Table 3.2. 2. Body weight (BW), food consumption (FC), liver weight and colon length. a Significant 
based on Student’s t-test at p < 0.05 compared to AOM/DSS WT group. All values are presented as 
means ± SEM. 
Group 
Initial 
BW(g) 
Final BW 
(g) 
FC 
(g/mouse/day) 
Liver  
weight 
(g) 
Relative 
liver  
weight 
(g/100 g 
BW) 
Length of 
large 
bowel 
(cm) 
Control 
WT (n=2) 
25.9 ± 
1.4 
34.4 ± 
2.1 
3.50 ± 0.07 
1.49 ± 
0.04 
4.675 ± 
0.005 
14.65 ± 
0.05 
DSS WT 
(n=2) 
24.2 ± 
1.6 
34.0 ± 
3.1 
3.87 ± 0.09 
1.24 ± 
0.09 
3.650 ± 
0.070 
12.05 ± 
0.25 
AOM WT 
(n=2) 
26.5 ± 
1.6 
30.7 ± 
0.5 
3.55 ± 0.15 
1.43 ± 
0.25 
4.690 ± 
0.910 
13.05 ± 
0.45 
AOM/DSS 
WT (n=10) 
25.9 ± 
0.8 
31.2 ± 
0.6 
3.91 ± 0.06 
1.33 ± 
0.03 
4.264 ± 
0.101 
12.88 ± 
0.41 
Control 
CAR (n=2) 
25.9 ± 
0.5 
36.0 ± 
2.3 
3.71 ± 0.08 
1.62 ± 
0.11 
4.035 ± 
0.265 
13.95 ± 
2.65 
DSS CAR 
(n=2) 
24.2 ± 
0.2 
34.2 ± 
0.9 
3.83 ± 0.071 
1.24 ± 
0.06 
3.635 ± 
0.095 
13.65 ± 
0.55 
AOM CAR 
(n=2) 
25.7 ± 
0.3 
30.5 ± 
1.0 
4.10 ± 0.21 
1.32 ± 
0.08 
4.315 ± 
0.115 
12.20 ± 
1.90 
AOM/DSS 
CAR 
(n=13) 
26.2 ± 
0.5 
32.7 ± 
1.0 
3.94 ± 0.11 
1.29 ± 
0.04 
3.952 ± 
0.089a 
13.07 ± 
0.38 
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Table 3.2. 3. Analysis of hematologic parameters: white blood cell count (WBC), neutrophils (Neutr), 
lymphocytes (Lym), monocytes (Mono), eosinophils (Eos), red blood cell count (RBC), hemoglobin (HGB), 
hematocrit (HTC). All values are presented as means ± SEM.  
a
 RBC determination error in all samples. 
 
 
 
 
 
 
WBC 
(103/µl) 
Neutr 
(%) 
Lym 
(%) 
Mono 
(%) 
Eos (%) 
RBC 
(106/µl) 
HGB 
(g/dl) 
HTC 
(%) 
Control 
WT 
n=2 
2.31 ± 
0.86 
19.3 ± 
6.5 
76.85 ± 
7.75 
3.85 ± 
1.25 
0 
8.57 ± 
0.32 
13.25 ± 
0.55 
40.15 ± 
1.05 
DSS 
WT 
n=2 
4.11 ± 
1.31 
11.55 ± 
2.85 
81.3 ± 
3.0 
11.5 ± 
0.4 
0 
9.5 ± 
0.5 
14.8 ± 
0.6 
44.45 ± 
2.95 
AOM 
WT 
n=2 
3.565 ± 
1.42 
14.1 ± 
3.40 
76.7 ± 
11.2 
8.85 ± 
7.95 
0 
9.405 ± 
0.38 
14.9 ± 
0.4 
44.45 ± 
1.55 
AOM/
DSS 
WT 
n=10 
2.815 ± 
0.390 
21.25 ± 
4.46 
72.14 ± 
4.36 
6.35 ± 
1.90 
0.06 ± 
0.06 
7.719 ± 
0.55 
12.61 ± 
0.88 
37.77 ± 
2.42 
Control 
CAR 
n=2 
1.155 ± 
0.285 
15.8 ± 
1.3 
81.55 ± 
2.95 
1.55 ± 
1.55 
0.8 ± 
0.2 
9.53 ± 
0.5 
14.95 ± 
0.55 
45.85 ± 
1.55 
DSS 
CAR 
n=2 
4.075 ± 
0.945 
3.985 ± 
0.865 
79.05 ± 
4.25 
17.95 ± 
3.45 
3.0 ± 
0.8 
- a 
9.47 ± 
0.18 
15.1 ± 
0.5 
AOM 
CAR 
n=2 
1.625 ± 
0.105 
20.75 ± 
6.95 
75.1 ± 
4.2 
3.5 ± 
2.8 
0.3 ± 
0.3 
8.815 ± 
0.325 
14.80 ± 
0.60 
43.9 ± 
2.8 
AOM/
DSS 
CAR 
n=13 
2.8031 
± 
0.6105 
19.584
6 ± 
2.2839 
73.138
5 ± 
2.6815 
6.9615 
± 
2.4912 
0.2154 
± 
0.1192 
7.554 ± 
0.4686 
12.292
3 ± 
0.8486 
37.476
9 ± 
2.4327 
3. CHAPTER 2  
 
72 
 
3.2.3.2. Incidence and multiplicity of colonic lesions after 6 to 12 weeks follow up 
by colonoscopy  
 
High-resolution endoscopy allowed the progression of tumor growth to be followed in 
individual animals by visualizing 3-4 cm of colon, and was carried out every 2 weeks 
(Figure 3.2.3A). The incidence of tumors in the AOM/DSS CAR group was lower than in 
the AOM/DSS WT group at earlier stages although the difference was not statistically 
significant (Figure 3.2.3B), but the incidence was similar in both groups at 12 weeks (p 
> 0.05). The AOM/DSS CAR group also had a lower tumor multiplicity in tumor-bearing 
mice and a lower tumor score compared to the corresponding WT animals (e.g. the 
tumor multiplicity 6 weeks after the AOM injection was 2.50 ± 1.15 in the WT group vs. 
0.87 ± 0.64 in the CAR group, and the tumor score was 10.00 ± 1.15 in the WT group 
vs. 4.33 ± 2.85 in the CAR group). Again, the difference in values was not statistically 
significant.  
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Figure 3.2. 3. Endoscopic images, incidence, multiplicity and score of colonic tumors identified by 
endoscopic visualization. (A) Representative colonoscopy images showing tumor progression: i) and iv) 
colitis at 6 weeks; ii) and v) small flat tumor at 8 weeks; iii) flat tumor at 12 weeks; vi) flat tumor and 
colitis at 10 weeks. (B) Quantitative analysis of tumor incidence in AOM/DSS WT (n = 10) and AOM/DSS 
CAR (n = 13) groups, and tumor multiplicity and score data in tumor-bearing mice (n = 8 in AOM/DSS WT 
and n = 10 in AOM/DSS CAR) obtained by endoscopic visualization. The tumor score per animal was 
based on the sum of size score of all tumors found by colonoscopy per animal and each tumor size was 
graded 1 (ranging from a from very small detectable tumor to a tumor covering up to 12.5% of the 
colonic circumference) or 2 (tumor covering ≥ 25% of the colonic circumference). All values are 
presented as means ± SEM. 
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3.2.3.3. Incidence and multiplicity of colonic lesions after 12 weeks  
 
The colonoscopy and colonic lesion necropsy data were compared at the end of the 
experiment to determine the reliability of the colonoscopy method. Twelve weeks 
after the AOM injection, it was possible to visualize 71% of the total colorectal lesions 
in the AOM/DSS WT group and 54% in the AOM/DSS CAR group, compared to the 
numbers observed by necropsy. 
The number of mice with macroscopic colonic lesions in dissected colons 12 weeks 
after the AOM injection was 8/10 (80%) in the AOM/DSS WT group and 10/13 (77%) in 
AOM/DSS CAR group, a difference that was not statistically significant (Table 3.2.4). 
One animal in the AOM WT group presented a tumor with an area of 0.375 mm2 (data 
not shown). There was a higher multiplicity of colonic lesions in the AOM/DSS WT 
group compared to the AOM/DSS CAR group (8.71 ± 2.60 vs. 5.60 ± 2.001). The mean 
colon tumor area in the AOM/DSS WT group was 0.968 ± 0.294 mm2 compared to 
0.547 ± 0.1875 mm2 in the corresponding CAR group, and the total tumor area was 
10.73 ± 4.618 mm2 in the WT group and 5.500 ± 3.905 mm2 in the corresponding CAR 
group. All these differences represented a definite trend but were not statistically 
significant (p > 0.05). 
Median values and quartiles were determined (Figure 3.2.4) showing that 50% of 
tumor-bearing mice in the AOM/DSS CAR group presented fewer than three tumors 
per animal, and 50% of tumor-bearing mice in the corresponding WT group presented 
more than eight tumors per animal. These data also revealed that 50% of the 
AOM/DSS WT mice had a mean colon tumor area greater than 0.090 mm2 whereas for 
those in the AOM/DSS CAR group the area was less than 0.036 mm2. 
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Table 3.2. 4. Tumor characteristics in dissected colons after 12 weeks: incidence and multiplicity of 
macroscopic colorectal lesions, tumor multiplicity, average tumor size and total tumor area per tumor-
bearing mouse presented as means ± SEM (n = 8 animals in the AOM/DSS WT group and n = 10 in the 
AOM/DSS CAR group).   
Group 
% Animals 
with colon 
tumors 
(incidence) 
Number of 
tumors/animal 
(multiplicity) 
Average size of 
tumors (mm2) 
Total tumor area 
(mm2) 
AOM/DSS 
WT 
80% 8.71 ± 2.60 0.968 ± 0.2941 10.73 ± 4.618 
AOM/DSS 
CAR 
77% 5.60 ± 2.00 0.547 ± 0.1875 5.500 ± 3.905 
 
 
Figure 3.2. 4. (A) Macroscopic image of the colon dissected from i) Control WT, ii) DSS CAR, iii) AOM/DSS 
WT and iv) AOM/DSS CAR groups, and median and quartile distributions for colorectal tumor multiplicity 
(B) and mean colon tumor area (C) in tumor-bearing animals (n = 8 in AOM/DSS WT and n = 10 in 
AOM/DSS CAR). 
 
 
. 
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3.2.3.4. Histopathology of colonic lesions 
 
The analysis of colonic lesions (Figure 3.2.5 and Figure 3.2.6) revealed that 18% of the 
lesions in the AOM/DSS WT group were inflammatory infiltrates containing 
lymphocytes responsible for the development of ulcers, 14% were instances of crypt 
dysplasia, 9% were adenomas and 59% were adenocarcinomas (ADCs). The AOM/DSS 
CAR group presented a higher proportion of mucosal ulcers (25%) but a lower 
proportion of ADCs (43%) compared to the AOM/DSS WT group. These data confirmed 
that there is statistically significant dependence between having neoplastic lesions and 
diet (p = 0.0336), and animals fed on high-carotenoid corn diet resulted in a reduction 
in neoplastic lesions. 
 
Figure 3.2. 5. Histopathology of colonic lesions after hematoxylin and eosin staining in the AOM/DSS WT 
(n = 8) and AOM/DSS CAR (n = 10) groups. (A) crypt dysplasia; (B) adenoma; (C) adenocarcinoma; (D) 
mucosal ulcer; (E) adenoma; (F) adenocarcinoma. Scale bar = 100 μm. 
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Figure 3.2. 6. Percentage of colonic lesion features found by investigative histology in AOM/DSS WT (n = 
8) and AOM/DSS CAR (n = 10) groups. 
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3.2.3.5. Immunohistochemical analysis of COX-2 expression 
 
 COX-2 is an important biological marker of inflammation and its levels are typically 
elevated in rodent colon tumor models (Sheng et al., 2001; Dong et al., 2003). 
 
 
Figure 3.2. 7. Immunohistochemical analysis of COX-2 expression in the normal colonic mucosa 
representing intensity scores of 1+ (A, D), 2+ (E), 3+ (B, F) and 4+ (C) in the AOM/DSS WT (n = 8) and 
AOM/DSS CAR (n = 10) groups. Scale bar = 100 μm.  
 
The immunohistochemical detection of COX-2 showed that the consumption of high-
carotenoid corn significantly reduced (p=0.042) the abundance of this marker in mice 
treated with AOM/DSS (Figure 3.2.7 and Figure 3.2.8). COX-2 was expressed primarily 
in colonic epithelial cells.  
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Figure 3.2. 8. Mean COX-2 immunohistochemical score (± SEM) determined in AOM/DSS WT (n = 8) and 
AOM/DSS CAR (n = 10) colonic tissues. *The differences between groups were significant according to 
Student t-test at p < 0.05.  
 
3.2.3.6. Quantitative real time PCR analysis of inflammation markers 
 
The expression of three additional inflammation markers (TNF-α, NF-B and NRF-2) 
was investigated by quantitative real-time PCR. Tumor necrosis factor alpha (TNF-α) is 
a mediator of inflammation and nuclear factor-kappa B (NF-B) is a transcription factor 
that plays an important role in inflammation, immunity, cell proliferation, apoptosis, 
and tumorigenesis (Kumar et al., 2004; Mukaida et al., 2011). Nuclear factor/erythroid 
2-related factor 2 (NRF-2) is a novel target for the prevention of colorectal cancer and 
several chemoprotective compounds including carotenoids are associated with the 
activation of NRF-2 (Kawabata et al., 2012; Tuzcu et al., 2012; Yang et al., 2014). NF-B 
and NRF-2 are both expressed in inflammatory and cancer cells in the AOM/DSS model 
(Suzuki et al., 2007b; Tanaka et al., 2010). However, there was no significant difference 
in the transcript levels of these markers when AOM/DSS-treated mice in the different 
diet groups were compared. 
 
3.2.3.7. Western blot analysis of COX-2 and p44/42 MAPK 
 
The abundance of COX-2 and MAPK was investigated by western blot, following the 
preparation of soluble extracts of the colonic mucosa from AOM/DSS-treated animals 
in both diet groups (Figure 3.2.9). Both markers were significantly depleted in mice fed 
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on the high-carotenoid corn diet, suggesting that the presence of carotenoids leads the 
suppression of COX-2 and p44/p42 MAPK expression in the colonic mucosa. 
 
Figure 3.2. 9. Western blots showing the impact of high-carotenoid corn on the expression of (A) COX-2 and 
(B) p44/42 MAPK in normal (non-tumor) colonic mucosa. Right-side panels show the corresponding 
histograms of quantitative densitometric values of the blots, normalized against Ponceau S staining as a 
loading control. *The differences were significant according to Student’s t-test (p < 0.05). 
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3.2.4. DISCUSSION 
 
The comparison of mice fed on diets containing either high-carotenoid corn or a near 
isogenic wild-type comparator showed that the high-carotenoid corn significantly 
inhibited the progression of pre-neoplastic lesions in a mouse model of colitis-
associated colorectal carcinogenesis induced by exposure to AOM/DSS. Although by 
the end of the feeding trial the incidence of tumors in mice was similar in both diet 
groups, there was two-fold increase in the percentage incidence of tumors in mice fed 
on the wild-type corn diet during the earlier stages of the trial (6 weeks after AOM 
injection) and these mice also showed a higher multiplicity of colonic lesions (1.42-
fold) and a larger overall mean colon tumor area than mice fed on high-carotenoid 
corn, although the differences did not reach the threshold for statistical significance. 
The data show a definite trend indicative of chemoprotective activity, and the analysis 
of several inflammatory markers suggested that the chemoprotective mechanism 
could involve the suppression of COX-2, an important mediator of inflammatory 
signaling. This is based on immunohistochemical data showing the significantly greater 
abundance of COX-2 in the non-tumor colonic mucosa of mice fed on the wild-type 
corn. These data therefore provide evidence that supports the proposed inhibitory 
effect of carotenoids on colorectal carcinogenesis in animals (Temple and Basu, 1987; 
Narisawa et al., 1996; Kim et al., 1998; Narisawa et al., 1999; Rijken et al., 1999; 
Tanaka et al., 2000; Suzuki et al., 2007; Nagendraprablhu et al., 2011; Yasui et al., 
2011; Kawabata et al., 2012).  
The link between carotenoids, COX-2 expression and the prevention of colorectal 
cancer is unclear. The high-carotenoid corn contains 112-fold more total carotenoids 
than the wild-type comparator and in order of decreasing abundance these are 
β-carotene, zeaxanthin, lycopene, lutein, α-cryptoxanthin, α-carotene, β-cryptoxanthin 
and γ-carotene (Naqvi et al., 2009). Dietary carotenoids are absorbed primarily by the 
small intestine and are transported to the liver as chylomicrons, but they are also 
bioaccessible in the large intestine, where they could have a direct effect on the 
colonic mucosa (Goñi et al., 2006). It is not clear whether individual carotenoids have a 
specific beneficial impact or whether the chemoprotective effects result from the 
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synergic activity of several provitamin A and non-provitamin A carotenoids in the 
whole corn matrix.  
The AOM/DSS mouse model is useful for the investigation of colitis-associated 
carcinogenesis because DSS induces chronic colitis and accelerates tumorigenesis 
(Tanaka et al., 2003; Clapper et al., 2007). Endoscopic colonoscopy in mice 6–12 weeks 
after the injection of AOM provided high-quality images allowing colon tumor 
development and progression to be evaluated at least in the distal 4 cm of colon. It is 
therefore a rapid and reproducible technique to evaluate colorectal tumor 
development in mice. Although the chemoprotective trend was not statistically 
significant, this is likely to reflect natural variability of disease progression in the mouse 
model and it is possible that larger studies with more animals would confirm the 
significance of the trends we observed in terms of tumor incidence, multiplicity and 
area. Biopsies taken over time would also provide more supportive evidence about the 
role of different biomarkers of inflammation. The incidence of animals developing 
macroscopic tumors 12 weeks after AOM injection was previously reported as 80–
100% with a multiplicity of 10 (Becker et al., 2005). In our experiments, both the 
incidence and multiplicity were lower at the end of the study (80% incidence with a 
multiplicity of 8.7) potentially because a lower dose of DSS was used, i.e. 1.5% instead 
of the 3% used by Becker et al. (2005). This lower dose is often used to study the 
potential chemoprotective effects of food (Ju et al., 2009; Oyama et al., 2009; Miyoshi 
et al., 2011). 
Although the molecular basis of the observed chemoprotective effect of carotenoids 
has not been unraveled, the anti-inflammatory effects attributed to carotenoids may 
reflect their antioxidant activity. Inflammatory markers such as iNOS, TNF-α, COX-2 
and IL-1β  are common modulators of tumor development and metastasis in chronic 
inflammatory diseases such as colitis-associated colorectal carcinogenesis (Tanwar et 
al., 2009; Nagendraprablhu et al., 2011; Yasui et al., 2011; Kawabata et al., 2012). 
COX-2 expression is upregulated during early colon carcinogenesis suggesting an 
important role in the progression of the disease, e.g. through the regulation of 
angiogenesis, apoptosis and tumor invasiveness (De Robertis et al., 2011). Western 
blotting and in situ immunohistochemistry showed that COX-2 levels in the normal 
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colonic mucosa were higher in AOM/DSS-treated mice fed on the wild-type corn than 
in those fed on the high-carotenoid corn. Previous studies have also suggested that 
carotenoids may be able to regulate the expression of  COX-2 during the progression of 
colon cancer (Nagendraprablhu et al., 2011; Tanwar et al., 2009; Kawabata et al., 
2012). 
The inhibition NF-B is known to suppress COX-2 expression and protect against 
colorectal cancer so this is a potential candidate that could be targeted by carotenoids  
(Tanwar et al., 2009; Nagendraprablhu et al., 2011; Yasui et al., 2011; Kawabata et al., 
2012; Tuzcu et al., 2012). We found that there was no significant change in NF-B 
mRNA expression levels when we compared the diet groups (p = 0.42) which indicates 
that the gene encoding NF-B is unlikely to be a target, although a direct effect on the 
protein, or perhaps another component of the same pathway (such as the inhibitor 
IB) cannot be ruled out. However, there was a significant reduction in the levels of 
p44/42 MAPK, an important modulator of cytokine production that controls the 
infiltration of monocytic cells, intestinal electrolyte and water secretion, and intestinal 
inflammation (Kyriakis and Avruch, 2001). Previous studies have shown that MAPKs 
induce COX-2 expression in intestinal epithelial cells and promote inflammatory 
diseases in the intestine (Hommes et al., 2002; Waetzig et al., 2002; Salh et al., 2003; 
Kim et al., 2005; Camacho-Barquero et al., 2007). Therefore, it is possible that 
carotenoids act upon this mediator, or upstream on other components of the receptor 
tyrosine kinase signaling pathway. 
In conclusion, the data presented herein suggest that high-carotenoid corn inhibits the 
progression of colon cancer in an AOM/DSS mouse model and the mechanism involves 
the suppression of the inflammatory modulator COX-2, possibly by interfering 
indirectly in an upstream signaling pathway mediated by p44/42 MAPK. 
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CHAPTER 3 
The effects of high-carotenoid corn on insulin sensitivity in a 
mouse model of obesity and insulin resistance induced by a high-
fat diet  
3.3.1. INTRODUCTION 
 
Overweight and obese individuals carry a higher risk of type-2 diabetes (T2D). This is a 
major concern given that 366 million people worldwide are now considered obese,  
55.2 million of whom live in Europe  (Pan et al., 2013; Breen et al., 2014).  
Studies in both experimental animals and humans have shown that dietary fat 
composition has an impact on insulin sensitivity, i.e. saturated fats promote high 
plasma insulin levels whereas unsaturated fats help to improve insulin sensitivity 
(Riccardi et al., 2004). Recent studies have shown that neutrophils mediate the 
development of insulin resistance in animal models of obesity induced by high-fat 
diets, reflecting the production of the pro-inflammatory neutrophil elastase (Talukdar 
et al., 2012). This means that insulin resistance can be reversed by life-style changes 
including the adoption of a healthy diet before the onset of clinical T2D (Solomon et 
al., 2010; Macotela et al., 2011). As well as T2D, obesity also increases the risk of 
several other chronic diseases, including cardiovascular disease, hypercholesterolemia, 
asthma, hypertriglyceridemia, hypertension/stroke, and certain forms of cancer 
(Mokdad et al., 2003; Greenberg and Obin, 2006).  
Adipose tissue grows by recruiting new fat cells from the adipose tissue precursor cell 
pool, which has a high capacity for adipocyte differentiation (Schling and Löffler, 2002; 
Jo et al., 2009). As individuals become obese, the adipose tissue undergoes molecular 
and cellular changes that affect systemic metabolism (Greenberg and Obin, 2006). 
Adipose tissue therefore plays an important role in the development of obesity-related 
insulin resistance because it secretes adipokines, cytokines and chemokines that 
influence glucose homeostasis, energy balance and fatty acid metabolism. Adipocytes 
accumulate triglycerides and thus reduce the circulation of free fatty acids, but when 
they reach their storage capacity they undergo senescence, apoptosis or necrosis, all 
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of which are linked to the infiltration of adipose tissue by immune cells and 
macrophages, causing inflammation that leads to vascular deterioration and hypoxia 
(Lafontan, 2014). The latter triggers the release of pro-inflammatory cytokines such as 
TNFα, interleukin-6 and C-reactive protein, and macrophage chemokines such as 
monocyte chemoattractant protein-1, which reduce the triglyceride storage capacity 
further and reinforce a feedback loop leading to greater dysfunction (Lafontan, 2014). 
Triglyceride synthesis declines and lipolysis is induced, increasing the levels of 
circulating free fatty acids and triglycerides which cause macrophages to infiltrate the 
liver and skeletal muscle, inhibiting the insulin signaling pathway (Schenk et al., 2008). 
The amount of adipose tissue can increase by hyperplasia (an increase of adipocyte 
number) or hypertrophy (an increase of adipocyte size) and the latter is associated 
with a worse lipid profile, greater glucose intolerance and higher levels of insulin 
(Roberts et al., 2009; Arner et al., 2010; Divoux et al., 2010).  
Phytochemicals can help to improve insulin sensitivity (Rayalam et al., 2008) and 
carotenoids in particular are valuable because they possess antioxidant activity and 
can act as cell growth regulators, gap junction communicators, and modulators of gene 
expression, the immune response and drug metabolism (Rao and Rao, 2007). However, 
the impact of carotenoids on adipose tissue is unclear, because this is where 
carotenoids and related retinoids are stored, including retinal, retinoic acid and retinyl 
palmitate, all of which can act as regulators of adipocyte differentiation, lipid 
metabolism and adipokine secretion thus increasing insulin sensitivity (Kawada et al., 
1996; Kumar et al., 1999; Bonet et al., 2003; Felipe et al., 2003; Ziouzenkova et al., 
2007). Even apocarotenals, the metabolic breakdown products of carotenoids, can 
influence adipocyte biology (Ho et al., 2007). 
The aim of the work described in this chapter was to investigate the potentially 
beneficial role of the mixture of carotenoids contained in the matrix of a genetically-
engineered high-carotenoid corn variety, specifically its effects on insulin sensitivity 
and energy balance in a mouse model of obesity induced by a high-fat diet. 
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3.3.2. MATERIALS AND METHODS 
 
3.3.2.1. Diet 
 
Experimental diets containing wild-type M37W corn or genetically engineered high-
carotenoid corn (grown under the same conditions and harvested at the same time) 
were prepared from freeze-dried powdered kernels under hygienic conditions. The 
diets were formulated to achieve isoproteic mixtures with a balanced macronutrient 
composition by complementing the corn component with corn starch, casein and corn 
oil to obtain the final normocaloric diets based on wild-type corn (NWT) and high-
carotenoid corn (NCAR). The equivalent hypercaloric diets based on wild-type corn 
(HWT) and high-carotenoid corn (HCAR) were prepared by including pork lard as an 
additional source of fats. 
 
3.3.2.2. General nutrient compositional analysis 
 
Nutrient compositional analysis was carried out at the Chemistry Department 
(University of Lleida) as described in Chapter 3. Briefly, the moisture level was 
determined by measuring the loss of weight after drying in an oven at 100°C to a 
constant weight, the fat content was measured by Soxhlet extraction, and ash levels 
were estimated by gravimetric analysis after ignition in an electric furnace. Crude fiber 
levels were determined by measuring the difference between the weight of the 
residue remaining after the sample was digested under specific conditions and the 
weight of the ash. The amount of protein was estimated by determining the total 
nitrogen content using the Dumas combustion method and applying a nitrogen-to-
protein conversion factor of 6.25 (AOAC International, 2000). 
Corn starch was measured following 30 min alkaline hydrolysis (4 M KOH) at room 
temperature. The hydrolysate was neutralized by adding 2 M HCl and incubating with 
-amiloglucosidase (Sigma) (pH 4.75, 60°C, 45 min) before measuring the glucose level 
using a commercial colorimetric enzyme assay (GOP-PAD, Spinreact 1001190) 
3. CHAPTER 3  
 
96 
 
 
3.3.2.3. Animal feeding study 
 
The study complied with Law 5/1995 and Act 214/1997 of the Autonomous 
Community (Generalitat) of Catalonia and EU Directive (EEC 63/2010), and was 
approved by the Ethics Committee on Animal Experiments of the University of Lleida.  
Twenty-eight 5-week-old male ICR (CD-1®) mice obtained from Harlan Laboratories 
(Sant Feliu de Codines, Spain) were acclimated for 1 week before the experiment by 
providing them with ad libitum access to a 2014 Teklad Global 14% protein rodent 
maintenance diet and water. Following acclimation, 6-week-old mice were placed in 
individual cages and seven mice were randomly assigned to each of the four diet 
groups: NWT, NCAR, HWT and  HCAR. The animal rooms were environmentally 
controlled and maintained at 20 ± 2°C and 50 ± 5% relative humidity, with a 12-h 
photoperiod. Body weight and food consumption were measured weekly over a 
duration of 4 months. 
Before the end of the experiment, the animals were injected with glucose to carry out 
a subcutaneous glucose tolerance test (ScGTT) followed a week later by an insulin 
injection to carry out an insulin tolerance test (ITT). After one further week, the mice 
were fasted for 12 h and sacrificed by decapitation. Blood was collected into EDTA-
coated capillary tubes, centrifuged at 1500 x g for 10 min and immediately frozen. 
Visceral and subcutaneous adipose tissue, skeletal muscle (rectus femoris) and liver 
tissue were collected and stored at –80°C. 
 
3.3.2.4. Subcutaneous glucose tolerance and insulin tolerance tests   
 
Mice that had been fasted for 12 h were injected subcutaneously with 2 g glucose per 
kg body weight and blood samples were taken for glucose measurements at 0, 20, 40, 
60 and 120 min after the injection to determine glucose levels using a glucose meter. 
For ITT, mice fasted for 2 h were injected subcutaneously with human insulin (12343, 
Sigma, USA) at 0.5 U/kg body weight and were taken for glucose measurements at 0, 
20, 40, 60 and 120 min after injection.  
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3.3.2.5. Blood biochemistry  
 
Clinical chemistry kits (Spinreact, Girona, Spain) were used to measure total 
cholesterol, low-density and high-density lipoproteins (LDL/HDL), triglycerides, uric 
acid, HbA1c and fructosamine. The concentration of non-esterified fatty acids (NEFAs) 
was measured using a commercial colorimetric enzyme NEFA assay kit (Roche, 
Mannheim, Germany).  
 
3.3.2.6. Antioxidant capacity  
 
The antioxidant capacity of the plasma was measured using two different assays. The 
first was a ferric reducing antioxidant power (FRAP) assay based on the reagents 2,4,6-
tripyridyl-S-triazine (T1253, Sigma-Aldrich, Steinheim, Germany), FeCl3 and acetate 
buffer (Serrano et al., 2013). Briefly, 900 µl of the FRAP reagent was mixed with 90 µl 
distilled water and 30 µl plasma. The absorbance was recorded at 595 mm using a 
spectrophotometer (Multiskan Ascent 96/384 Plate Reader, Finland). The second used 
3-ethylbenzothiazoline-6-sulphonate (ABTS) to determine antioxidant capacity in 
terms of free radical scavenging activity (Hervert-Hernández et al., 2011). Briefly, ABTS 
radical cation (ABTS+·) was produced by reacting 7 mmol/l ABTS stock solution with 
2.45 mmol/l potassium persulphate in the dark at room temperature for 12-16 h. The 
ABTS+· solution was diluted with 5 mM phosphate-buffered saline (PBS, pH 7.4) to an 
absorbance of 0.70 ± 0.02 at 730 nm. After adding 0.1 ml of sample to 3.9 ml of diluted 
ABTS+· solution, the absorbance was measured every 20 s for 6 min using a Multiskan 
Ascent spectrophotometer. The inhibition of absorbance over time was plotted and 
the area below the curve (0–6 min) was calculated. A calibration curve was prepared 
using 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) as a standard. 
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3.3.2.7. Insulin measurements  
 
Plasma insulin was measured using the MILLIPLEX magnetic bead-based immunoassay 
(Millipore, Billerica, USA). 
 
3.3.2.8. Leptin measurements 
 
Plasma leptin was measured by enzyme-linked immunosorbent assay (ELISA) using the 
Leptin Mouse ELISA Kit (Abcam, Cambridge, UK). 
 
3.3.2.9. DNA extraction 
 
Genomic DNA was extracted from visceral adipose tissue using the Genomic DNA Mini 
kit (Invitrogen, Barcelona, Spain) and quantified using a Nanodrop spectrophotometer. 
 
3.3.2.10. Tissue homogenization and western blot analysis 
 
Frozen liver, skeletal muscle and visceral/subcutaneous adipose tissues were 
homogenized at 4°C in a Polytron device containing the appropriate buffer: 180 mM 
KCl, 5 mM MOPS, 2 mM EDTA, 1 mM diethylenetriaminepentaacetic acid, 1 μM 
butylated hydroxyl toluene, 10 μg/mk aprotinin, 1 mM NaF, 1 mM Na3VO4 and 1% v/v 
80–6501-23 protease inhibitor mix (GE Healthcare, USA). The total soluble protein 
concentration was determined by the Bradford method (after brief centrifugation to 
remove cellular debris) and pooled homogenates containing equal amounts of protein 
from all mice per group were separated by sodium dodecylsulfate–polyacrylamide gel 
electrophoresis (SDS-PAGE) on 10% polyacrylamide gels (15-40 g total protein per 
lane) and transferred to polyvinylidenedifluoride membranes (Immobilon-P Millipore, 
Bedford, MA, USA) using Bio-Rad apparatus. The primary and secondary antibodies are 
listed in Table 3.3.1. Protein bands were visualized with the Luminol ™ Western 
Chemiluminiscent HRP method (Millipore, Billerica, MA, USA) and the band intensity 
was measured using the Bio-Rad Gel Doc/Chemi Doc Imaging System and Image Lab 
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software v4.0.1 (Bio-Rad Laboratories). Anti-β-tubulin (Abcam, ab7291) and silver 
staining were used as protein loading controls. 
Table 3.3. 1. Primary and secondary antibodies used for western blot immunodetection. 
Antigen Supplier Reference Dilution 
AMPKα Cell Signaling 2532 1:1000 
p44/42 MAP kinase Cell Signaling 4695 1:1000 
GLUT4 Abcam ab654 1:2500 
Ubiquitin Sigma U5379 1:100 
DNP Sigma D9565 1:2000 
MDAL Academy Bio-
Medical Company 
Md20a 1:1000 
Anti-β-tubulin Abcam ab7291 1:1000 
Anti-mouse IgG GE-Healthcare NA931 1:5000 
Anti-rabbit IgG Thermo Scientific 
Pierce 
31460 1:100000 
Anti-goat Santa Cruz SC2020 1:12000 
 
3.3.2.11. Analysis of oxidative damage by protein carbonyl detection 
 
Tissue damage by oxidation was evaluated by measuring protein carbonyl groups with 
2,4-dinitrophenylhydrazine (DNP) as previously described (Portero-Otín et al., 1999). 
Briefly, 15 µl of each homogenate was adjusted to 3.75 µg/µl total protein 
concentration and SDS was added to a final concentration of 6%. Samples were boiled 
for 3 min at 95°C and 20 µl of 10 mM DNP (in 10% trifluoroacetic acid) was added and 
incubated for 7 min at room temperature. The reaction was neutralized and samples 
were prepared for SDS-PAGE by adding 24 µl of a solution containing 2 M Tris base, 
30% glycerol and 15% β-mercaptoethanol. Band intensities were measured in the 
range 30–250 kDa.  
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3.3.2.12. Carotenoid and retinoid extraction from liver and adipose tissues 
 
Liver tissue (100 mg wet weight) was lyophilized in a Telstar cryodos-50 for 20 h and 
dried samples were ground to powder. Visceral adipose tissue (50 mg wet weight) was 
homogenized with a Polytron device using the buffer described above. The samples 
were mixed by vortexing with 200 µl 30% potassium hydroxide, 1 ml ethanol, 0.01% 
butylated hydroxytoluene in 100 µl ethanol and 20 µM β-apo-8'-carotenal in 100 µl 
ethanol (internal standard). After incubating at 37°C for 45 min, the samples were 
extracted three times with 3 ml ether:hexane (2:1 v:v) followed by centrifugation at 
13,000 x g for 5 min to separate the phases. The extracts were evaporated to dryness 
under nitrogen, redissolved in 100 µl Phase A buffer and passed through an Eppendorf 
UltraFree 5-kDa filter (UFC3LTK00, Millipore, Bedford, MA, USA).  
 
3.3.2.13. Carotenoid and retinoid analysis by high-performance liquid 
chromatography 
 
The processed samples were separated by high-performance liquid chromatography 
(HPLC) using a YMC C30 column (250 x 4.6 mm, internal diameter 3 µm) at 35°C in a 
110 series HPLC system (Agilent Waldbronn, Germany). Mobile phase A consisted of 
methanol/acetone (60:40) and mobile phase B consisted of acetone/deionized water 
(60:40). Carotenoids were separated at a flow rate of 0.5 ml/min using a gradient of 
60–30% B (0–3 min), 30% B (3–22 min), 30–10% B (22–26 min), 10% B (26–41.5min), 
10–60% B (41.5–45 min) and 60% B (45–90 min). Retinoids were separated using 100% 
mobile phase A (0–30 min). Carotenoids were detected at 450 nm and retinoids at 325 
nm. 
  
3.3.2.14. Statistical analysis 
 
Student’s t-test or either one-way or two-way ANOVA were used for statistical 
comparisons after data normalization, or in other cases a non-parametric test was 
used. Values of p < 0.05 were considered statistically significant. 
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3.3.3. RESULTS 
 
3.3.3.1. Nutritional parameters and general observations 
 
Five-week-old mice were fed for 16 weeks on normocaloric or hypercaloric diets 
supplemented with either wild-type M37W corn and or the genetically-engineered 
near isogenic high-carotenoid corn. The high-carotenoid corn was shown, as expected, 
to contain higher levels of several carotenoids: 60 µg/g β-carotene, 23 µg/g lycopene, 
36 µg/g zeaxanthin, 15 µg/g lutein, 13 µg/g α-cryptoxanthin, 7 µg/g α-carotene, 5 µg/g 
β-cryptoxanthin and 5 µg/g γ-carotene (see Chapter 1 Table 3.1.1 for the full 
comparison).  
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Table 3.3. 2. Composition of the NWT, NCAR, HWT and HCAR diets. 
 
NWT (kg diet) NCAR (kg diet) HWT (kg diet) HCAR (kg diet) 
Energy (kcal/g) 3.7 3.7 5.2 5.2 
Protein (g/kg 
diet) 
249 249 249 249 
Carbohydrate 
(g/kg diet) 
476 476 285 285 
Lipids (g/kg diet) 109 109 340 340 
Dietary fiber 
(g/kg diet) 
58 58 58 58 
Casein (g/kg 
diet) 
195.9 172.7 228.8 223.0 
L-cysteine (g/kg 
diet) 
3.6 3.5 3.5 3.5 
Saccharose 
((g/kg diet) 
181.3 175.8 199.8 198.2 
Lard (pork) (g/kg 
diet) 
0.0 0.0 249.8 247.8 
Corn oil (g/kg 
diet) 
97.9 90.9 85.9 84.3 
Cellulose (g/kg 
diet) 
43.8 38.4 54.0 51.5 
Calcium 
phosphate 
(g/kg) 
3.5 3.4 3.4 3.4 
Choline bitrate 
(g/kg) 
3.1 3.0 3.0 3.0 
Mineral mix AIN-
93G (g/kg) 
44.8 43.4 43.0 42.6 
Vitamin mix AIN-
93G (g/kg) 
19.8 19.2 19.0 18.8 
Freeze-dried 
corn (g/kg) 
406.3 449.5 109.9 123.9 
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Table 3.3. 3. Final body weight, body weight gain and dietary intake (means ± SEM) of mice maintained 
on the NWT, NCAR, HWT and HCAR diets.  
 NWT (n = 7) NCAR (n = 7) HWT (n = 5) HCAR (n = 6) 
Final body 
weight (g) 
44.7 ± 1.5 45.0 ± 2.1 57.1  ± 2.4 56.0 ± 3.3 
Body weight 
gain (%) 
70.80 ± 5.41 69.17 ± 7.42 112.1 ± 8.04 111.2 ± 11.56 
Weight 
gain/food 
intake (%) 
3.627 ± 0.223 3.840 ± 0.348 6.714 ± 0.389 6.660 ± 0.595 
Diet intake 
(g/day) 
4.836 ± 0.118 4.523 ± 0.110 4.262 ± 0.112 4.215 ± 0.213 
Energy 
(kcal/day) 
17.70 ± 0.387 17.25 ± 0.4745 22.17 ± 0.579 21.80 ± 1.107 
Protein 
(g/day) 
1.206 ± 0.030 1.126 ± 0.027 1.060 ± 0.028 1.050 ± 0.053 
Carbohydrates 
(g/day) 
2.301 ± 0.056 2.153 ± 0.052 1.216 ± 0.0326 1.202 ± 0.0600 
Fat (g/day) 0.527 ± 0.013 0.493 ±  0.012 1.45 ± 0.038 1.43 ± 0.073 
 
Before the end of the trial, the mice were subjected to glucose tolerance and insulin 
tolerance tests. Blood samples were taken and analyzed for biochemical markers as 
well as insulin, leptin and GLUT4, which can be used to infer insulin resistance. The 
adipocyte cell number was investigated to determine whether the presence of 
carotenoids in the diet caused hypertrophy or hyperplasia in the adipose tissue. 
Additional protein markers for insulin sensitivity, energy homeostasis and oxidative 
damage were then analyzed by western blot. Finally, carotenoid and retinoid levels 
were tried to be measured in the liver and adipose to determine whether the high-
carotenoid diet caused an increase in the levels of stored retinoids in these tissues, 
which would indicate that the carotenoids are bioavailable and their presence in these 
tissues may be responsible for differences between the animals in the four diet groups.  
The corn component was complemented with additional corn starch, casein and corn 
oil to obtain the nutritionally-balanced and normocaloric diets, and pork lard was 
added to formulate the hypercaloric diets (Table 3.3.2). Two animals in the HWT group 
were excluded from the study because there was evidence of a cutaneous reaction, 
and the application of topical glucocorticoids had the potential to alter the results. One 
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animal in the HCAR group was also excluded due to spontaneous leg swelling (edema) 
which was also likely to interfere with the results, especially those based on the 
detection of inflammation markers. Neither of the conditions was directly associated 
with the diets. 
The hypercaloric diet induced obesity as shown in Table 3.3.3. The final body weight, 
body weight gain and feed efficiency (weight gain in relation to food intake) were 
significantly higher in the animals reared on the hypercaloric diets compared to those 
on the normocaloric diets. Although the study was designed to compare the effects of 
the wild-type and high-carotenoid corn, comparisons between the hypercaloric and 
normocaloric diets nevertheless confirmed the ability of the hypercaloric diet to 
induce obesity efficiently.  Mice reared on the HCAR diet gained less weight than those 
reared on the HWT diet although the mean difference of 1.1 g was not statistically 
significant. Nevertheless, these data hinted at the potential benefits of the high-
carotenoid diet on insulin sensitivity, which were therefore investigated in more detail 
as described below. 
 
3.3.3.2. Biochemical characteristics  
 
The induction of obesity and the resulting insulin resistance cause the accumulation of 
fat and modify the fatty acid composition in several tissues. In the current study, this 
was tested by measuring glucose tolerance, the glycemic response to insulin and 
plasma insulin levels after 4 months on the experimental diets. 
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The glucose and insulin tolerance tests showed that the hypercaloric diet induced both 
glucose intolerance and insulin resistance. However the glucose homeostasis recovery 
period was shorter in the HCAR group than the HWT group, and the plasma glucose 
level 60 min after glucose injection was also significantly lower (p = 0.0318) in the mice 
fed on the HCAR diet (Figure 3.3.1A). The plasma glucose levels remained slightly lower 
in the HCAR diet group at the end of the test (120 min) and the area under the glucose 
curve was 42904 ± 1857 mg/dl x 2h in the HWT group but only 36853 ± 2418 mg/dl x 
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Figure 3.3. 1. . Blood biochemistry parameters in mice maintained on the NWT, NCAR, HWT and HCAR 
diets. (A) Subcutaneous glucose tolerance. (B) Glycemic response to insulin (C) Blood insulin levels and 
LDL/HDL cholesterol ratio. Differences were analyzed using Student’s t-test: *p < 0.05, **p < 0.01; 
***p<0.001. Statistically significant differences are shown with lower case letters: a: statistically 
significant difference versus NWT group; b: statistically significant difference versus NCAR group; c: 
statistically significant difference versus HWT group. Glucose, insulin and LDL/HDL cholesterol levels 
were determined in n = 7 (NWT), n = 7 (NCAR), n = 5 (HWT) and n = 6 (HCAR) animals. All values are 
presented as means ± SEM. 
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2h in the HCAR group (p = 0.087). The insulin tolerance test (Figure 3.3.1B) showed 
that mice in the HCAR had a lower hypoglycemic response to insulin than those in HWT 
group after the injection of 2 g/kg body weight of glucose. The HCAR group also 
showed a faster glucose recovery rate (tested 60 min after the insulin injection) and a 
higher glycemic response (p < 0.05) after 120 min, i.e. 168.0 ± 10.71 mg/dl in the HWT 
group compared to 207.7 ± 11.95 mg/dl in the HCAR group.  
The basal plasma insulin concentrations were determined by immunoassay (Figure 
3.3.1C). Animals fed on the hypercaloric diets showed evidence of hyperinsulinemia as 
expected, and this was more severe in the animals fed on the HWT diet (3130 ± 972.5 
pg/ml) than in those fed on the HCAR diet (2734 ± 523.5 pg/ml) although the 
difference between the corn lines was not significant. There was also no significant 
difference when the two normocaloric diets were compared (NWT = 395.2 ± 94.82 
pg/ml and NCAR = 430.9 ± 106.1 pg/ml). 
Metabolic syndrome can result from fat accumulation in non-adipose tissue when its 
storage capacity is exhausted (Slawik and Vidal-Puig, 2007). Lipids accumulate in 
metabolically-active non-adipose tissues such as the liver and skeletal muscle, leading 
to lipotoxicity, insulin resistance, T2D and other chronic diseases (Slawik and Vidal-
Puig, 2007). Differences in glucose and insulin sensitivity between the normocaloric 
and hypercaloric diet groups could therefore reflect differences in fat storage in 
adipose tissue and non-adipose tissues such as the liver and skeletal muscle. The levels 
of total cholesterol, HDL, LDL, NEFA and triglycerides were therefore tested, and the 
corresponding ratios were calculated as shown in Table 3.3.4. The most striking finding 
was the significantly lower (p = 0.021) LDL/HDL cholesterol ratio in the HCAR group 
compared to the HWT group (Figure 3.3.1).  
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Table 3.3. 4. Blood biochemistry in animals fed on normocaloric and hypercaloric diets, showing  total 
cholesterol (CHOL), HDL, LDL, non-esterified fatty acids (NEFA), triglycerides (TG), TG/HDL, LDL/HDL and 
total CHOL/HDL, all presented as means ± SEM. Differences were analyzed using Student’s t-test: *p < 
0.05. 
 NWT 
n=7 
NCAR 
n=7 
t test 
p 
value 
HWT 
n=5 
HCAR 
n=6 
t test 
p 
value 
CHOL 
(mg/dL) 
187.2  ± 
13.6 
189.2 ± 
15.6 
0.92 228.4 ± 
17.7 
266.9 ± 
23.3 
0.23 
HDL 
(mg/dL) 
93.4 ± 5.6 93.3 ± 7.0 0.99 109.7 ± 9.0 127.2 ± 
17.1 
0.15 
LDL 
(mg/dL) 
115.7 ± 
11.0 
120.4 ± 
13.0 
0.79 147.6 ± 
22.5 
120.6 ± 
13.1 
0.31 
NEFA 
(nmol/µL) 
2.68 ± 0.05 2.68 ± 0.01 0.97 2.50 ± 0.07 2.47 ± 0.06 0.70 
TG 
(mg/dL) 
95.0 ± 32.9 122.0 ± 
13.2 
0.24 82.1 ± 17.6  81.0 ± 9.0 0.94 
TG/ HDL 
(mg/dL) 
1.04 ± 0.17 1.32 ± 0.19 0.29 0.74 ± 0.06 0.66 ± 0.11 0.55 
LDL/ HDL 
(mg/dL) 
1.23 ± 0.07 1.29 ± 0.29 0.11 1.32 ± 0.14 0.93 ± 
0.05* 
0.021 
CHOL/ 
HDL 
(mg/dL) 
2.00 ± 0.09  2.03 ± 0.06 0.82 2.09 ± 0.09 2.08 ± 0.10 0.96 
 
The levels of enzymatic and non-enzymatic plasma antioxidant activity were measured 
using the FRAP method (Figure 3.3.2). Although there was more antioxidant activity in 
the HCAR group (343.2 ± 19.84 µmol Trolox equivalent (TE)/g) than the HWT group 
(322.5 ± 15.72 µmolTE/g) the differences were not significant (p > 0.05), and were 
similar to the levels observed in the normocaloric diet groups (NWT = 346.9 ± 26.69 
µmolTE/g, NCAR = 337.3 ± 23.94 µmolTE/g). There were also no significant differences 
among the diet groups in the plasma ABTS radical assay, although again the HCAR 
group showed the highest activity of 4273 ± 117.5 µmolTE/g.  
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Uric acid is the final oxidation product of purine catabolism and it has been recognized 
as an effective antioxidant (Koenig and Meisinger, 2008). However, excess levels of uric 
acid in the blood are associated with a higher risk of cardiovascular disease, metabolic 
syndrome, obesity and insulin resistance among others, and it can act as a pro-oxidant 
(Hayden and Tyagi, 2004; Strazzullo and Puig, 2007). Blood uric acid levels were lower 
in the HCAR diet group (0.79 ± 0.12 µmol/l) than in the other three groups (NWT = 1.3 
± 0.30 µmol/l, NCAR = 1.14 ± 0.19 µmol/l, HWT = 1.03 ± 0.23 µmol/l in HWT) although 
the difference was not statistically significant. 
 
3.3.3.3. Glucose transport and GLUT4 translocation  
 
The uptake of glucose into skeletal muscle and visceral adipose tissue is mediated by 
insulin-responsive glucose transporter type 4 (GLUT4) which therefore plays a key role 
in glucose homeostasis (Olson, 2012). Western blots showed that animals fed on the 
high-carotenoid corn diet had higher levels of GLUT4 in skeletal muscle and visceral 
adipose tissue compared to animals fed on wild-type corn (Figure 3.3.3). In the HCAR 
group, with lower (albeit not significantly lower) blood insulin levels, the stronger 
expression of GLUT4 in the skeletal muscle may have contributed to the observed 
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Figure 3.3. 2. Results from the ferric reducing ability of plasma (FRAP) and 3-ethylbenzothiazoline-6-
sulphonate (ABTS) blood assays of mice fed on normocaloric and hypercaloric diets. FRAP and ABTS 
levels were determined in n = 7 (NWT), n = 7 (NCAR), n = 5 (HWT) and n = 6 (HCAR) animals. All values 
are presented as means ± SEM. 
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insulin sensitivity and reduced glycemia, and in adipose tissue it may have ensured that 
the adipocytes retained the capacity to store energy.  
 
 
Figure 3.3. 3. Western blot analysis of GLUT4 expression in muscle (M) and visceral adipose tissue (VAT). 
The histogram shows the expression levels normalized against tubulin and presented as values relative 
to the expression level in the NWT diet group. Liver (L) homogenates were used as a negative control.  
 
3.3.3.4. AMPKα expression in visceral adipose tissue and skeletal muscle 
 
Adenosine-monophosphate-activated protein kinase (AMPKα) is a key mediator of 
glycemic homeostasis, fatty acid oxidation and the inhibition of lipogenesis in the liver 
(Viollet et al., 2006). AMPKα levels in the skeletal muscle, visceral adipose tissue and 
liver tissue from animals in the four different diet groups were analyzed by western 
blot. There were no significant differences among the diet groups in terms of AMPKα 
levels in skeletal muscle (Figure 3.3.4). However, there was a significant reduction in 
the level of AMPKα signaling in the visceral adipose tissue of the HCAR diet group 
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compared to the HWT and NCAR groups. This showed that the key pathway controlling 
glucose uptake and fatty acid oxidation was downregulated in response to the high-fat 
diet, suggesting that the adipose tissue was able to take up fatty acids. The significant 
increase in AMPKα levels in the livers of HCAR mice suggested that lipogenesis, 
cholesterol synthesis and triglyceride synthesis were inhibited and that hepatic AMPK 
activation may therefore play an important role in the prevention of fatty 
atherosclerosis, liver disease and dyslipidemia in T2D (Winder and Hardie, 1999; Li et 
al., 2011).     
 
 
Figure 3.3. 4. Western blot analysis of AMPKα expression in skeletal muscle (Skl Msc), visceral adipose 
tissue (VAT) and liver. The histogram shows the expression levels normalized against tubulin and 
presented as values relative to the expression level in the NWT diet group. Differences were analyzed 
using Student’s t-test: *p<0.05; **p<0.01; a: statistically significant difference versus NWT group, b: 
statistically significant difference versus NCAR group; c: statistically significant difference versus NWT 
group. 
 
3.3.3.5. Glycemic control: glycosylated hemoglobin and fructosamine  
 
Blood glucose levels can be estimated over time by measuring glycosylated 
hemoglobin (Hb1Ac) and this indicated lower average glucose levels in the HCAR group 
compared to the HWT group, although difference was not statistically significant 
(Figure 3.3.5). Hb1Ac levels can also be influenced by differences in the lifespan of red 
blood cells between the groups (Cohen et al., 2008) so fructosamine levels were also 
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tested to evaluate glycemic control because this shows the amount of plasma protein 
glycation, and plasma proteins are synthesized predominantly in the liver. There was a 
significant difference (p < 0.05) between the two carotenoid-enriched diets compared 
to the normocaloric diet based on wild-type corn, suggesting that the presence of 
carotenoids results in higher levels of plasma protein glycation regardless of whether 
the diet is normocaloric or hypercaloric. 
 
3.3.3.6. The role of visceral adipose tissue in insulin sensitivity 
To determine the effect of high-carotenoid corn on adipocyte differentiation and 
whether the growth of adipose tissue was associated with a higher adipose cell 
number (hyperplasia) or an increase in size (hypertrophy), adipocyte genomic DNA was 
isolated and the relative amounts of DNA and total protein were quantified as 
previously described (Patel et al., 2003). The adipose tissue in the HCAR diet group 
contained nearly twice as much DNA (1.83-fold more) than the HWT group, which in 
turn contained about the same amount of DNA as the NWT and NCAR groups (Figure 
3.3.6). The adipose tissue of the HCAR diet group also contained 1.52-fold more 
protein than the HWT group, which in turn was marginally lower than the NWT and 
NCAR groups.  Although none of these differences were statistically significant, the 
data clearly indicated that the growth of adipose tissue in the HCAR diet group is 
mostly due to the higher number of adipocytes per gram of tissue, suggesting that 
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Figure 3.3. 5. Analysis of the glycemic control indicators glycosylated hemoglobin and fructosamine. 
Differences were analyzed using Student’s t-test: *p<0.05; a: statistically significant difference versus 
NWT group 
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a hypercaloric diet. 
Figure 3.3. 6. Absolute amounts of DNA and protein per gram of visceral adipose tissue (VAT) in the four 
diet groups.  
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Figure 3.3. 7. Plasma leptin levels in the four diet groups. Differences were analyzed using Student’s 
t-test: **p<0.01 and ***p<0.001; a: statistically significant difference versus NWT group; b: statistically 
significant difference versus NCAR group. Levels were determined in n = 7 (NWT), n = 7 (NCAR), n = 5 
(HWT) and n = 6 (HCAR) animals. All values are presented as means ± SEM. 
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Leptin is an adipocyte-derived hormone that regulates energy expenditure, food intake 
and glucose metabolism (Friedman and Halaas, 1998). A leptin-specific ELISA was used 
to measure the levels of this hormone in the plasma of all four diet groups (Figure 
3.3.7). The results showed that both hypercaloric diets induced the production of 
leptin resulting in significant differences between the HCAR/HWT and NCAR/NWT 
groups. There was also a slight increase in leptin levels in the mice fed on high-
carotenoid corn (HCAR and NCAR) compared to their counterparts fed on wild-type 
corn, with the greatest difference observed between the HCAR group (12.84 ± 2.28 
ng/ml) and the HWT group (10.21 ± 36 ng/ml). Although the carotenoid-dependent 
differences were not statistically significant, the lower leptin levels in animals fed on 
the wild-type corn diets may reflect the lower number of adipocytes (and the absence 
of adipocyte atrophy) based on the data presented in Figure 3.3.7. 
 
Figure 3.3. 8. Western blot analysis of p44/42 MAPK expression in visceral adipose tissue. The histogram 
shows the expression levels normalized against tubulin, presented as values relative to the expression 
level in the NWT diet group. Differences were analyzed using Student’s t-test: *p<0.05 and **p<0.01;  a: 
statistically significant difference versus NWT group; c: statistically significant difference versus HWT 
group.  
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The expression of  p44/42 MAPK was evaluated by western blot to determine whether 
the MAPK signaling pathway was affected by the carotenoid-rich diets, given that this 
pathway initiates a transcriptional program that leads to cellular proliferation or 
differentiation (Saltiel and Kahn, 2001). There was a statistically significant 1.1-fold 
increase (p = 0.0062) in the HCAR group compared to the HWT group, indicating that 
the pathway may be modulated by the presence of carotenoids in the diet (Figure 
3.3.8).  
  
3.3.3.7. Oxidative damage assays 
 
Three assays were carried out to survey the degree of oxidative damage in the skeletal 
muscle, visceral adipose tissue and liver of mice from all four diet groups to determine 
if the antioxidant activity of carotenoids had a protective effect. The abundance of 
protein-reactive carbonyls was determined by western blot (based on the detection of 
carbonylated proteins) showing a significant increase in the skeletal muscle of mice 
fed on both hypercaloric diets compared to those fed on the corresponding 
normocaloric diets, but a significant (p = 0.0066) reduction in the livers of mice in 
the HCAR group compared to those in the HWT group (Figure 3.3.9). 
A malondialdehyde-lysine (MDAL) assay was carried out because MDAL is an end 
product of lipid peroxidation (Gaweł et al., 2004). There were no significant 
differences in skeletal muscle MDAL levels among the different diet groups, but the 
level of MDAL was significantly higher in the visceral adipose tissue of mice fed on 
the HCAR diet compared to the HWT diet group, suggesting that animals in the 
HCAR diet group were exposed to increased lipid oxidative stress (Figure 3.3.10). 
There were no significant differences among the four diet groups in terms of the 
abundance of ubiquitinylated proteins in skeletal muscle or adipose tissue, but 
mice fed on the HCAR diet showed significantly higher levels of ubiquitinylated 
proteins in the liver (Figure 3.3.11).  
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Figure 3.3. 9. Western blot analysis for protein reactive carbonyls (DNP) in skeletal muscle (Skl Msc) and 
liver. The histogram shows the expression levels normalized against Gallyas staining and quantified by 
densitometry. Differences were analyzed by Student’s t-test: *p < 0.05 and **p < 0.01; b: statistically 
significant difference versus NCAR group, c: statistically significant difference versus HWT group. 
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Figure 3.3. 10. Western blot analysis of MDAL in skeletal muscle (Skl Msc) and visceral adipose tissue 
(VAT) to show the level of lipoxidation. The histogram shows the expression levels normalized against 
Gallyas staining and quantified by densitometry. Differences were analyzed by Student’s t-test: *p < 
0.05; a: statistically significant difference versus NWT group; c: statistically significant difference versus 
HWT group. 
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Figure 3.3. 11. Western blot analysis of ubiquitinylated proteins (Ubiq) in skeletal muscle (Skl Msc), 
visceral adipose tissue (VAT) and liver. The histogram shows the expression levels normalized against 
Gallyas staining and quantified by densitometry. Differences were analyzed by Student’s t-test: *p < 
0.05; c: statistically significant difference versus HWT group. 
3.3.3.8. HPLC analysis of the liver and adipose tissue retinoid content 
The retinoid content of the liver and visceral adipose tissue in the four diet groups was 
determined by HPLC (Figure 3.3.12). It was not possible to measure specific carotenoid 
levels directly because the retention times overlapped. The livers of animals reared on 
the hypercaloric diets stored lower levels of retinoids (retinol and retinoic acid) than 
those reared on the normocaloric diets, indicating that the hypercaloric diets interfere 
with the hepatic storage of pro-vitamin A carotenoids. The visceral adipose tissue 
generally stored 10-fold lower levels of retinoids than the liver, but the visceral 
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adipose tissue of the NCAR diet group stored more than twice the amount of retinoic 
acid as in any other diet group.  
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Figure 3.3. 12. HPLC analysis of retinol and retinoic acid levels in the liver and visceral adipose tissue in 
all four diet groups. Results are shown as µM/g wet tissue. Differences were analyzed by Student’s t-
test: *p < 0.05 and **p < 0.01; a: statistically significant difference versus NWT group; b: statistically 
significant difference versus NCAR group. Retinoic acid and retinol levels were determined in n = 7 
(NWT), n = 7 (NCAR), n = 5 (HWT) and n = 6 (HCAR) animals. All values are presented as means ± SEM. 
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3.3.4. DISCUSSION  
 
The comparative impact of high-carotenoid and wild-type corn on energy homeostasis 
was evaluated using a mouse model of obesity and insulin resistance induced by the 
consumption of a hypercaloric diet. Normocaloric control groups based on each type 
of corn were also tested, yielding four different diet groups: HCAR, HWT, NCAR and 
NWT. 
Lipid-rich diets are known to modulate gene expression, hormone sensitivity and 
morphology in pre-existing adipocytes (Li et al., 2002). The hypercaloric diets 
administered to mice in our feeding trial contained threefold more lipids than the 
normocaloric diets resulting in a 1.25-fold increase in final body weight, a 1.6-fold 
increase in weight gain and a 1.8-fold increase in the weight gain/food intake ratio. 
There was a difference of just over 1 g in the mean final body weight of the HWT and 
HCAR diet groups, and although the difference was not significant it could nevertheless 
indicate that carotenoid-enriched corn can reduce weight gain in mice fed on high-fat 
diet, perhaps by affecting insulin sensitivity or perhaps through the modulation of 
adipose tissue responses. 
Tests for glucose tolerance and the glycemic response to insulin showed that the 
hypercaloric diet induced insulin resistance, but not aggressively, because the basal 
levels of glucose in both groups were similar (see Figure 3.3.1). However, following the 
injection of glucose and insulin, the mice in the normocaloric diet groups normalized 
the basal glucose levels more quickly than those in the hypercaloric diet groups. Mice 
fed on the HCAR diet recovered more quickly than those on the HWT diet reflecting 
the stronger induction of GLUT4, and they demonstrated improved insulin sensitivity 
and insulin-mediated uptake of glucose by skeletal muscle and adipose tissue 
compared to HWT mice. However, all mice on the hypercaloric diets presented with 
insulin resistance (hyperglycemia and hyperinsulinemia) compared to the normocaloric 
diet groups). The enhanced insulin sensitivity and glucose tolerance in the HCAR group 
correlated with the observed modulation of the lipid profile, which was characterized 
by a 1.2-fold increase in the relative amount of HDL cholesterol and a significantly 
lower LDL/HDL ratio. HDL cholesterol helps to prevent atherosclerotic vascular disease 
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(Barter et al., 2007), and may also promote glucose homeostasis and insulin sensitivity 
through its anti-inflammatory activity, by increasing glucose uptake and by stimulating 
pancreatic β-cell insulin secretion (Brunham et al., 2007; Fryirs et al., 2010; Drew et al., 
2012).  
The increase in adipose tissue mass in obese mice can be driven by increasing the 
number of adipocytes (hyperplasia) or the size of existing cells (hypertrophy). 
Comparison of total DNA and protein levels across groups showed a 1.8-fold increase 
in the amount of DNA and a 1.5-fold increase in the amount of protein in the adipose 
tissue of the HCAR group, strongly suggesting hyperplasia as the underlying 
mechanism even though the differences were not statistically significant. Moreover, 
the activation of MAPK kinase can phosphorylate transcription factors that promote 
cellular proliferation or differentiation (Saltiel and Kahn, 2001). The data from this 
study suggest that MAPKs were significantly upregulated in HCAR mice and could 
therefore induce cellular differentiation and proliferation in visceral adipose tissue. 
Adipose tissue growth is therefore likely to involve hyperplasia (adipogenesis) in which 
new adipocytes are recruited from precursor cells via the proliferation and 
differentiation of preadipocytes (Hausman et al., 2001). The induction of adipogenesis 
reflects the need to store excess calories and the formation of new cells is a safe way 
to adapt to this increased energy intake (Rosen and Spiegelman, 2014). 
The analysis of oxidative stress in skeletal muscle showed that high-carotenoid corn 
had no effect in this tissue, but MDAL levels were significantly higher in the HCAR 
group compared to the HWT group, suggesting a higher rate of lipid oxidation. 
Oxidative stress caused by exposure to hydrogen peroxide can directly modulate 
adipose cell differentiation (Schneider and Chan, 2013). The HCAR mice also showed a 
significant reduction in the level of oxidative damage in the liver (DNP assay) and 
significantly higher levels of ubiquitin-conjugated proteins compared to HWT mice, the 
latter indicating that any increase in oxidation damage was counteracted by 
endogenous repair processes. Levels of oxidation were similar between the 
normocaloric and hypercaloric groups indicating that the high-fat diet did not induce 
severe oxidative stress. However, further experiments are needed to determine 
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whether high-carotenoid corn has a specific impact on the regulation of oxidative 
stress. 
A higher calorific intake reduces the adenosine monophosphate: adenosine 
triphosphate (AMP:ATP) ratio (Kahn et al., 2005) by inhibiting AMPK, reflecting a feed-
forward effect of lipid overload (Liu et al., 2006; Martin et al., 2006; Wu et al., 2007). 
The significant increase of AMPK levels in hepatocytes could protect against 
hyperlipidemia and hepatic steatosis in this mouse model of diet-induced obesity and 
insulin resistance as previously reported (Li et al., 2011). There was a significant 
reduction in the level of AMPKα in the visceral adipose tissue of the HCAR diet group, 
showing that the key pathway controlling glucose and lipid uptake was downregulated 
in response to the high-fat diet, and suggesting that adipocytes remain functional and 
can incorporate fats when AMPKα levels are low, thus stimulating adipogenesis and 
increasing the activity of MAPK. The larger number of fatty cells means that adipose 
tissue avoids energy excess in the adipose tissue and allows the uptake of glucose 
(shown by GLUT4 results). The increased MAPK levels in HCAR mice suggests that 
these animals were able to respond to insulin signaling and regulate fundamental 
cellular functions including survival and cell differentiation (Eisenmann et al., 2003). 
Further investigations should be carried out to confirm the reduced AMPK signaling in 
HCAR mice i.e. by analyzing downstream targets such as PPAR-γ and SREBP (Li et al., 
2011; Yoon, 2011). 
The levels of retinoids in liver and adipose tissue were similar to those published in 
earlier studies (Kane et al., 2008; Kim et al., 2008). The elevation of retinoid levels in 
the normocaloric diet groups may reflect the lower intake of high-carotenoid corn in 
the hypercaloric groups, where the corn represented only 12% of the diet compared to 
45% in the normocaloric group.  
In conclusion, the high-carotenoid corn improved systemic glucose homeostasis and 
the LDL/HDL cholesterol ratio in obese mice by increasing the sensitivity of skeletal 
muscle and adipose tissue to circulating insulin, probably by inducing the expression of 
GLUT4. The increase in adipose tissue mass was explained by hyperplasia rather than 
hypertrophy (suggested by the increased DNA and protein levels) and adipogenesis 
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was stimulated by an increased level of MAPK signaling. It appears that carotenoids 
(and their conversion to retinal) could offer an alternative treatment for insulin 
resistance. A mouse model of obesity and insulin resistance induced by a high-fat diet 
was fed on high-carotenoid corn for 4 months with no changes in oxidative damage. 
However, further experiments are required to determine the precise impact of high-
carotenoid corn in this model.  
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CHAPTER 4 
Influence of a high-carotenoid corn diet on tumor development 
and risk parameters related to metabolic syndrome and insulin 
sensitivity in PTEN+/- mice 
3.4.1. INTRODUCTION 
 
PTEN (lipid and protein phosphatase and tensin homolog) is a tumor suppressor 
protein encoded by a gene on human chromosome 10. It plays an important role in the 
PI3K-AKT-mTOR signaling pathway, named after the components phosphatidylinositol-
3-kinase, Akt and mammalian target of rapamycin (Figure 3.4.1). The PTEN protein is a 
phosphoinositide phosphatase that antagonizes PI3K by dephosphorylating 
phosphatidylinositol trisphosphate PI(3,4,5)P3 to produce phosphatidylinositol 
bisphosphate PI(4,5)P2. PTEN opposes the activity of PI3K signaling upstream of the  
AKT-mTORC1 components of the pathway, which are implicated in the promotion of 
cancer and metabolic dysfunction (Maehama and Dixon, 1998; Myers et al., 1997).  
The phosphatase activity of PTEN regulates migration, apoptosis, cell cycle 
progression, transcription and translation (Stambolic et al., 1998; Yin and Shen, 2008). 
The mutation or loss of PTEN causes hyperactive PI3K signaling and this is thought to 
be the basis of several cancers (Carracedo et al., 2008). Germ-line mutations in the 
PTEN gene cause Cowden syndrome, a rare autosomal dominant disorder 
characterized by hamartomas of the skin (Liaw et al., 1997). Homozygous deletion or 
somatic mutations of PTEN have been described in several sporadic (nonhereditary) 
cancers such as glioblastoma (20–75%), endometrial cancer (34–50%), small-cell lung 
cancer (40%), prostatic cancer (10-49%), thyroid cancer, leukemia, lymphoma, breast 
cancer, colon cancer and anaplastic meningioma (Suzuki et al., 1998; Hollander et al., 
2011). Loss of heterozygosity or mutation at the PTEN locus increases in cases of 
advanced glioma and late-stage breast and prostate tumors (Suzuki et al., 1998).  
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Figure 3.4. 1. The PI3K-AKT-mTOR pathway and the role of PTEN. PI3K can be activated by the binding of 
growth factors to a receptor tyrosine kinase, whereupon P13K is recruited to the receptor complex. 
Activated PI3K converts PIP2 to PIP3, which subsequently phosphorylates Akt via phosphoinositide-
dependent kinase 1 (PDK1). Phosphorylated Akt acts on a large number of substrates, but one of its 
most important targets is mTOR, which controls cell growth, proliferation and survival. PTEN negatively 
regulates the pathway by removing the 3-phosphate from PIP3, converting it back to PIP2. Loss of PTEN 
leads to Akt hyperactivity, which in turn is linked to uncontrolled cell proliferation, inhibition of 
apoptosis and enhanced tumor angiogenesis. Adapted from Phin et al. (2013). 
 
Endometrial cancer is the most common malignancy of the female genital tract in 
Europe and North America (Murali et al., 2014). The PI3K/AKT pathway is activated by 
growth factors stimulated by the endometrial stromal cells in response to estrogen, 
boosting the levels of PIP3 and thus promoting the phosphorylation of AKT and in turn 
the activation of proteins that regulate survival, growth and cell proliferation (Joshi et 
al., 2012). The antagonistic activity of PTEN is an important gatekeeper role and its loss 
of function therefore results in the hyperactivation of the pathway, leading then to the 
development of endometrial hyperplasia and carcinoma (Joshi et al., 2012). PTEN+/- 
mice are heterozygous for a null PTEN allele and spontaneously develop complex
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hyperplasia at a higher rate than wild-type mice, with 20% progressing to endometrial 
cancer (Joshi et al., 2012). Loss of PTEN expression has also been reported in 20–40% 
of colorectal cancers (Naguib et al., 2011) and the frequency of loss and mutation 
increases as the disease progresses from normal colonic mucosa to adenoma, primary 
colorectal cancer and ultimately metastasis (Jang et al., 2010; Hocking et al., 2014). 
PTEN is not only involved in the PI3K signaling pathway as a tumor suppressor.  
Abnormal PTEN activity is also linked to the development of hepatic diseases related to 
obesity, including diabetes, hepatitis B and C, alcohol abuse, insulin resistance and 
hepatocellular carcinoma (Peyrou et al., 2010). 
In the liver, insulin activates PI3K signaling to promote lipid accumulation (He et al., 
2010). Because PTEN antagonizes the PI3K/AKT pathway, hepatic PTEN deficiency 
causes the liver to accumulate high levels of triglycerides even though there is systemic 
hypoglycemia in mice lacking PTEN activity in the liver, thus promoting insulin 
sensitivity (Stiles et al., 2004; Knobbe et al., 2008; He et al., 2010). Loss of PTEN activity 
also causes hepatic steatosis in mice, which is aggravated with increasing age (Horie et 
al., 2004; Stiles et al., 2004). A similar link has been found in humans (Vinciguerra et 
al., 2008). Fatty liver disease is attributed to the activation of genes involved in fatty 
acid and triglyceride synthesis (Horie et al., 2004). Upregulation of the transcription 
factor sterol regulatory element binding protein 1c (SREBP-1c) increases the uptake of 
free fatty acids into liver cells, and the upregulation of peroxisome proliferator-
activated receptor γ (PPARγ) promotes the generation of reactive oxygen species (ROS) 
and inflammatory cell infiltration (Ishii et al., 2009). The loss of PTEN activity not only 
affects liver homeostasis and insulin metabolism but also increases susceptibility to 
hepatic adenomas and hepatocellular carcinomas (Knobbe et al., 2008). The 
restoration of physiological PTEN activity in the liver could therefore help to prevent or 
reduce the incidence of non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, 
alcoholic liver disease, viral hepatitis, hepatic adenoma and hepatocellular carcinoma 
(Peyrou et al., 2010). 
The potential chemoprotective effect of carotenoids has been reported in the context 
of several liver disorders (Shimizu et al., 2011; Sugiura et al., 2006; Gradelet et al., 
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1998;  Chamberlain et al., 2009; Chung et al., 2012). Carotenoids also reduce the risk of 
several cancers, including colorectal cancer as discussed in Chapter 4 (Tanaka et al., 
2012). Carotenoids appear to inhibit estrogenic signaling in estrogen-dependent 
cancer cells, and to inhibit breast and endometrial cancer cell proliferation (Amir et al., 
1999; Nahum et al., 2001; Hirsch et al., 2007; Veprik et al., 2012). The aim of the work 
described in this chapter was to analyze the dietary effect of a high-carotenoid corn 
diet in PTEN+/- mice during a 36-week feeding trial. This model is genetically 
engineered mice to delete a single PTEN allele, because the loss of both alleles is 
embryonic lethal (Hollander et al., 2011). The experiments compared high-carotenoid 
corn and wild-type corn diets, focusing on the impact on colon, endometrium and liver 
tissues. 
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3.4.2. MATERIALS AND METHODS 
 
3.4.2.1.  Diets 
 
Experimental diets containing wild-type M37W corn or high-carotenoid corn (grown 
under the same conditions and harvested at the same time) were prepared from 
freeze-dried powdered kernels under hygienic conditions. Compositional analysis was 
carried out as described in Chapter 3. The feed was prepared by mixing the purified 
AIN-76A diet (Research Diets, Inc., New Brunswick, USA) with the appropriate freeze-
dried corn powder in a 60:40 (w/w) ratio. 
 
3.4.2.2.  Animal feeding study 
 
The study complied with Law 5/1995 and Act 214/1997 of the Autonomous 
Community (Generalitat of Catalonia) and EU Directive EEC 63/2010, and was 
approved by the Ethics Committee on Animal Experiments of the University of Lleida 
and the Ethics Commission in Animal Experimentation of the Generalitat de Catalunya. 
Female C57BL/6 PTEN+/- mice (B6.129-Ptentm1Rps) were obtained from the National 
Cancer Institute mouse repository (NCI, Frederick, MD, USA).  Mice were acclimated in 
individual cages 1 week before the experiment, with ad libitum access to a standard 
2014 Teklad Global 14% Protein Rodent Maintenance Diet (www.harlan.com) and 
water. The animal rooms were environmentally controlled  (20 ± 2°C, relative humidity 
50 ± 5%, 12-h photoperiod). 
Mice were genotyped by earmarking and DNA was isolated from tail tissue in 
proteinase K lysis buffer. PCR was carried out with GoTaq Polymerase (Promega, 
Madison, USA) using a common forward primer 5'-TTG CAC AGT ATC CTT TTG AAG-3' 
and the PTEN+/+ reverse primer 5'-GTC TCT GGT CCT TAC TTC-3'  or the PTEN+/- reverse 
primer 5'-ACG AGA CTA GTG AGA CGT GC-3'.  
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Following acclimation, 48 6-week-old female PTEN+/- mice and 10 6-week-old female 
PTEN+/+ mice were randomly assigned to the two diets, resulting in four groups: 
PTEN+/+ WT, PTEN+/+ CAR, PTEN+/- WT and PTEN+/- CAR. The mice were housed in cages 
(4–5 mice per cage) with ad libitum access to food and water as above. Body weight 
was measured weekly during the first month, every two weeks during the second 
month and monthly thereafter until the animals were 42 weeks old. Fresh food was 
supplied twice each week. 
 
3.4.2.3. Blood analysis and histopathology  
 
Fasted animal blood was collected from the submandibular vein under 4% isoflurane 
anesthesia 8 and 20 weeks after the start of the experiment. Blood was collected into 
an EDTA-coated tube and the plasma was separated by centrifugation at 1500 x g for 
10 min and stored at –80°C. At the end of the experiment (36 weeks) blood samples 
were taken by cardiac puncture under 4% isoflurane anesthesia. Whole blood was 
collected and separated as above. The glucose, total cholesterol, triglycerides, total 
protein, albumin, lactate and fructosamine concentrations were measured using 
commercial clinical chemistry kits (Spinreact, Girona, Spain). 
When the mice had been sacrificed, the organs were removed to determine the colon 
length (cecum, distal and proximal) and liver and spleen weights. Colons were excised, 
flushed with PBS, fixed in 10% neutral-buffered formalin and embedded in paraffin. 
Sections (4-5 µm) were stained with hematoxylin and eosin for histopathology. Uterus 
and liver tissue samples were also sectioned and stained as above for histopathology 
and the remaining samples were frozen in liquid nitrogen and stored at –80°C. Normal 
colon mucosa and colon tumors were analyzed for colon length (cm), tumor incidence 
(number of animals with tumors), tumor multiplicity (number of tumors per tumor-
bearing animal) and tumor size (mm2). The incidence of lymphoma was determined 
macroscopically. For lipid staining, frozen sections (10-20 µm) were stained with Oil 
Red O and counterstained with hematoxylin (see Section 3.4.5). Hepatic 
histopathology was carried out as described by Kleiner et al. (2005) and abnormalities 
were graded as none (0–5%), mild (5–33%), moderate (33–66%) or severe (> 66%). 
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3.4.2.4. Immunohistochemistry 
 
Uterine tissue was fixed embedded and sectioned as above, and the sections were 
dried for 16 h at 56°C, cleared in xylene, dehydrated through a graded ethanol series 
and washed in phosphate-buffered saline (PBS). The sections were heated in a 
pressure cooker for 2 min in 10 mmol/l citrate buffer (pH 6.5) or EDTA buffer (pH 8.0) 
to achieve antigen retrieval. Endogenous peroxidase activity was blocked by immersing 
the sections in hydrogen peroxide. The primary antibody was anti-PTEN (D4.3) XP (Cell 
Signaling Technology, Beverly, MA, USA) used at 1:200 dilution. After incubation, 
horseradish peroxidase activity was visualized using the EnVision Detection Kit (DAKO, 
Carpinteria, USA) with 3,3’-diaminobenzidine chromogen as the substrate. All sections 
were counterstained with hematoxylin. 
 
3.4.2.5. Oil Red O staining 
 
Oil Red O staining (Sigma-Aldrich, Munich, Germany) was used to measure lipid 
accumulation. Tissue was fixed in 10% formaldehyde, washed in PBS and stained with 
0.21% (w/v) Oil Red O solution (60% isopropanol, 40% water). The triacylglyceride 
content was determined after drying the cells and extracting the Oil Red O with 100% 
isopropanol followed by photometric measurement at 495 nm. 
 
3.4.2.6. Total RNA extraction and quantitative real-time PCR 
 
Total RNA was extracted from the uterine endometrium using the RNeasy Total RNA 
kit (Qiagen, Valencia, CA, USA) and cDNA was generated using the High Capacity cDNA 
Archive Kit (Applied Biosystems, Foster City, USA). The cDNA was amplified by heating 
to 95°C for 10 min, followed by 40 PCR cycles of 95°C for 15 s and 60°C for 1 min using 
the ABI Prism 7900 Sequence Detection System (Applied Biosystems) and Promega 
GoTaq® qPCR Master Mix (Madison, USA). Relative mRNA expression levels were 
calculated using the ∆∆Ct method and are presented as ratios to the housekeeping 
gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Primers were based on 
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the following GenBank sequences: TNF-α, Mm00443260_g1; Nfκb1, 
Mm00476361_m1; Nrf-2, Mm00477784_m1; GAPDH, Mm99999915_g1.  
 
3.4.2.7. Retinoid extraction 
 
Liver tissue (~100 mg wet weight) was lyophilized in a Telstar cryodos-50 for 20 h and 
the dried samples were ground to powder and pooled from all mice per group before 
vortexting with 200 µl 30% potassium hydroxide, 1 ml ethanol, 0.01% butylated 
hydroxytoluene in 100 µl of ethanol and 100 µl 20 µM apo-carotenal in ethanol 
(internal standard) and incubating at 37°C for 45 min. The samples were extracted 
three times with 3 ml ether:hexane (2:1, v:v), centrifuged at 13,000 x g for 5 min to 
separate the phases and evaporated to dryness under nitrogen. The powder was 
redissolved in 100 µl phase A buffer and passed through an Eppendorf UltraFree 5-kDa 
filter (UFC3LTK00, Millipore, Bedford, MA, USA).  
 
3.4.2.8. Retinoid identification and quantification by HPLC 
 
The processed samples were separated using a YMC C30 column (250 x 4.6 mm, 
internal diameter 3 µm) at 35°C in a 110 series HPLC system (Agilent Waldbronn, 
Germany) at a flow rate of 0.5 ml/min in 100% mobile phase A (methanol/acetone, 
60:40 v/v) 0–30 min. Retinol and retinoic acid were detected at 325 mm. 
 
3.4.2.9. Statistical analysis 
 
Values are presented as means ± standard errors of the mean (SEM). Data were 
compared using Student’s t-test or one-way ANOVA, with p < 0.05 considered as 
significant. Fisher’s Exact Probability test was used to compare the incidence of 
histopathological lesions between groups. 
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3.4.3. RESULTS  
 
3.4.3.1. Feeding experiments – general observations 
 
Two animals originally assigned to the PTEN+/- CAR group were reassigned to the 
PTEN+/+ CAR group following the discovery of a genotyping error. Two animals from the 
PTEN+/- CAR group died following blood extraction after failing to recover from 
anesthesia. Two animals each from the PTEN+/- WT and CAR groups were sacrificed 
when lymphoma tumors reached the ethical limit. The high-carotenoid corn diet did 
not produce any observable unexpected effects. 
 
3.4.3.2. Animal body weight and relative organ weights 
 
There were no significant differences in final body weights or relative spleen weights 
between the diet groups, but the relative liver weights were significantly lower in the 
PTEN+/- CAR group compared to the PTEN+/- WT group (Table 3.4.1).  
 
Table 3.4. 1.  Final body weights and relative organ weights in the four experimental diet groups. Values 
are means ± SEM and differences are significant* at p < 0.05. 
 
 PTEN+/+  
WT (n=5) 
PTEN+/+  
CAR (n=7) 
p value PTEN+/-  
WT (n=22) 
PTEN+/- 
CAR 
(n=18) 
p value 
Final 
body 
weight (g) 
23.25 ± 
0.80 
22.74 ± 
0.68 
0.6328 28.00 
±0.52 
28.36 ± 
0.52 
0.6304 
Relative 
liver 
weight 
(%) 
3.743 ± 
0.087 
3.752 ± 
0.116 
0.9593 4.939 ± 
0.174 
4.098 ± 
0.322* 
0.0207 
Relative 
spleen 
weight 
(%) 
0.3277 ± 
0.05752 
0.2880 ± 
0.03010 
0.5215 0.7809 ± 
0.1157 
0.5591 ± 
0.1395 
0.1202 
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3.4.3.3. Tumor incidence, multiplicity and histopathology in PTEN+/- mice 
 
PTEN+/- mice fed on the wild-type corn (PTEN+/- WT) showed a higher incidence of 
100% lymphoid tumors than those fed on the high-carotenoid corn (PTEN+/- CAR), but 
the tumor multiplicity was slightly lower in the PTEN+/- CAR group although the 
difference between diets was not statistically significant (Table 3.4.2). Similarly, the 
PTEN+/- WT group showed a higher incidence of colorectal tumors (52%) than the 
PTEN+/- CAR group (38%) but the differences were not significant. The multiplicity of 
colorectal tumors and the tumor area were similar in both groups (Figure 3.4.2). 
Finally, the PTEN+/- WT group showed a higher incidence of endometrial lesions (cystic 
hyperplasia, complex hyperplasia and carcinoma) than the PTEN+/- CAR group. 
However, there was no statistically significant relationship between the wild-type corn 
diet and the incidence of malignant endometrial lesions such as complex hyperplasia 
and carcinoma (Figure 3.4.3). The incidence of endometrial carcinoma was 9.5% in the 
PTEN+/- WT group and 0% in the PTEN+/- CAR group. The PTEN genotype of the 
endometrium (normal vs heterozygous) was confirmed by immunohistochemistry. 
 
Table 3.4. 2. Macroscopic observations and histopathology of PTEN
+/- 
mice in the WT and CAR diet 
groups.  The incidence of lymphomas, colorectal lesions and endometrial lesions is represented by the 
percentage of tumor-bearing animals. The multiplicity of lymphomas and colorectal tumors is 
represented by the mean number of tumors in tumor-bearing animals. The mean area of colorectal 
tumors was evaluated by necropsy. Normal endometrial appearance and mild cystic changes are not 
included in table data. Data show means ± SEM. 
 
Group Lymphomas Colorectal lesions Endometrial lesions 
 
Multiplici
ty/Incide
nce 
Multiplicit
y/Incidenc
e 
Area (mm) 
Cystic 
hyperplasi
a 
Complex 
hyperplasi
a 
Carcinom
a 
PTEN+/- 
WT 
n=22 
3.273 ± 
0.3430 
(100%) 
1.67 ± 
0.28 
(52.2%) 
0.5125 ± 
0.167 
52.4% 19% 9.5% 
PTEN+/-
CAR 
n=18 
2.667 ± 
0.2801 
(100%) 
1.14 ± 
0.14 
(38.8%) 
0.6214 ± 
0.3489 
50% 16.7% - 
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Figure 3.4. 2. Representative histopathology of colonic tissue sections stained with hematoxylin and 
eosin, and the percentage of animals with histopathological findings, i.e. follicular hyperplasia and 
adenoma. (A) and (D) represent normal colonic mucosa, (B) and (E) represent follicular hyperplasia, and 
(C) represents adenoma. The incidence of animals presenting these colonic findings (follicular 
hyperplasia and adenomas) analyzed by histopathology was n = 7 in the PTEN
+/- 
WT group and n = 5 in 
the PTEN
+/-
 CAR group. Magnification = 20x. 
 
The vast majority of lesions in the colonic mucosa were classed as follicular hyperplasia 
(71% in the PTEN+/- WT group and 100% in the PTEN+/- CAR group) whereas 29% of the 
PTEN+/- WT group progressed to adenoma, which is considered a pre-malignant 
neoplasm (Figure 3.4.2). 
 
Figure 3.4. 3. Representative histopathology of uterine endometrium sections stained with hematoxylin 
and eosin. (A) and (E) represent normal endometrium, (B) and (G) represent cystic hyperplasia, (C) and 
(H) represent complex hyperplasia, (D) represents carcinoma and (F) represents mild cystic changes. 
Magnification = 20x. 
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Furthermore, 19% of the PTEN+/- WT group presented lesions classed as complex 
hyperplasia and 52% presented lesions classed as cystic hyperplasia. These data 
suggested that mice in the PTEN+/- WT group tended more towards the advanced 
stages of the disease compared to the PTEN+/- CAR group, in which none of the animals 
developed endometrial carcinomas, only 17% presented lesions classed as complex 
hyperplasia and 50% presented lesions classed as cystic hyperplasia (Figure 3.4.3). 
 
3.4.3.4. Histological evaluation of the liver 
 
Histological evaluation of the liver (Figure 3.4.4) showed that 20% of the PTEN+/+ WT 
group and 17% of the PTEN+/+ CAR group presented with mild steatosis (5–33%), 
whereas 18% of the PTEN+/- WT group presented with moderate steatosis (33–66%) 
and an additional 14% with mild steatosis. In the PTEN+/- CAR group, there were no 
animals with moderate steatosis, 28% with mild steatosis and 72% with no steatosis 
(0–5%). There was a significant correlation (p = 0.0486) between the high-carotenoid 
corn diet and the absence of steatosis, and between the wild-type corn diet and the 
presence of mild to moderate steatosis. Oil Red O staining was also used to support 
the analysis of hepatic lipid content. 
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Figure 3.4. 4. Representative histopathology of liver sections stained with hematoxylin and eosin, with 
liver steatosis graded as described by Kleiner et al. (2005): none = 0–5%; mild = 5–33%, moderate = 33–
66%. (A) and (D) represent no steatosis, (B) and (E) represent mild steatosis, and (C) represents 
moderate steatosis. Lower magnification (x10) and higher (x40). Histogram shows the percentage of 
animals in each liver steatosis grade. The incidence of mild and moderate steatosis was 7/22 (32%) 
animals in the PTEN
+/-
 WT group and 5/18 (28%) animals in the PTEN
+/-
 CAR group.  
 
3.4.3.5. Biochemical analysis 
 
The significant correlation between the different diets and the prevalence of steatosis 
in PTEN+/- mice was investigated by studying the lipid profile and other biochemical 
parameters in blood drawn from mice in each of the diet groups. The accumulation of 
fatty acids in the liver could reflect the increased uptake of fatty acid by liver cells or a 
higher rate of de novo lipogenesis (Stahl et al., 2001). Furthermore, fasting glucose and 
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fructosamine levels were monitored due to the improved glucose tolerance observed 
in mice with a liver-specific PTEN+/- genotype (Stiles et al., 2004, Horie et al., 2004). 
The fructosamine and glucose levels were significantly higher (p < 0.05) in the PTEN+/- 
CAR group compared to the PTEN+/- WT group (Figure 3.4.5 and Figure 3.4.6). The 
fructosamine levels in the PTEN+/- WT group were also significantly lower than in the 
PTEN+/+ WT group (p = 0.0327). 
Total plasma cholesterol was lower in both PTEN+/- and PTEN+/+ mice fed on the high-
carotenoid corn diet compared with their counterparts fed on wild-type corn. There 
were no significant differences in plasma triglycerides suggesting that the loss of one 
PTEN allele does not change the systemic levels of triglycerides because of hepatic 
fatty acid secretion and synthesis.  
Total protein and albumin levels were measured to confirm that the changes in 
fructosamine levels (which indicate the levels of glycated proteins) did not reflect a 
general loss of liver function. No significant differences were observed between the 
diet groups (Figure 3.4.6) confirming that the observed differences in fructosamine 
levels were due to underlying changes in the abundance of glucose. 
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Figure 3.4. 5. Total cholesterol, lactate, fasting glucose and triglyceride levels in the blood of mice from 
the four different diet groups. Differences are significant according to Student’s t-test at *p < 0.05 ***p < 
0.001; a - statistically significant difference versus PTEN
+/+ 
WT group; c - statistically significant difference 
versus PTEN
+/-
 WT group. Total cholesterol levels were analyzed in n = 5 PTEN
+/+ 
WT, n = 7 PTEN
+/+
 CAR, n 
= 20  PTEN
+/-
 WT and n = 13 in PTEN
+/-
 CAR mice. Glucose was analyzed in overnight fasted mice (n = 4 
PTEN
+/+ 
WT, n = 7 PTEN
+/+
 CAR, n = 13 PTEN
+/-
 WT and n = 16 PTEN
+/-
 CAR) and lactate and triglycerides 
were analyzed also in fasted animals (n = 4 PTEN
+/+ 
WT, n = 7 PTEN
+/+
 CAR, n = 13 PTEN
+/-
 WT and n = 12 
PTEN
+/-
 CAR). The remaining samples were not analyzed because there was insufficient blood. All values 
are presented as means ± SEM. 
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Figure 3.4. 6. Fructosamine, albumin and total protein levels. Differences are significant according to 
Student’s t-test at *p < 0.05; a - statistically significant difference versus PTEN
+/+ 
WT group; c - 
statistically significant difference versus PTEN
+/-
 WT group. Fructosamine, albumin and total protein 
levels were analyzed in n = 5 PTEN
+/+ 
WT, n = 7 PTEN
+/+
 CAR, n = 20 PTEN
+/-
 WT and n = 18 PTEN
+/-
 CAR 
mice. The remaining samples were not analyzed because there was insufficient blood. All values are 
presented as means ± SEM. 
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3.4.3.6. Quantitative real-time PCR 
 
The expression levels of TNFα, NF-B and Nrf-2 (key markers of inflammation) showed 
no significant differences between the PTEN+/- WT and PTEN+/- CAR groups. There was 
also a large background variation in expression levels between animals in the same 
group. 
 
3.4.3.7. Retinol and retinoic acid levels in liver tissue 
 
PTEN+/- mice fed on the high-carotenoid corn diet showed a significant increase in the 
levels of hepatic retinol (p = 0.0010) and retinoic acid (p = 0.0229) compared to the 
PTEN+/- WT group (Figure 3.4.7).  PTEN +/+ mice fed on the high-carotenoid corn diet 
also showed a significant increase in the levels of hepatic retinol (p = 0.0277) 
compared to the PTEN +/+ WT group, but there was no significant difference in liver 
retinoic acid levels between the PTEN +/+ CAR and WT groups. The levels of retinol and 
retinoic acid in the PTEN +/- WT group were very low and differed significantly from all 
three other groups. 
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Figure 3.4. 7. Levels of hepatic retinol and retinoic acid determined by HPLC.  Differences are significant 
according to Student’s t-test at *p < 0.05 and **p < 0.01; a - statistically significant differences versus 
PTEN
+/+ 
WT group; b - statistically significant differences versus PTEN
+/+ 
CAR group; c - statistically 
significant differences versus PTEN
+/-
 WT group.
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3.4.4. DISCUSSION 
 
The feeding trial described in this chapter compared the effects of a diet 
supplemented with genetically-engineered high-carotenoid corn and a diet 
supplemented with a near-isogenic wild-type variety on PTEN+/- and PTEN+/+ mice over 
36 weeks. The heterozygous PTEN+/- knockout model has been used to study diverse 
organ neoplasias (Suzuki et al., 1998; Podsypanina et al., 1999) although in this study, 
the analysis was restricted to the liver, colon and endometrial tissue (Viñas-Salas et al., 
1992; Viñas-Salas et al., 1998; Llobet et al., 2009; Mirantes et al., 2013). Previous 
studies have indicated that carotenoids may protect against endometrial 
carcinogenesis by inhibiting estrogen signaling (Hirsch et al., 2007) or by inhibiting cell 
cycle progression (Nahum et al., 2001). PTEN also plays a role in the development of 
hepatic disorders such as insulin resistance and steatosis, so PTEN+/- and PTEN+/+ mice 
reared on the two diets were also investigated in terms of markers of liver disease. 
There was a statistically significant relationship between the wild-type corn diet and 
the progression of colorectal cancer, with the most severe form (colorectal adenoma) 
occurring only in the PTEN+/- WT group. The most severe endometrial pathology 
(endometrial complex hyperplasia and carcinoma) was also 1.65-fold more prevalent 
in the PTEN+/- WT group, although this difference was not statistically significant. A 
100% incidence of endometrial hyperplasia (both cystic and complex types) was not 
observed in all PTEN+/- females, in contrast to previous studies (Podsypanina et al., 
1999; Stambolic et al., 2000). However, the incidence of endometrial hyperplasia and 
carcinoma was higher in PTEN+/- mice fed on wild-type corn (81%) than those fed on 
the high-carotenoid variety (67%). 
Several studies have demonstrated that carotenoids inhibit colorectal and endometrial 
cancer, based on in vivo data (Tao et al., 2005; Pelucchi et al., 2008) and experiments 
with endometrial cancer cells (Nahum et al., 2001; Hirsch et al., 2007). Carotenoids can 
inhibit estradiol signaling in mammals and genistein signaling in plants, suggesting a 
general inhibitory role in the estrogen pathway. However, carotenoids are not among 
the substances which have been tested in PTEN+/- mice to determine their effects on 
endometrial hyperplasia (Begum et al., 2006; Wu et al., 2008; Yu et al., 2010). The 
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results presented in this chapter suggest that the high-carotenoid corn variety inhibits 
the development and progression of colon and endometrial tumors. 
In addition to its impact on colorectal and endometrial carcinogenesis, the high-
carotenoid corn variety also has a beneficial impact on hepatic disorders. The relative 
liver weights of the PTEN+/- mice were higher than those in the corresponding PTEN+/+ 
diet groups confirming that PTEN deficiency causes hepatomegaly as previously 
reported (Butler et al., 2002; Horie et al., 2004). However, the liver weights of PTEN+/- 
mice fed on the high-carotenoid corn diet were closer to those of the PTEN+/+ mice and 
significantly lower than the liver weights of PTEN+/- mice fed on wild-type corn. PTEN 
deficiency also induces steatosis, steatohepatitis and hepatocellular carcinoma (Horie 
et al., 2004; Stiles et al., 2004; Vinciguerra et al., 2008). Accordingly, the feeding trial 
showed that liver steatosis was more severe in PTEN+/- mice fed on wild-type corn 
(18% of animals showed moderate steatosis) than in those fed on the high-carotenoid 
corn, where all the animals showed either mild steatosis or the complete absence of 
steatosis. This suggests that the high-carotenoid corn reduces hepatic triglyceride 
deposition, which could be caused by elevated circulating free fatty acids and their 
incorporation into the liver, as well as factors such as the inhibition of lipid β-oxidation 
and enhanced de novo lipogenesis (Musso et al., 2009). Blood glucose and 
fructosamine levels were higher in the PTEN+/- CAR group than the PTEN+/- WT group, 
and were similar to the fasting glucose and fructosamine levels in PTEN+/+ mice. This 
suggested that only PTEN+/- mice fed on the wild-type corn diet showed increased 
glucose tolerance. Fructosamine levels were lower in PTEN+/- mice fed on the wild-type 
corn diet compared with PTEN+/+ mice on the same diet. The observed increase in 
insulin sensitivity confirm the results of several previous studies (Wong et al., 2007; Pal 
et al., 2012).  
Biochemical analysis also indicated that the high-carotenoid corn reduced total plasma 
cholesterol levels as revealed by other carotenoid feeding experiments (Palozza et al., 
2011; Choi et al., 2013; Harari et al., 2013). Hepatic steatosis involves an inflammatory 
response and oxidative stress, hyperinsulinemia, hyperleptinemia and abnormal 
cholesterol loading (Takahashi, 2012). However, the total cholesterol levels in PTEN+/- 
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and PTEN+/+ mice were similar suggesting that the steatosis was mild and not 
accompanied by severe inflammation, supporting the histopathological data. 
Further experiments, including the measurement of insulin, would confirm the 
enhanced glucose tolerance and insulin hypersensitivity of PTEN+/- mice feeding on 
wild-type corn and would demonstrate any differences with the same mice on feeding 
on the high-carotenoid variety. The PI3K-PKB-Akt pathway is activated by insulin 
signaling, so PTEN deficiency is accompanied by the loss of inhibition of the PI3k 
signaling pathway which is indispensable for the transduction of insulin signals in 
insulin-responsive adipose, muscle and hepatic tissues (Guenzl et al., 2013)  
Furthermore,  the analysis of nonesterified fatty acids, leptin, adiponectin and liver 
triglycerides (Stiles et al., 2004) would show whether the PTEN+/- genotype would be a 
useful replacement for the liver-specific PTEN-deficient mice as a model for non-
alcoholic steatohepatitis or hepatic steatosis. 
The improved glucose tolerance of mice in the PTEN +/- WT group could reduce blood 
glucose levels and promote glucose uptake by the liver. In addition, enhanced insulin 
signaling in the liver may help to redistribute body fat from adipose tissue to the liver 
as previously described (Stiles et al., 2004). The liver could then use the glucose for 
lipogenesis and triglyceride storage, leading to hepatic steatosis and steatohepatitis as 
the liver is sacrificed to maintain glucose control (Stiles et al., 2004; Qiu et al., 2008). 
However, high-carotenoid corn helps to reverse the PTEN-deficiency effects because 
animals in the PTEN+/- CAR group exhibited glucose levels similar to PTEN+/+ mice, 
developed less severe steatosis and had lower relative liver weights than animals in 
the PTEN+/- WT group. High-carotenoid corn provides an important source of vitamin A 
through the conversion of three provitamin A carotenoids (β-carotene, α-carotene and 
β-cryptoxanthin) into active forms of vitamin A such as retinol, retinal and retinoic acid 
(Harrison, 2005). The levels of liver retinol and retinoic acid were higher in PTEN+/- 
mice fed on the high-carotenoid corn compared to those fed on wild-type corn. The 
levels of retinoids in all groups were similar to those previously reported (Kane et al., 
2008; Kim et al., 2008) and also similar to the levels reported in Chapter 3 5, although 
retinol was slightly more abundant in the PTEN+/+ CAR mice compared to the 
normocaloric CAR mice discussed in that chapter.  
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Retinoids not only play an important role in liver metabolism but also in glucose and 
lipid metabolism (Chen, 2013). The asymmetric cleavage of β-carotene can produce 
apocarotenals such as β-apo-14'-apocarotenal, which has the ability to inhibit the 
activities of the peroxisome proliferator-activated receptors PPARγ and PPARα, and 
also the retinoid X receptors (RXRs), which are important regulators of transcription 
(Ziouzenkova et al., 2007). All three of these regulators are induced in PTEN-deficient 
mice and contribute to hepatic steatosis and to the activation of genes involved in 
fatty acid oxidation, which could cause oxidative stress and inflammation in the liver 
(Desvergne and Wahli, 1999; Browning and Horton, 2004). The PPARγ gene is activated 
by SREBP-1c, which is also strongly expressed in PTEN-deficient mice because insulin-
mediated activation of the PI3/Akt pathway acts on the same target, and it may be 
inhibited by AMPK (Browning and Horton, 2004; Horie et al., 2004; Piguet et al., 2010). 
Interestingly, the accumulation of lutein and zeaxanthin in the liver can lead to the 
activation of AMPK thus preventing hepatic steatosis in mice (Lin et al., 2014). In this 
last study, adding wolfberry to a high-fat diet showed increased the hepatic levels of 
lutein and zeaxanthin and the subsequent activation of AMPKα, which in turn activated 
lipid β-oxidation and secretion (i.e. PPARα) and other signaling pathways resulting in 
the prevention of hepatic steatosis (Lin et al., 2014). The diet-induced obesity and 
insulin resistance mouse model described in Chapter 3 showed a significant increase in 
hepatic AMPK levels when fed on high-carotenoid corn, so this variety appears not 
only to reduce the progression of endometrial and colorectal cancer, but also to 
reduce the risk of hepatic steatosis in PTEN+/- mice, improve glucose homeostasis and 
regulate insulin sensitivity. Further experiments are needed to determine the 
molecular mechanisms underlying this phenomenon and the potential role of 
carotenoids and their metabolic products (retinoids and apocarotenals) in the 
regulation of PPAR, RXR, AMPK and SREBP-1c signaling. 
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4. GENERAL DISCUSSION 
 
The work described in this thesis links two major global challenges: undernutrition and 
overnutrition, both of which can be described as types of malnutrition. Although it may 
seem paradoxical to consider these opposite conditions under one umbrella, they are 
united by a common basis – the inability to achieve a balanced and healthy diet that 
provides adequate nutrition (Shetty, 2006). One of the consequences of malnutrition is 
a higher risk of chronic disease. For example, overnutrition leads to obesity, increasing 
the risk of cancer, insulin resistance, diabetes, nonalcoholic fatty liver disease and 
metabolic disease, which affect many people and cause millions of deaths globally 
every year.  
The consequences of malnutrition are major concerns not only in developing countries 
but also in industrialized countries, where undernourishment and obesity are both 
increasing in prevalence. High-carotenoid corn is a biofortified staple that can help to 
address undernourishment in developing countries (Berman et al., 2013). However, 
the high content of carotenoids embedded in the corn matrix may also provide 
additional health-promoting effects that counteract the diseases listed above. This 
hypothesis can be tested by using the high-carotenoid corn and its near isogenic wild-
type comparator (which was transformed to generate the enriched variety) in head-to-
head feeding trials using the same animal models of chronic disease. This approach can 
also be used to compare the effects of carotenoids added as supplements to those 
integrated in the corn matrix, which might affect both their bioaccessibility (the 
amount released from the food in the gut, i.e. the amount with the potential to be 
absorbed) and their bioavailability (the amount which actually is taken up and either 
stored or metabolized). The bioavailability of a nutrient depends on its bioaccessibility 
and it is likely that the latter is affected by how the nutrient is presented – i.e. as a 
supplement or as a complex with other components of the plant matrix, such as 
dietary fibers (Palafox-Carlos et al., 2011).  
Carotenoids are lipophilic molecules, so bioavailability depends on their efficient 
release from the food matrix by digestive enzymes and subsequent solubilization by 
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bile acids. This results in the formation of micelles and solubilized free carotenoids 
(Palafox-Carlos et al., 2011). For example, soluble dietary fibers (the indigestible 
components of plant cell walls) may attenuate the absorption of dietary lipids in the 
gut and could therefore also inhibit the absorption of carotenoids (Rock et al., 1998). 
There is little data concerning the bioavailability of dietary fats and carotenoids 
contained in the food matrix (Palafox-Carlos et al., 2011). In most animal studies, 
carotenoid supplements have been added to standard diets, e.g. carotenoids isolated 
from plants or algae or synthetic commercial carotenoid powders (Kim et al., 1998; 
Narisawa et al., 1999; Tanaka et al., 2008; Kawabata et al., 2012). In other studies, 
animals disease models have been fed on standard diets supplemented with 
carotenoid-rich foods such as tomato to investigate the impact of carotenoids and 
other antioxidants contained in the food matrix (Pannellini et al., 2010; Tanaka et al., 
2012). The carotenoid-rich corn can be analyzed in the same comparative manner 
using the wild-type corn variety as a comparator, but because it is a novel corn variety 
the first priority is to evaluate its safety as an ingredient.  
To monitor for unintended effects, a whole-food 90-day subchronic toxicity study in 
mice was carried out using one dose of feed, a 40:60 mixture of powdered high-
carotenoid corn with a standard diet. No other doses were tested because only a 
limited quantity of transgenic maize seeds was available at the time, although different 
doses are recommended by EFSA (EFSA, 2011a). This was the first animal feeding trial 
involving high-carotenoid transgenic corn and it provided information about 
palatability as well as safety. The corn was palatable, thereby avoiding the need to 
feed the mice by oral gavage, and the results confirmed that the high-carotenoid corn 
was as safe as its unmodified counterpart.  
This initial toxicity assessment was the first step towards the eventual deregulation of 
high-carotenoid corn as a new genetically-engineered crop aiming to address hunger 
and malnutrition in developing countries. Laboratory animals are needed to evaluate 
novel foods for any unintended negative effects (safety assessment) but can also be 
used to investigate potential beneficial effects, such as nutritional enhancement and 
protection against chronic diseases (Argilés, 2005; Key, 2011; Kalupahana et al., 2012). 
4. GENERAL DISCUSSION 
 
167 
 
The effect of a high-carotenoid corn was tested on the mouse AOM/DSS model of 
colitis-associated cancer, using rigid colonoscopy during the trial and gross necropsy, 
histopathology and molecular analysis at its conclusion. The data showed that high-
carotenoid corn has a chemoprotective effect and delays the progression of the 
disease from colitis to the development of adenocarcinomas, although the differences 
in values in some of the comparisons failed to reach the threshold for statistical 
significance because there was a degree of background variability in the model itself. 
Similar conclusions can be drawn about the ability of high-carotenoid corn to prevent 
the formation of colon adenomas in the PTEN+/- mouse model. Both models therefore 
confirmed a trend towards chemoprotective activity, and it is likely that larger-scale 
studies with more animals would confirm a statistically significant difference. The high-
carotenoid corn also delayed the development and progression of endometrial cancer. 
The high-carotenoid corn was also fed to mice maintained on a high-fat diet to induce 
obesity and insulin resistance, thus testing its ability to prevent or ameliorate the 
symptoms of this disease. The high-carotenoid corn improved systemic glucose 
homeostasis and promoted higher insulin sensitivity than wild-type corn. In the PTEN+/- 
model of fatty liver disease and insulin hypersensitivity, the high-carotenoid corn also 
reduced the incidence and severity of hepatic steatosis. As was the case for the 
AOM/DSS model, some of the observed differences were not statistically significant, 
but there was a distinct trend showing that high-carotenoid corn has health-promoting 
effects and reduces risk parameters related to metabolic syndrome, such as total 
cholesterol, the LDL/HDL ratio and insulin resistance. 
The work described in this thesis evaluated the effects of feeding a novel, carotenoid-
enriched corn (compared to a wild-type variety lacking these carotenoids) to mouse 
models of diseases that affect millions of people. Although further investigations are 
required with larger numbers of animals to define the beneficial effects more clearly, 
the data strongly suggest that high-carotenoid corn is beneficial in a number of 
pathological scenarios and should be tested in humans not only to address 
malnutrition in developing countries but also for the development of ‘functional foods’ 
with health-promoting effects. The high-carotenoid corn could also be used as the 
basis for further studies that compare the benefits of carotenoid supplements with 
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carotenoids produced as part of the food matrix, and the potential synergic effects of 
multiple carotenoids present in the same food.  
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5. CONCLUSIONS 
1. High-carotenoid corn did not exhibit any unintended effects towards 
experimental animals and it was shown to be as safe as its conventional 
counterpart. 
 
2. High-carotenoid corn delayed the progression of pre-neoplasms to malignant 
neoplasms in an induced AOM/DSS colitis-associated carcinogenesis murine 
model . 
 
3. In animals fed with high-carotenoid corn inhibition of MAPK signaling appeared 
to mediate COX-2 down-regulation in non-lesional colonic mucosa in the 
AOM/DSS model. 
 
4. High-carotenoid corn diets improved systemic glucose homeostasis and insulin 
sensitivity through increased GLUT4 expression in adipose tissue and skeletal 
muscle in a high-fat diet induced obesity and insulin resistance mouse model. 
 
5. Hypercaloric feed diets induced glucose intolerance and insulin resistance in 
mice. Glucose tolerance assessments revealed a faster recovery of blood 
glucose basal levels in animals fed on a fat diet enriched with high-carotenoid 
corn. 
 
6. High-carotenoid enriched fat diets modulated the lipid profile in mice by 
increasing HDL cholesterol and lowering LDL/HDL cholesterol ratios. 
 
7. An increase in adipose tissue cell number was observed through total DNA and 
protein quantification which suggests that it increase by hyperplasia rather 
than by hypertrophy in animals fed on a fat diet enriched on high-carotenoid 
corn. 
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8. The increased adipogenesis can be related to the increase of MAPK through an 
increase of insulin signaling in animals fed on a fat diet enriched on high-
carotenoid corn. 
 
9. Increases in adipose tissue cell numbers were attributed to increased content 
of retinoids (retinol and retinoic acid) in animals fed on a fat diet enriched with 
high-carotenoid corn. 
 
10. High-carotenoid corn exhibited a protective effect towards the development of 
colon and endometrial carcinogenesis in PTEN +/- mice. 
 
11. High-carotenoid corn reduced hepatic steatosis and improved liver metabolism 
by decreasing insulin hypersensitivity in PTEN +/- mice. 
 
12. Pro-vitamin A carotenoids in high-carotenoid corn increased hepatic vitamin A 
reserves in PTEN +/- mice.  
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